Clinical Trials - NVO

NCT IDTitleStatusPhasesStart DateCompletion DatePrimary Completion Date
NCT07214870A Research Study of a Potential New Medicine (NNC4005-0001) for Liver Disease in Adult Participants With Increased Body Weight and Liver FatNOT_YET_RECRUITINGPHASE12025-10-072027-05-142027-05-14
NCT07184632A Research Study on How Well Different Doses of the Medicine NNC0662-0419 Help People Living With Overweight or ObesityNOT_YET_RECRUITINGPHASE22025-10-012026-12-012026-12-01
NCT07184086A Study to See How Metabolism is Influenced by Weight Loss Due to Intervention With Cagrilintide and Semaglutide Compared to DietRECRUITINGPHASE12025-09-262027-10-122027-10-12
NCT07207811CLEOPATTRA: A Research Study to Look at the Effects of Treatment With a Medicine Called Coramitug (NNC6019-0001) in People With Heart Failure Due to Transthyretin Amyloid (ATTR) AmyloidosisNOT_YET_RECRUITINGPHASE32025-09-262029-06-292029-06-29
NCT07157423A Research Study to See How Safe is Eptacog Alfa When Used to Stop Heavy Bleeding in Women After Giving Birth in IndiaRECRUITINGPHASE42025-08-262027-03-262027-03-26
NCT07112339A Research Study to See How Well Weekly Insulin Icodec Maintains Blood Sugar Levels Compared to Daily Basal Insulins in Adults With Type 2 DiabetesRECRUITINGPHASE42025-08-152028-08-312026-08-04
NCT07076199A Research Study to See How a Weekly Insulin, Insulin Icodec, Helps in Reducing the Blood Sugar Compared to Daily Insulin Glargine, Both in Combination With Insulin Aspart, in Adults With Type 1 DiabetesRECRUITINGPHASE32025-08-112026-12-282026-11-23
NCT07121153A Research Study on How NNC0487-0111, a New Medicine, Works in Chinese Participants When Injected Under the Skin.RECRUITINGPHASE12025-08-112026-01-112026-01-11
NCT07153172Safety Follow-up Study of Participants Dosed With INV-347 in Study INV-CL-108RECRUITINGPHASE12025-08-062027-09-152027-09-15
NCT07101783A Research Study on How a Dose of NNC0662-0419 Works in Japanese, Chinese and Non-Asian Participants Living With Overweight or ObesityRECRUITINGPHASE12025-08-012025-11-022025-11-02
NCT07068295A Study to Test How Insulin NNC0471-0119 H Works in the Body in Participants With Type 2 Diabetes When Given by an Insulin PumpRECRUITINGPHASE12025-07-112026-01-122026-01-12
NCT07087795A Study to See the Effect of NNC0194-0499 Alone or in Combination With Semaglutide on Blood Sugar Control in People Living With Type 1 DiabetesRECRUITINGPHASE12025-07-012026-09-252026-09-12
NCT06979375A Research Study Comparing CDR132L With Placebo on the Structure and Function of the Heart in People With Heart Failure With Reduced/Mildly Reduced Ejection Fraction and Left Ventricular HypertrophyRECRUITINGPHASE22025-06-302028-01-232027-05-16
NCT06979362A Research Study Comparing Different Doses of CDR132L With Placebo on the Structure and Function of the Heart in People With Heart Failure With Preserved Ejection Fraction and Left Ventricular HypertrophyRECRUITINGPHASE22025-06-272028-01-232027-05-16
NCT07029568A Study to See How Safe a New Medicine (NNC0705-0001) is in Healthy PeopleRECRUITINGPHASE12025-06-132026-07-222026-07-22
NCT07010432The Role of the Amylin Analogue Cagrilintide in Bone MetabolismRECRUITINGPHASE12025-06-122028-05-032028-05-03
NCT07023029A Study on the Effect of Etavopivat on Heart Rhythm in Healthy ParticipantsCOMPLETEDPHASE12025-06-092025-09-152025-09-12
NCT07011667A Research Study to Look at How Well CagriSema Helps People Living With Obesity Lose Weight and Maintain Weight Loss in the Long-termACTIVE_NOT_RECRUITINGPHASE32025-06-032028-11-012026-12-15
NCT07004322A Research Study of the New Medicine NNC0519-0130 in Male Chinese Participants Living With Excess Body WeightRECRUITINGPHASE12025-05-262026-04-072026-04-07
NCT06855563Cities for Better Health Childhood Obesity Prevention InitiativeRECRUITINGNA2025-04-302027-12-312027-12-31
NCT06891365Multiple Dose Study for a New Medication to Potentially Treat Liver DiseasesRECRUITINGPHASE12025-03-122027-01-252027-01-25
NCT06612268A Study to Evaluate How Well Etavopivat Works in People With Sickle Cell DiseaseRECRUITINGPHASE32025-02-172028-09-222027-08-27
NCT06780449A Research Study to Look Into the Long-term Effect on Weight Loss of CagriSema in People With ObesityRECRUITINGPHASE32025-02-102028-11-172028-08-28
NCT06820476A Research Study on How NNC0487-0111, a New Medicine, Works in Chinese Participants After 10 Days of Oral DosingCOMPLETEDPHASE12025-02-092025-05-142025-05-14
NCT06813924A Research Study of the Effect of Etavopivat on Other Drugs in Healthy ParticipantsCOMPLETEDPHASE12025-02-062025-05-272025-05-27
NCT06809621A Study to Test How Insulin NNC0471-0119 H Works in the Body in Participants With Type 1 Diabetes When Given by an Insulin PumpCOMPLETEDPHASE12025-01-292025-07-282025-07-16
NCT06797869A Research Study to Investigate the Effects of CagriSema Compared to Placebo in People With Type 2 Diabetes and Painful Diabetic Peripheral NeuropathyRECRUITINGPHASE22025-01-292026-08-212026-08-21
NCT06609226A Research Study Looking at Long-term Treatment With Etavopivat in People With Sickle Cell Disease or ThalassaemiaRECRUITINGPHASE32025-01-102030-12-302030-12-30
NCT06737536A First-in-human Research Study on How NNC0662-0419 Works in People Living With Overweight or ObesityCOMPLETEDPHASE12024-12-182025-07-262025-07-26
NCT06719011A Study on How NNC0174-1213 Works in People With Overweight or Obesity.RECRUITINGPHASE12024-12-032026-05-172026-03-26
NCT06717698A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney DiseaseRECRUITINGPHASE22024-12-022026-09-292026-09-01
NCT06716307A Research Study to Compare Blood Levels of Cagrilintide and Semaglutide After Single Doses of Different Versions of Injectable CagriSema in Adults With Overweight or ObesityCOMPLETEDPHASE12024-12-022025-05-222025-03-28
NCT06718998A Research Study Comparing Different Ways of Increasing the Dose of NNC0519-0130 in Participants With Overweight or ObesityRECRUITINGPHASE12024-11-202026-01-082026-01-08
NCT06859073A Research Study to Evaluate the Safety of NNC4004-0002 When Given to Participants With Asymptomatic HyperuricemiaRECRUITINGPHASE12024-11-132026-06-012026-06-01
NCT06685185A Research Study of a New Medicine NNC0363-1063 in Healthy Participants and Participants With Type 1 DiabetesRECRUITINGPHASE12024-11-122026-05-152026-05-15
NCT06534411A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Tirzepatide in People With Type 2 Diabetes Treated With Metformin, SGLT2 Inhibitor or BothACTIVE_NOT_RECRUITINGPHASE32024-11-052026-07-142026-06-02
NCT06642571A Research Study to Compare How Much of the Medicine NNC0519-0130 is in the Blood of People With Overweight or Obesity Who Receive 2 Preparations of the MedicineCOMPLETEDPHASE12024-10-152025-05-312025-05-17
NCT06642584A Research Study Looking at New Protein-based Tablets in Healthy Men - Oral Formulation IVRECRUITINGPHASE12024-10-152025-05-252025-02-25
NCT06625307A Research Study on the Effects of NNC0537-1482 in Healthy Individuals When Injected Under the SkinCOMPLETEDPHASE12024-10-032025-05-042025-05-04
NCT06649630A Study Looking at How Different Doses of Study Medicine (Inno8) Works in the Body of Healthy MenRECRUITINGPHASE12024-09-232026-05-042026-05-04
NCT06571383STEP TEENS Weight Maintenance: A Research Study on How Well Semaglutide Helps Teenagers With Excess Body Weight to Lose Weight and Maintain Weight LossRECRUITINGPHASE42024-09-172031-11-152028-11-15
NCT06588504Research Study in Japan to Compare Dasiglucagon With Glucagon in Treating Very Low Levels of Blood Sugar in Asian Adults With Type 1 Diabetes and Testing of Dasiglucagon for the Same Condition in Japanese AdolescentsCOMPLETEDPHASE12024-09-102025-07-202025-06-24
NCT06577766A Research Study on How NNC0638-0355, a New Medicine, Works in People Living With Overweight or ObesityACTIVE_NOT_RECRUITINGPHASE12024-09-022025-11-182025-09-23
NCT06581627A Research Study Looking at a Single Dose of Etavopivat in Healthy Chinese ParticipantsCOMPLETEDPHASE12024-08-262024-10-312024-10-31
NCT06559527A Research Study Looking Into Blood Levels of the Medicine NNC0487-0111 in the Body and How Well it is Tolerated in Participants With Reduced Kidney Function and Normal Kidney FunctionCOMPLETEDPHASE12024-08-202025-03-052025-02-24
NCT06542536A Research Study Investigating Safety and Concentration in the Blood After One Dose Tablet of the New Medicine Monlunabant in Healthy Weight Japanese and Caucasian MenCOMPLETEDPHASE12024-08-092024-10-252024-10-25
NCT06542874A Research Study Comparing How Well Different Doses of the Medicine NNC0487-0111 Lower Blood Sugar in People With Type 2 DiabetesRECRUITINGPHASE22024-08-072025-10-242025-10-01
NCT06567041A Research Study of How Safe a New Medicine Called NNC0519 0130 is and to Test Its Effect in People Living With Excess Body Weight With or Without Type 2 DiabetesACTIVE_NOT_RECRUITINGPHASE12024-08-072025-12-102025-12-10
NCT06513104A Research Study Looking Into the Effect of NNC0519-0130 on Blood Levels of a Birth Control Pill and Emptying of the Stomach in Women After MenopauseACTIVE_NOT_RECRUITINGPHASE12024-07-182025-10-012025-09-09
NCT06478563A Research Study Looking at Different Oral Formulations and the Effect of Food Intake on How the Medicine NNC0487-0111 Behaves in the Body of Participants Living With Overweight or ObesityCOMPLETEDPHASE12024-06-272025-07-012025-06-05
NCT06118281ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With a Heart AttackRECRUITINGPHASE32024-06-252026-09-032026-09-03
NCT06388187A Research Study to See How Well Different Doses of CagriSema Help People With Excess Body Weight Lose WeightACTIVE_NOT_RECRUITINGPHASE32024-06-242026-04-212026-04-21
NCT06461039A Research Study Looking at How the Compound NNC0487-0111 Works With Birth Control Pills and Affects Emptying of the Stomach in Women Not Able to Become PregnantCOMPLETEDPHASE12024-06-142025-04-042025-03-16
NCT06504368Safety, Tolerability, and Pharmacokinetics of DCR-PDL1 in Adults With Solid TumorsRECRUITINGPHASE12024-05-292027-12-312025-06-01
NCT06433661A Research Study of the Effect of Food on Etavopivat in Healthy ParticipantsCOMPLETEDPHASE12024-05-282024-07-082024-07-06
NCT06409130Effects of NNC0194-0499, Cagrilintide, and Semaglutide Alone or in Combinations on Liver Damage and Alcohol Use in People With Alcohol-related Liver DiseaseACTIVE_NOT_RECRUITINGPHASE22024-05-202026-01-012025-11-13
NCT06336018A Research Study on Etavopivat in Participants With and Without Liver DiseaseCOMPLETEDPHASE12024-05-202025-08-012025-08-01
NCT06403761Investigating How CagriSema, Semaglutide and Cagrilintide Regulate Insulin Effects in the Body of People With Type 2 DiabetesACTIVE_NOT_RECRUITINGPHASE12024-05-062026-02-132026-01-05
NCT06340854A Research Study to See How Switching From a Daily Basal Insulin to a New Weekly Insulin, Insulin Icodec, Helps in Reducing the Blood Sugar Compared to Daily Insulin Glargine in Adults With Type 2 DiabetesCOMPLETEDPHASE32024-04-192025-06-132025-05-08
NCT06370819A Research Study Looking Into Blood Levels of the Medicine NNC0519-0130 in the Body in Participants With Normal or Reduced Kidney FunctionCOMPLETEDPHASE12024-04-152024-11-272024-11-27
NCT06200207A Research Study Looking Into How Ziltivekimab Works Compared to Placebo in Participants With Heart Failure and InflammationRECRUITINGPHASE32024-04-012027-01-122026-10-05
NCT06131372A Research Study to See if Kidney Damage in People With Chronic Kidney Disease and Type 2 Diabetes Living With Overweight or Obesity Can be Reduced by CagriSema Compared to Semaglutide, Cagrilintide and PlaceboACTIVE_NOT_RECRUITINGPHASE22024-04-012025-11-062025-09-25
NCT06336005A Study to See How Safe a New Medicine (NNC6022-0001) is in Healthy PeopleCOMPLETEDPHASE12024-03-282025-02-172025-02-10
NCT06323161A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Placebo in People With Type 2 Diabetes Treated With Once-daily Basal Insulin With or Without MetforminACTIVE_NOT_RECRUITINGPHASE32024-03-262025-10-242025-09-09
NCT05725902Study of the Effect of Etavopivat on Cerebral Hemodynamic Response in Children With Sickle Cell DiseaseACTIVE_NOT_RECRUITINGPHASE22024-03-252026-02-262025-12-08
NCT06323174A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Placebo in People With Type 2 Diabetes Treated With Diet and ExerciseACTIVE_NOT_RECRUITINGPHASE32024-03-192025-12-262025-10-03
NCT06326047A Research Study Comparing How Well Different Doses of the Medicine NN0519-0130 Lower Blood Sugar in People With Type 2 DiabetesRECRUITINGPHASE22024-03-182025-10-132025-09-15
NCT06326060A Research Study Comparing How Well Different Doses of the Medicine NN0519-0130 Help People With Excess Body Weight Lose WeightCOMPLETEDPHASE22024-03-182025-05-012025-04-10
NCT06291285A Study to Test How Either a Capsule or a Tablet With NDec (Decitabine and Tetrahydrouridine) Works in the Body of Healthy PeopleCOMPLETEDPHASE12024-02-272024-06-102024-06-10
NCT06289504A Study on How CagriSema Affects Levels of Atorvastatin and Warfarin in the Blood of Participants With Excess Body WeightCOMPLETEDPHASE12024-02-272024-11-152024-10-16
NCT06288412A Study to Test How a New Long-acting Insulin Works in the Body of Patients With Type 2 Diabetes During Exercise and Prolonged FastingCOMPLETEDPHASE12024-02-262025-04-142025-03-10
NCT06207877A Research Study to Look at How CagriSema Influences Food Intake, Appetite and Emptying of the Stomach in People With Excess Body WeightCOMPLETEDPHASE12024-02-232024-11-222024-10-16
NCT06260709A Research Study to Look at Long-term Treatment With a Medicine Called NNC6019-0001 for People Who Have Heart Failure Due to Transthyretin AmyloidosisACTIVE_NOT_RECRUITINGPHASE22024-02-202028-08-152028-02-29
NCT06269107A Research Study to See How Well New Weekly Medicine IcoSema, Which is a Combination of Insulin Icodec and Semaglutide, Controls Blood Sugar Levels in People With Type 2 Diabetes (T2D), Compared to Daily Insulin Glargine (COMBINE 4)COMPLETEDPHASE32024-02-152025-07-082025-05-27
NCT06267092A Study of How CagriSema Works on Appetite in People With Excess Body WeightACTIVE_NOT_RECRUITINGPHASE12024-02-152025-12-222025-04-07
NCT06284798A Research Study of a New Medicine (NNC0650-0013) in Healthy MenCOMPLETEDPHASE12024-01-292024-07-252024-07-25
NCT06083675Research Study to Compare Semaglutide Tablets With Empagliflozin or Metformin Tablets in People With Type 2 DiabetesWITHDRAWNPHASE32024-01-262027-05-282025-01-24
NCT06221969A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Tirzepatide in People With Type 2 Diabetes Treated With Metformin With or Without an SGLT2 InhibitorACTIVE_NOT_RECRUITINGPHASE32024-01-162026-04-032026-02-20
NCT06188026A Research Study Looking at How the Compound NNC0194-0499 Works With Birth Control Pills in Women Not Able to Bear Children.COMPLETEDPHASE12023-12-182024-12-302024-12-30
NCT06131437A Research Study to See How Well CagriSema Compared to Tirzepatide Helps People With Obesity Lose WeightACTIVE_NOT_RECRUITINGPHASE32023-11-272026-01-132025-08-27
NCT06133270A First Human Dose Study Investigating Safety and Concentration of Study Medicine in the Blood Following Once Daily Oral Dosing of NNC0560-0004 in Healthy Adults.COMPLETEDPHASE12023-11-132024-07-042024-07-04
NCT06069895Investigation of Safety, Tolerability and Pharmacokinetics of Multiple Doses of NNC0113-6856 in Healthy Participants, Including a Subset of Healthy Japanese ParticipantsCOMPLETEDPHASE12023-10-042025-04-232025-04-23
NCT06097390A Research Study Looking at New Protein-based Tablets in Healthy Men - Oral Formulation IIICOMPLETEDPHASE12023-09-282024-03-272024-02-22
NCT06065540A Research Study to See How Well CagriSema Compared to Semaglutide, Cagrilintide and Placebo Lowers Blood Sugar and Body Weight in People With Type 2 Diabetes Treated With Metformin With or Without an SGLT2 InhibitorACTIVE_NOT_RECRUITINGPHASE32023-09-272026-01-052025-11-17
NCT05813912A Research Study to See How a New Weekly Insulin, Insulin Icodec When Given Along With Semaglutide Helps in Reducing the Blood Sugar Level in Patients With Type 2 DiabetesCOMPLETEDPHASE32023-09-222025-05-162025-04-14
NCT06064006A Research Study to See How a New Medicine (NNC0487-0111) Works in People With Overweight or Obesity When Injected Under the SkinCOMPLETEDPHASE22023-09-152024-11-272024-11-27
NCT06041217A Research Study to See How Well Semaglutide Helps People Who Have a Body Weight Above the Healthy Weight RangeCOMPLETEDPHASE32023-09-152025-05-072025-04-02
NCT06049329A Research Study of How a New Medicine Called Amycretin, Given as Tablets, Works in Japanese Men With ObesityCOMPLETEDPHASE12023-09-142023-12-152023-12-15
NCT05891834Study of INV-202 in Patients With Obesity and Metabolic SyndromeCOMPLETEDPHASE22023-09-082025-02-142024-06-13
NCT05996848A Research Study to See How Well CagriSema Helps People in China With Excess Body Weight Lose WeightCOMPLETEDPHASE32023-08-152025-02-222025-01-16
NCT06098651A Study of DCR-STAT3 in Adults With Solid TumorsCOMPLETEDPHASE12023-08-142025-09-172025-09-17
NCT05996874A Research Study Comparing the Effect of Different Dosing Conditions on Blood Levels of Semaglutide in a New Tablet Composition in Healthy ParticipantsCOMPLETEDPHASE12023-08-122024-04-182024-04-18
NCT05979428A Study to Look at How Safe a New Medicine (NNC0491-6075) is in Healthy People and in Participants With High Levels of Fat in the BloodCOMPLETEDPHASE12023-08-072025-03-142025-03-14
NCT05726227A Research Study on How Well Semaglutide Helps Children and Teenagers With Excess Body Weight Lose WeightACTIVE_NOT_RECRUITINGPHASE32023-07-072026-12-072025-09-29
NCT05917938A Research Study Looking at How a Single Dose of the Study Medicine NNC0194-0499 Behaves in Participants With Reduced Liver Function Compared to Participants With Normal Liver FunctionCOMPLETEDPHASE12023-07-042024-12-162024-12-16
NCT05878938A Research Study Looking at How Safe it is to Switch From Emicizumab to Mim8 in People With Haemophilia A (FRONTIER 5)COMPLETEDPHASE32023-06-262024-07-192024-07-18
NCT05953584A Phase 2 Open-label Study to Evaluate the Activity of Etavopivat on Transcranial Doppler Velocities in Pediatric Patients With Sickle Cell Disease Who Are at Increased Risk for Primary StrokeRECRUITINGPHASE22023-06-202027-09-202027-09-20
NCT05891496A Research Study Looking at the Effect of Semaglutide on the Immune System and Other Biological Processes in People With Alzheimer's DiseaseACTIVE_NOT_RECRUITINGPHASE32023-06-202025-09-112024-08-19
NCT05890976Research Study Looking at How Well Semaglutide Tablets Taken Once Daily Work in Chinese Adults Who Are Above a Healthy Weight Range (OASIS 3)COMPLETEDPHASE32023-05-302025-01-162025-01-16
NCT05870670A Research Study of a New Medicine NNC0519-0130 in Japanese and Non-Japanese MenCOMPLETEDPHASE12023-05-152023-10-162023-10-07
NCT05636176A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With Heart Failure and InflammationRECRUITINGPHASE32023-05-082027-07-022027-07-02
NCT05790681A Study to Test How New Long-acting Insulin (Insulin Icodec) Works in the Body of Children and TeenagersCOMPLETEDPHASE12023-04-252024-02-082024-02-08
NCT05804162A Research Study Looking at How Cagrilintide Works on the Heart Rhythm in Healthy ParticipantsCOMPLETEDPHASE12023-04-122023-09-182023-08-12
NCT05823948A Study Using Flash Glucose Measurements for a New Once-weekly Insulin (Insulin Icodec) in People With Type 2 Diabetes Who Have Not Used Insulin Before (ONWARDS 9)COMPLETEDPHASE32023-04-112024-04-112024-03-06
NCT05564104A Research Study Looking at How a Single Dose of the Medicine Cagrilintide Works in Participants With Reduced Liver Function and in Healthy Participants With Normal Liver Function and How Cagrilintide is Absorbed and Used by the BodyCOMPLETEDPHASE12023-04-052024-12-192024-09-06
NCT05813925A Research Study to See How Well CagriSema Helps People in East Asia With Excess Body Weight Lose WeightCOMPLETEDPHASE32023-04-032025-03-072025-01-17
NCT05784402A Research Study to Compare How Much Semaglutide is Found in the Blood With Different Tablets of Oral Semaglutide in Healthy ParticipantsCOMPLETEDPHASE12023-03-162024-03-292024-02-23
NCT05766709A Research Study Comparing Blood Levels of Medicines NNC0194-0499 and Semaglutide Administered as a Combination Formulation Versus Two Separate FormulationsCOMPLETEDPHASE12023-03-022024-02-092024-01-05
NCT05669755REDEFINE 3: A Research Study to See the Effects of CagriSema in People Living With Diseases in the Heart and Blood VesselsACTIVE_NOT_RECRUITINGPHASE32023-03-012027-10-132027-09-01
NCT05742919A Research Study Looking at How a Single Dose of the Medicine NNC0194-0499 Behaves in Chinese MenCOMPLETEDPHASE12023-02-162023-06-132023-06-13
NCT05727644A Research Study Looking Into Blood and Urine Levels of the Medicine NNC0194-0499 in the Body and How Well it is Tolerated in Participants With Reduced Kidney Function and Normal Kidney FunctionCOMPLETEDPHASE12023-02-152023-11-102023-11-10
NCT05685238A Research Study Looking at Long-term Treatment With Mim8 in People With Haemophilia A (FRONTIER 4)ACTIVE_NOT_RECRUITINGPHASE32023-02-132028-06-302028-06-30
NCT05721989A Research Study Looking Into Blood Levels of Three Different Formulations of the Study Medicine ZiltivekimabCOMPLETEDPHASE12023-02-032024-01-082024-01-08
NCT05394519A Research Study to See How Well CagriSema Helps People With Type 2 Diabetes and Excess Body Weight Lose WeightCOMPLETEDPHASE32023-02-012025-02-032025-01-28
NCT05723835A Research Study Looking at How Safe Somapacitan is and How Well it Works in Children Who Need Help to Grow - REAL 9ACTIVE_NOT_RECRUITINGPHASE32023-02-012027-10-292024-06-07
NCT05845398Phase 1b Study of DCR-AUD in Healthy VolunteersCOMPLETEDPHASE12023-01-292023-08-222023-08-22
NCT05579249A Research Study Comparing Wegovy to Other Weight Management Drugs in People Living With Obesity in AmericaCOMPLETEDPHASE42023-01-192024-11-272024-11-27
NCT05689099A Research Trial Looking at the Comparability of 2 Different Concentrations of Semaglutide for the 0.5 Milligram (mg) DoseCOMPLETEDPHASE12023-01-172023-05-302023-05-30
NCT06198712A Study to Evaluate the Pharmacokinetics and Safety of Etavopivat in Pediatric Patients With Sickle Cell DiseaseRECRUITINGPHASE22023-01-122029-08-082029-08-08
NCT05646706A Research Study to See How Semaglutide Helps People With Excess Weight, Lose Weight (STEP UP)COMPLETEDPHASE32023-01-042024-11-262024-10-30
NCT05649137A Research Study to See How Semaglutide Helps People With Excess Weight and Type 2 Diabetes Lose WeightCOMPLETEDPHASE32023-01-042024-12-132024-10-28
NCT05681845A Study to Compare the Blood Levels of Mim8 in Healthy Men When Administered With the DV3407-C1 Pen Injector or a Syringe and CartridgeCOMPLETEDPHASE12023-01-022023-10-132023-09-12
NCT05599945First Human Dose Trial for a New Medication to Potentially Treat Liver DiseasesCOMPLETEDPHASE12022-11-232025-08-292025-08-29
NCT05568225A Study of Etavopivat for the Treatment of Anemia in Patients With Myelodysplastic Syndromes (MDS)TERMINATEDPHASE22022-11-222024-07-152024-07-15
NCT05624580A Study to Look at Safety and Tolerability of NNC0582-0001, How it is Transported Throughout the Body and How it Works in Healthy AdultsACTIVE_NOT_RECRUITINGPHASE12022-11-152025-10-252025-10-25
NCT05567796A Research Study to See How Well CagriSema Helps People With Excess Body Weight Lose WeightACTIVE_NOT_RECRUITINGPHASE32022-11-012026-10-192024-10-30
NCT05514548Phase 2 Study of INV-202 in Patients With Diabetic Kidney DiseaseCOMPLETEDPHASE22022-10-192024-09-032024-08-20
NCT05564117Research Study Looking at How Well Semaglutide Tablets Taken Once Daily Work in People Who Have a Body Weight Above the Healthy RangeCOMPLETEDPHASE32022-10-112024-05-072024-04-18
NCT05444153Research Study to Compare Semaglutide Tablets With Empagliflozin Tablets Taken Once Daily in People With Type 2 Diabetes and ObesityWITHDRAWNPHASE32022-10-062025-08-292024-10-02
NCT05514535A Research Study to Look Into How Semaglutide, Together With a Lower Dose of Insulin Glargine, Compares to a Higher Dose of Insulin Glargine Alone in People With Type 2 Diabetes (SUSTAIN OPTIMIZE)COMPLETEDPHASE32022-08-292025-04-092025-03-05
NCT05521256A Research Study of a New Medicine NNC0113-6856 in Healthy MalesCOMPLETEDPHASE12022-08-262023-03-272023-03-27
NCT04998136Research Study Investigating How Well Semaglutide Works in People From Thailand and South Korea Living With ObesityCOMPLETEDPHASE32022-08-152023-11-202023-10-16
NCT05498610A Research Study of How the Medicine NNC0480-0389 Taken With Semaglutide Works in the Body of Healthy Chinese MenCOMPLETEDPHASE12022-08-112022-10-122022-10-12
NCT05330325A Research Study to Compare Somapacitan Once a Week With Norditropin® Once a Day in Children Who Need Help to GrowACTIVE_NOT_RECRUITINGPHASE32022-08-102027-10-292024-08-05
NCT05486065A Research Study to Look Into How Well Semaglutide Medicine Works at Different Doses in People With Type 2 Diabetes and OverweightCOMPLETEDPHASE22022-08-082023-12-132023-10-12
NCT05478252A Research Study to Compare Two Semaglutide Medicines in People With Type 2 DiabetesCOMPLETEDPHASE32022-08-032023-09-182023-08-09
NCT05442047A Research Study to Look at How a New Medicine Called NNC6019-0001 Works and How Safe it is for People Who Have Heart Disease Due to Transthyretin (TTR) AmyloidosisCOMPLETEDPHASE22022-08-022025-05-132025-05-13
NCT05405114Research Study Investigating How Well NDec Works in People With Sickle Cell DiseaseACTIVE_NOT_RECRUITINGPHASE22022-07-072025-08-272025-08-27
NCT05435677A Research Study to Look at How Insulin Icodec and Semaglutide Work in the Body of People From China With Type 2 Diabetes When Given Alone or TogetherCOMPLETEDPHASE12022-06-222023-04-252023-04-25
NCT05429593A Research Study Investigating How Semaglutide and Dapagliflozin Act in Your Body When Dosed in One TabletCOMPLETEDPHASE12022-06-222023-04-132023-03-10
NCT05352815A Research Study to See How Well the New Weekly Medicine IcoSema, Which is a Combination of Insulin Icodec and Semaglutide, Controls Blood Sugar Level in People With Type 2 Diabetes Compared to Weekly Insulin IcodecCOMPLETEDPHASE32022-06-012024-04-232024-03-19
NCT05379829A Research Study of How the Medicine Ziltivekimab Works in the Body of Chinese Men and Women With Kidney Disease and InflammationCOMPLETEDPHASE12022-05-302024-09-022022-09-02
NCT05365217A Research Study Investigating Nonacog Beta Pegol (N9-GP) for Treatment and Prevention of Bleedings in Chinese People With Haemophilia BCOMPLETEDPHASE32022-05-182024-05-112024-04-11
NCT05369390A Research Study on How NNC0487-0111 Works in People With Overweight or ObesityCOMPLETEDPHASE12022-05-112024-01-092024-01-09
NCT05533632Safety Study of Weekly Semaglutide in Chilean Participants With Type 2 DiabetesCOMPLETEDPHASE42022-04-252024-01-182024-01-18
NCT05363774A Research Study of a New Medicine NNC0519-0130 in Healthy People, People With High Body Weight and People With Type 2 Diabetes.COMPLETEDPHASE12022-04-202024-04-022024-04-02
NCT05333107A Research Study Looking at New Protein-based Tablets in Healthy Men - Oral Formulation IICOMPLETEDPHASE12022-04-122022-09-232022-07-22
NCT05259033A Research Study to See How Well the New Weekly Medicine IcoSema, Which is a Combination of Insulin Icodec and Semaglutide, Controls Blood Sugar Level in People With Type 2 Diabetes Compared to Weekly Semaglutide (COMBINE 2)COMPLETEDPHASE32022-04-112024-01-162023-12-13
NCT05306418A Research Study Looking at Mim8 in Children With Haemophilia A With or Without InhibitorsCOMPLETEDPHASE32022-04-042024-11-132024-11-13
NCT05314283A Study Investigating the Safety and Performance of DV3395, a New Concept Device for the Delivery of Medicine.COMPLETEDPHASE12022-03-282022-11-082022-11-08
NCT05135559A Research Study on How Well Concizumab Works for You if You Have Haemophilia A or B With or Without InhibitorsACTIVE_NOT_RECRUITINGPHASE32022-03-242029-11-022029-09-14
NCT04987489A Study of Etavopivat in Patients With Thalassemia or Sickle Cell DiseaseACTIVE_NOT_RECRUITINGPHASE22022-03-202025-09-032025-09-03
NCT05254158A Research Study of How NNC0174-0833 Behaves in Chinese Volunteers Who Are Normal Weight, Overweight or With ObesityCOMPLETEDPHASE12022-03-032022-09-072022-09-07
NCT05262595A Study to Look at How Insulin NNC0471-0119 Works in the Body in People With Type 1 Diabetes When Injected by Insulin PumpCOMPLETEDPHASE12022-03-032022-09-052022-08-29
NCT05282446A Study to Explore the PK and PD of INV-202 in Metabolic SyndromeCOMPLETEDPHASE12022-03-012022-10-012022-09-11
NCT05001269Nedosiran in Pediatric Patients From Birth to 11 Years of Age With PH and Relatively Intact Renal FunctionCOMPLETEDPHASE22022-02-222025-02-052025-02-05
NCT05236517A Research Study Looking at How 50 mg Semaglutide Daily Affects Food Intake and Emptying of the Stomach in People With ObesityCOMPLETEDPHASE12022-02-082022-11-072022-09-29
NCT05227196A Research Study Looking at the Comparability of 2 Different Forms of Oral Semaglutide in Healthy PeopleCOMPLETEDPHASE12022-02-042023-08-082023-06-28
NCT05232708A Clinical Trial Looking at the Comparability of 2 Different Forms of SemaglutideCOMPLETEDPHASE12022-01-192022-08-302022-08-30
NCT05178550A Study in Healthy Participants Investigating Biomarkers After Exposure to Heparin When Heparin is Administered in the Fasted State or After a High-fat Meal. Heparin, a Registered Drug, is an Anticoagulant (Blood Thinner) That Prevents the Formation of Blood Clots.COMPLETEDEARLY_PHASE12021-12-172022-01-172022-01-11
NCT05153564A Research Study Looking Into the Effect of Semaglutide and NNC0480 0389 on Blood Levels of a Birth Control Pill in Woman After MenopauseCOMPLETEDPHASE12021-12-132022-09-012022-08-13
NCT05091073A Research Study Looking at the Effect of Food Intake on How the Medicine NN0385-0434 Behaves in the Body of Healthy ParticipantsCOMPLETEDPHASE12021-12-092022-05-312022-04-07
NCT05053139A Research Study Investigating Mim8 in Adults and Adolescents With Haemophilia A With or Without InhibitorsCOMPLETEDPHASE32021-12-022024-12-172024-03-11
NCT05146882An Extension Study of Belcesiran in Patients With Alpha-1 Antitrypsin Deficiency Associated Liver Disease (AATLD)WITHDRAWNPHASE22021-122022-05-232022-05-23
NCT05134987A Multiple Dose Study Investigating Pharmacokinetics and Pharmacodynamics of Subcutaneous NNC0363-0845 in Participants With Type 1 Diabetes Pharmacokinetics and Pharmacodynamics: How Insulin NNC0363-0845 is Transported Throughout the Body and How It WorksCOMPLETEDPHASE12021-12-012022-05-062022-05-06
NCT05013229A Research Study to See How Well the New Weekly Medicine IcoSema, Which is a Combination of Insulin Icodec and Semaglutide, Controls Blood Sugar Level in People With Type 2 Diabetes Compared to Insulin Glargine Taken Daily With Insulin Aspart (COMBINE 3)COMPLETEDPHASE32021-11-302023-11-142023-11-14
NCT05144984A Research Study Looking at How Well a Combination of the Medicines Semaglutide and NNC0480-0389 Works in People With Type 2 DiabetesCOMPLETEDPHASE22021-11-292023-03-232023-02-13
NCT05132088Research Study to Investigate How Well Semaglutide Tablets Taken Once Daily Work in East Asian People Who Are Overweight or Living With ObesityCOMPLETEDPHASE32021-11-162023-09-012023-07-11
NCT05094934A Research Study Looking Into Levels of the Medicine NNC0385-0434 in the Body and How Well it is Tolerated in Participants With Impaired Kidney Function Compared to Participants With Normal Kidney FunctionTERMINATEDPHASE12021-11-092022-08-242022-07-15
NCT05129891A Research Study Looking at New Protein-based Tablets in Healthy Male ParticipantsCOMPLETEDPHASE12021-11-032023-05-042023-02-26
NCT05064735Research Study Looking at How Well Semaglutide Works in People Suffering From Obesity and Knee OsteoarthritisCOMPLETEDPHASE32021-10-012023-09-082023-07-24
NCT05082116Efficacy and Safety of Turoctocog Alfa Pegol (N8-GP) for Prophylaxis and Treatment of Bleeding Episodes in Previously Treated Chinese Patients With Haemophilia A (pathfinder10)COMPLETEDPHASE32021-09-272022-12-282022-12-28
NCT05021640Study of DCR-AUD in Healthy VolunteersCOMPLETEDPHASE12021-09-212022-12-312022-12-31
NCT05035095Research Study to Investigate How Well Semaglutide Tablets Taken Once Daily Work in People Who Are Overweight or Living With Obesity (OASIS 1)COMPLETEDPHASE32021-09-132023-05-122023-03-24
NCT04817644A Research Study to See How Much Semaglutide and SNAC is in the Milk of Healthy, Breastfeeding Women Taking Semaglutide TabletsCOMPLETEDPHASE12021-09-102023-07-032023-05-26
NCT05040971Research Study Looking at How Well Semaglutide Works in People Living With Obesity and PrediabetesCOMPLETEDPHASE32021-09-062023-07-142023-01-06
NCT05046873A Research Study Looking Into Blood Levels of Semaglutide and NNC0480-0389 When Given in the Same Injection or in Two Separate Injections in Healthy PeopleCOMPLETEDPHASE12021-09-062022-01-052022-01-05
NCT05035082A Research Study Comparing RYBELSUS® to Other Blood Sugar Lowering Tablets in People Living in America With Type 2 Diabetes (REALYSE)COMPLETEDPHASE42021-09-012025-06-182025-06-18
NCT05016882Research Study on Whether a Combination of 2 Medicines (NNC0194 0499 and Semaglutide) Works in People With Non-alcoholic Steatohepatitis (NASH)COMPLETEDPHASE22021-08-312025-03-142024-12-17
NCT05021835ZEUS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With Cardiovascular Disease, Chronic Kidney Disease and InflammationACTIVE_NOT_RECRUITINGPHASE32021-08-302026-06-262026-06-26
NCT05015894A Research Study Looking Into Blood Levels of the Medicine NNC0480-0389 in Participants With Reduced Kidney Function Compared to Participants With Normal Kidney FunctionCOMPLETEDPHASE12021-08-302022-08-022022-08-02
NCT05003440A Research Study Looking at How the Medicine NNC0385-0434 Works in the Body of Healthy Japanese MenCOMPLETEDPHASE12021-08-192022-01-192022-01-19
NCT04992065A Research Study Looking at How NNC0385-0434 Tablets Work to Lower Blood Cholesterol in People With Heart Disease or a High Risk of Heart DiseaseCOMPLETEDPHASE22021-08-032022-06-202022-04-26
NCT04982575Research Study to Look at How Well Cagrilintide Together With Semaglutide Works in People With Type 2 DiabetesCOMPLETEDPHASE22021-08-022022-07-072022-07-07
NCT04970654A Research Study in Chinese Children With a Low Level of Hormone to Grow. Treatment is Somapacitan Once a Week Compared to Norditropin® Once a Day.COMPLETEDPHASE32021-07-222023-12-182023-11-17
NCT04969939A Research Study to Investigate How Well NNC0165-1875 in Combination With Semaglutide Works in People With ObesityCOMPLETEDPHASE22021-07-152023-01-302022-12-06
NCT05127473A Research Study of How a New Medicine NNC0365-3769 (Mim8) Works in the Body of Healthy PeopleCOMPLETEDPHASE12021-07-142022-05-142022-05-14
NCT04940078A Research Study to Compare Blood Levels of Cagrilintide and Semaglutide After Combined Versus Separate Injections in People With Overweight or ObesityCOMPLETEDPHASE12021-07-072022-02-162022-01-19
NCT04916470Research Study to Look at How Well Semaglutide Works in People Living With Heart Failure, Obesity and Type 2 DiabetesCOMPLETEDPHASE32021-06-152023-10-112023-10-11
NCT04777409A Research Study Investigating Semaglutide in People With Early Alzheimer's Disease (EVOKE Plus)ACTIVE_NOT_RECRUITINGPHASE32021-05-182026-10-062025-09-19
NCT04777396A Research Study Investigating Semaglutide in People With Early Alzheimer's Disease (EVOKE)ACTIVE_NOT_RECRUITINGPHASE32021-05-182026-10-232025-09-19
NCT04878406A Research Study of How the Medicine NNC0480-0389 Taken With Semaglutide Works in the Body of Healthy Japanese MenCOMPLETEDPHASE12021-05-182021-07-202021-07-20
NCT04880850A Research Study to Compare Two Types of Insulin, a New Weekly Insulin, Insulin Icodec and an Available Daily Insulin, Insulin Glargine, Both in Combination With Mealtime Insulin, in People With Type 2 Diabetes Who Use Daily Insulin and Mealtime Insulin (ONWARDS 4)COMPLETEDPHASE32021-05-142022-06-162022-06-16
NCT04848480A Research Study to Compare a New Weekly Insulin, Insulin Icodec, and an Available Daily Insulin, Insulin Degludec, Both in Combination With Mealtime Insulin in People With Type 1 Diabetes (ONWARDS 6)COMPLETEDPHASE32021-04-302022-12-022022-04-28
NCT04865770A Research Study to Find Out How Semaglutide Works in the Kidneys Compared to Placebo, in People With Type 2 Diabetes and Chronic Kidney Disease (the REMODEL Trial)COMPLETEDPHASE32021-04-282024-11-212024-11-21
NCT04857398A Study to Test How a New Long-acting Insulin (Insulin Icodec) Works in the Body of People From China With Type 2 DiabetesCOMPLETEDPHASE12021-04-282022-04-062022-04-06
NCT04698018A Research Study to Look at How Faster Aspart Works in Chinese People With Type 1 Diabetes or Type 2 DiabetesCOMPLETEDPHASE12021-04-202023-04-252023-04-25
NCT04580420Safety & Efficacy of DCR-PHXC in Patients With PH1 and ESRDRECRUITINGPHASE22021-04-152032-01-302031-12-30
NCT04822181Research Study on Whether Semaglutide Works in People With Non-alcoholic Steatohepatitis (NASH)ACTIVE_NOT_RECRUITINGPHASE32021-04-012029-04-252029-04-25
NCT04795531A Research Study to Compare Two Types of Insulin, a New Insulin, Insulin Icodec and an Available Insulin, Insulin Degludec, in People With Type 2 Diabetes Who Have Not Used Insulin Before (ONWARDS 3)COMPLETEDPHASE32021-03-242022-06-232022-06-23
NCT04788511Research Study to Investigate How Well Semaglutide Works in People Living With Heart Failure and ObesityCOMPLETEDPHASE32021-03-162023-04-182023-04-18
NCT04770532A Research Study to Compare Two Types of Insulin, a New Weekly Insulin, Insulin Icodec and an Available Daily Insulin, Insulin Degludec, in People With Type 2 Diabetes Who Use Daily InsulinCOMPLETEDPHASE32021-03-052022-03-012022-01-27
NCT04775082SCALE KIDS: Research Study to Look at How Well a New Medicine is at Lowering Weight in Children With ObesityACTIVE_NOT_RECRUITINGPHASE32021-03-042027-01-152023-08-01
NCT04760626A Research Study to Compare a New Weekly Insulin, Insulin Icodec Used With DoseGuide App, and Daily Insulins in People With Type 2 Diabetes Who Have Not Used Insulin BeforeCOMPLETEDPHASE32021-03-012022-08-292022-08-12
NCT04764448A Study of Belcesiran in Patients With AATLDTERMINATEDPHASE22021-02-122024-05-292023-12-08
NCT04722653A Research Study Looking at How the Medicine NNC0194-0499 Behaves in Japanese and Non-Asian MenCOMPLETEDPHASE12021-02-022021-04-272021-04-27
NCT04624659A Study of Etavopivat in Adults and Adolescents With Sickle Cell Disease (HIBISCUS)ACTIVE_NOT_RECRUITINGPHASE32021-01-292027-03-192026-02-20
NCT04707469Research Study to Compare Three Doses of Semaglutide Tablets Taken Once Daily in People With Type 2 DiabetesCOMPLETEDPHASE32021-01-152023-03-082023-03-07
NCT04575766A Study of FT-7051 in Men With MCRPCTERMINATEDPHASE12020-12-302022-11-152022-11-08
NCT04597697A Study to Test How a New Long-acting Insulin (Insulin Icodec) Works in the Body of People With Liver DiseaseCOMPLETEDPHASE12020-12-222022-03-242022-03-24
NCT04251156Research Study of How Well Semaglutide Works in People Living With Overweight or Obesity.COMPLETEDPHASE32020-12-082022-08-232022-08-23
NCT04676906A Study Investigating the Distribution and Metabolism of Three 14C-labeled Radioactive Study CompoundsCOMPLETEDPHASE12020-11-262021-04-282021-04-28
NCT04460885A Research Study to Compare Two Types of Insulin, a New Insulin, Insulin Icodec and an Available Insulin, Insulin Glargine, in People With Type 2 Diabetes Who Have Not Used Insulin BeforeCOMPLETEDPHASE32020-11-252022-12-012022-05-29
NCT04655690A Study to Look at How Safe Insulin NNC0471-0119 is and How it Works in People With Type 1 Diabetes MellitusCOMPLETEDPHASE12020-11-092021-11-262021-11-26
NCT04596631A Research Study to Compare a New Medicine Oral Semaglutide to a Dummy Medicine in Children and Teenagers With Type 2 DiabetesACTIVE_NOT_RECRUITINGPHASE32020-11-022026-02-042025-04-29
NCT04626505Trial to Evaluate Reduction in Inflammation in Patients With Advanced Chronic Renal Disease Utilizing Antibody Mediated IL-6 Inhibition in Japan.COMPLETEDPHASE22020-10-222021-09-282021-08-03
NCT04575181A Clinical Study to Compare the Efficacy and Safety of a Novel Medicine (NNC0268-0965) With Insulin GlargineCOMPLETEDPHASE12020-10-212021-12-242021-12-10
NCT04582435A Trial Investigating the Pharmacokinetic and Pharmacodynamic Properties of Insulin Icodec in Subjects With Type 2 DiabetesCOMPLETEDPHASE12020-10-162022-04-222022-04-22
NCT04588259Research Study to Compare a New Medicine "Fast-acting Insulin Aspart" to Another Medicine "Insulin Aspart" in Chinese People With DiabetesCOMPLETEDPHASE32020-10-092022-08-052022-07-05
NCT04560998A Research Study to Compare a Medicine Called Semaglutide Against Placebo in People With Peripheral Arterial Disease and Type 2 DiabetesCOMPLETEDPHASE32020-10-012024-07-122024-06-05
NCT04582448A Study Looking at How Insulin Icodec is Taken up in the Blood When Administered in Different Injection Sites in People With Type 2 DiabetesCOMPLETEDPHASE12020-10-012021-09-272021-09-27
NCT04569994A Study to Look at the Safety of NNC0363-0845 in Healthy People and People With Type 1 DiabetesCOMPLETEDPHASE12020-09-302021-06-232021-06-23
NCT04524832Research Study Comparing New Tablets of Semaglutide in New Doses, in Healthy PeopleCOMPLETEDPHASE12020-09-292022-02-252022-02-25
NCT04555486Study to Evaluate Safety, Tolerability, PK and PD of DCR-PHXC in PH Type 3 PatientsCOMPLETEDPHASE12020-09-142021-09-072021-09-07
NCT04531150Safety, Tolerability, and Pharmacokinetics of Single Ascending Oral Doses of INV-101 in Healthy Male and Female SubjectsCOMPLETEDPHASE12020-09-082021-05-162021-01-16
NCT04513704A Clinical Trial Comparing Semaglutide in Healthy People Who Eat and Take the Medicine at Different TimesCOMPLETEDPHASE12020-08-282021-05-262021-04-20
NCT04482725Injection Site Pain Comparison of Excipient SolutionsCOMPLETEDPHASE12020-07-202020-09-252020-09-24
NCT04287179SUSTAIN SWITCH: A Research Study to Compare Two Dose Schedules of Semaglutide Taken Once Weekly in People With Type 2 DiabetesWITHDRAWNPHASE32020-03-092021-01-252020-11-16
NCT04262661A Study to Look at How Safe NNC0472-0147 is in Healthy People and in People With Type 2 DiabetesCOMPLETEDPHASE12020-03-022020-09-252020-09-25
NCT04259801First Research Study to Look at How Two Medicines, NNC0480-0389 and Semaglutide, Work Together in Healthy People, in People With High Body Weight and in People With DiabetesCOMPLETEDPHASE12020-02-172022-03-162022-03-16
NCT04238962A Research Study to Compare Two Different Forms of Once-weekly Semaglutide in Two Different Injection PensCOMPLETEDPHASE12020-02-032020-10-202020-10-20
NCT04228354A Research Study Looking at the Comparability (Bioequivalence) of Two Versions of SemaglutideCOMPLETEDPHASE12020-01-292020-06-012020-06-01
NCT04209049A Research Study Looking Into Blood Levels of NNC0174-0833 in People With Normal and Impaired Kidney FunctionCOMPLETEDPHASE12020-01-152021-01-052021-01-05
NCT04204408A Research Study Investigating Mim8 in People With Haemophilia ACOMPLETEDPHASE22020-01-102023-10-062023-10-06
NCT04187300A Research Study Looking at the Comparability (Bioequivalence) of Two Forms of Semaglutide in Two Different Pen-injectors in People With Overweight or ObesityCOMPLETEDPHASE12019-12-162020-09-232020-09-23
NCT04189848Comparison of Injection Site Pain Experience for Semaglutide and Dulaglutide scCOMPLETEDPHASE42019-12-032020-02-272020-01-29
NCT04152915A Research Study Looking at Similarity Between Once-weekly Semaglutide Versions for Different Injection PensCOMPLETEDPHASE12019-11-252020-05-252020-05-25
NCT04082429Research Study to Look at How Well the Drug Concizumab Works in Your Body if You Have Haemophilia Without InhibitorsACTIVE_NOT_RECRUITINGPHASE32019-11-132028-02-212022-07-12
NCT04136067A Study to Look at How Safe NNC0268-0965 is in People With Type 2 DiabetesCOMPLETEDPHASE12019-10-292020-08-232020-08-23
NCT03847909A Study to Evaluate DCR-PHXC in Children and Adults With Primary Hyperoxaluria Type 1 and Primary Hyperoxaluria Type 2COMPLETEDPHASE22019-10-282021-06-292021-06-21
NCT04143945A Study Comparing the Injection Site Pain Experience After the Injection of Semaglutide B and Semaglutide D With 2 Different Injection Pens, a Compound for the Treatment of Type 2 Diabetes and ObesityCOMPLETEDPHASE22019-10-282020-01-042020-01-04
NCT04174118Study of DCR-A1AT in Healthy Adult VolunteersCOMPLETEDPHASE12019-10-242023-03-062021-07-06
NCT04083781Research Study to Look at How Well the Drug Concizumab Works in Your Body if You Have Haemophilia With InhibitorsACTIVE_NOT_RECRUITINGPHASE32019-10-212027-02-212021-12-27
NCT04016974A Research Study of How Oral Semaglutide Tablets Work in Healthy People Who Are ChineseCOMPLETEDPHASE12019-10-082021-02-262021-01-23
NCT04102189A Research Study on How Well Semaglutide Works in Adolescents With Overweight or ObesityCOMPLETEDPHASE32019-10-072022-03-282022-03-25
NCT04109508A Research Study Comparing Active Drug in the Blood in Healthy Participants Following Dosing of the Current and a New Formulation (C) Semaglutide TabletsCOMPLETEDPHASE12019-10-022021-01-272020-12-24
NCT04109547A Research Study Comparing a New Medicine Oral Semaglutide to Placebo in People With Type 2 DiabetesCOMPLETEDPHASE32019-10-012021-10-272021-09-23
NCT04097600A Research Study Comparing Active Drug in the Blood in Healthy Participants Following Dosing of the Current and a New Formulation (D) Semaglutide TabletsCOMPLETEDPHASE12019-09-302021-01-202020-12-16
NCT04074174Research Study to Investigate the Effect of NNC0174-0833 on a Birth Control Pill in Women Who Are Not Able to Become PregnantCOMPLETEDPHASE12019-09-122020-03-062020-03-06
NCT04074161Research Study to Investigate How Well Semaglutide Works Compared to Liraglutide in People Living With Overweight or ObesityCOMPLETEDPHASE32019-09-112021-05-112021-03-27
NCT04058834A Research Study Investigating How NNC0385-0434 is Tolerated in People With or Without High Cholesterol LevelsCOMPLETEDPHASE12019-08-202020-04-232020-04-23
NCT04059367Research Study to Investigate How a Study Medicine (NNC9204- 1177) Affects Blood Levels of Other Medicines in Healthy PeopleCOMPLETEDPHASE12019-08-152020-01-022020-01-02
NCT04032197A Research Study of How Semaglutide Works in People With Disease Affecting the Heart and/or Blood Vessels and Type 2 DiabetesCOMPLETEDPHASE12019-08-122023-06-062022-12-16
NCT04017832A Research Study Comparing a New Medicine Oral Semaglutide to Sitagliptin in People With Type 2 DiabetesCOMPLETEDPHASE32019-07-292021-10-272021-10-27
NCT04012255A Research Study to Compare Two Forms of Semaglutide in Two Different Pen-injectors in People With Overweight or ObesityTERMINATEDPHASE12019-07-152019-10-222019-08-30
NCT04010786A Research Study Investigating NNC0247-0829 for Weight Management in People With Overweight or ObesityCOMPLETEDPHASE12019-07-112022-06-212022-06-11
NCT04042402Long Term Extension Study in Patients With Primary HyperoxaluriaACTIVE_NOT_RECRUITINGPHASE32019-07-092030-04-012030-04-01
NCT03878446A Research Study in Children Born Small and Who Stayed Small. Treatment is Somapacitan Once a Week Compared to Norditropin® Once a DayACTIVE_NOT_RECRUITINGPHASE22019-07-042026-12-232021-05-05
NCT04007107A Study Comparing the Injection Site Pain Experience After the Injection of 2 Different Solutions of Semaglutide With 2 Different Injection Pens, a Compound for the Treatment of Type 2 Diabetes and ObesityCOMPLETEDPHASE22019-06-272019-09-042019-07-28
NCT03989232A Research Study to Compare Two Doses of Semaglutide Taken Once Weekly in People With Type 2 DiabetesCOMPLETEDPHASE32019-06-192020-11-092020-09-18
NCT03987451A Research Study on How Semaglutide Works in People With Fatty Liver Disease and Liver DamageCOMPLETEDPHASE22019-06-182021-06-102021-04-22
NCT03914326A Heart Disease Study of Semaglutide in Patients With Type 2 DiabetesCOMPLETEDPHASE32019-06-172024-08-232024-08-23
NCT03819153A Research Study to See How Semaglutide Works Compared to Placebo in People With Type 2 Diabetes and Chronic Kidney DiseaseCOMPLETEDPHASE32019-06-172024-01-092024-01-09
NCT03965013A Study to Look at How Safe NNC0268-0965 is in Healthy People and People With Type 1 DiabetesCOMPLETEDPHASE12019-06-052019-12-142019-12-14
NCT03926117Trial to Evaluate Reduction in Inflammation in Patients With Advanced Chronic Renal Disease Utilizing Antibody Mediated IL-6 InhibitionCOMPLETEDPHASE22019-06-032020-06-262020-06-26
NCT03811535A Research Study in Children With a Low Level of Hormone to Grow. Treatment is Somapacitan Once a Week Compared to Norditropin® Once a Day (REAL4)ACTIVE_NOT_RECRUITINGPHASE32019-05-202025-09-302021-11-10
NCT04004325A Study of FT 4101 in Overweight/Obese Participants With Non-alcoholic SteatohepatitisTERMINATEDPHASE1, PHASE22019-05-172020-01-202020-01-20
NCT03922750A Research Study in People With Type 2 Diabetes to Compare Two Types of Insulin: Insulin 287 and Insulin GlargineCOMPLETEDPHASE22019-05-092020-01-272019-12-19
NCT03951805A Research Study to Compare Two Types of Insulin: Insulin 287 and Insulin Glargine in People With Type 2 Diabetes Who Have Not Used Insulin BeforeCOMPLETEDPHASE22019-05-092020-01-172019-12-12
NCT03811561A Research Study to Look at How Semaglutide Compared to Placebo Affects Diabetic Eye Disease in People With Type 2 DiabetesACTIVE_NOT_RECRUITINGPHASE32019-05-082027-11-072026-12-25
NCT03945656A Research Study of How Overdosing of a New Once Weekly Medicine NNC0148-0287 C (Insulin 287) Influences the Blood Sugar Level in People With Type 2 DiabetesCOMPLETEDPHASE12019-05-072021-09-272021-09-27
NCT03905850A Study to Compare the Uptake Into the Blood of Two Strengths of Somapacitan After Injection Under the Skin in Healthy SubjectsCOMPLETEDPHASE12019-03-292019-07-152019-07-15
NCT03856047Research Study Investigating How Well NNC0174-0833 Works in People Suffering From Overweight or Obesity.COMPLETEDPHASE22019-03-012021-03-252020-03-02
NCT03816761Research Study to Look at Fast-acting Insulin Aspart With the Insulin Pump System 'iLet™' in Adults With Type 1 DiabetesCOMPLETEDPHASE22019-02-252019-06-102019-05-31
NCT03842202A Research Study to Look at How Semaglutide Affects Gastric Emptying in People With ObesityCOMPLETEDPHASE12019-02-152019-11-042019-11-04
NCT03811574STEP 6: Research Study Investigating How Well Semaglutide Works in People Living With Overweight or ObesityCOMPLETEDPHASE32019-01-212020-11-202020-11-20
NCT03789578A Research Study to Look at How Insulin 287 and Semaglutide Work in the Body of People With Type 2 Diabetes When Taken Alone or TogetherCOMPLETEDPHASE12019-01-172019-10-102019-10-10
NCT03799198Real World Effectiveness of Combining an Employer-based Weight Management Program With Medication for Chronic Weight Management in Employees With ObesityCOMPLETEDPHASE42019-01-072020-05-222020-05-22
NCT03787225A Research Study of How NNC0174-0833 Behaves in Japanese and Caucasian Volunteers Who Are Normal Weight, Overweight or With ObesityCOMPLETEDPHASE12019-01-072019-06-042019-06-04
NCT03772249Study of Safety and Tolerability of DCR HBVSCOMPLETEDPHASE12018-12-282022-07-122022-07-12
NCT03815695A SAD/MAD to Assess the Safety, PK/PD of FT-4202 in Healthy Volunteers and Sickle Cell Disease PatientsCOMPLETEDPHASE12018-12-112021-12-172021-12-17
NCT03766854A Research Study of How Different Amounts of a New Medicine NNC0148-0287 C (Insulin 287) Works on the Blood Sugar of People Who Are Japanese With Type 1 Diabetes When Given Once a WeekCOMPLETEDPHASE12018-12-072019-12-092019-12-09
NCT03723772A Research Study of How Different Doses of a New Medicine NNC0148-0287 C (Insulin 287) Work on the Blood Sugar in People With Type 1 Diabetes When it is Taken Once a WeekCOMPLETEDPHASE12018-11-292020-06-262020-06-26
NCT03751657A Research Study to Compare Insulin 287 Once a Week to Insulin Glargine (100 Units/mL) Once a Day in People With Type 2 Diabetes.COMPLETEDPHASE22018-11-292020-01-172019-12-16
NCT03723785A Research Study of How a New Medicine NNC0148-0287 C (Insulin 287) Works in the Body of People With Kidney ProblemsCOMPLETEDPHASE12018-11-092019-09-062019-09-06
NCT03684811A Study of FT-2102 in Patients With Advanced Solid Tumors and Gliomas With an IDH1 MutationCOMPLETEDPHASE1, PHASE22018-11-012022-06-132021-05-24
NCT03723759A Research Study Looking at How Faster Aspart Injected in Double Concentration Works in the Body of People With Type 1 Diabetes MellitusCOMPLETEDPHASE12018-10-262019-03-272019-03-21
NCT03574597Semaglutide Effects on Heart Disease and Stroke in Patients With Overweight or ObesityCOMPLETEDPHASE32018-10-242023-06-292023-06-21
NCT03707990A Research Study of NNC0165-1875 Alone or Together With Semaglutide in People Who Are Overweight or ObeseCOMPLETEDPHASE12018-10-152019-08-132019-08-13
NCT03693430Two-year Research Study Investigating How Well Semaglutide Works in People Suffering From Overweight or ObesityCOMPLETEDPHASE32018-10-052021-03-232021-01-29
NCT03687827A Research Study to Compare the Effect of Insulin Degludec and Insulin Glargine on Blood Sugar Levels in People With Type 2 Diabetes - the SWITCH PRO StudyCOMPLETEDPHASE42018-10-022019-12-272019-12-20
NCT03689374A Research Study to Compare Semaglutide to Insulin Aspart, When Taken Together With Metformin and Insulin Glargine, in People With Type 2 DiabetesCOMPLETEDPHASE32018-10-012021-02-222021-02-22
NCT03661879Research Study of a New Medicine (NNC9204-1706) in People With Overweight or ObesityCOMPLETEDPHASE12018-09-122019-10-092019-09-05
NCT03638778Research Study Comparing Different Tablets With the Study Medicine Semaglutide in Healthy MenCOMPLETEDPHASE12018-08-172018-12-052018-12-05
NCT03617081First Research Study of the Possible New Medicine NNC0113-2023 in Healthy Men.COMPLETEDPHASE12018-08-092018-12-132018-12-13
NCT03611322A Trial to Compare Blood Concentration Levels of Semaglutide Following Subcutaneous Injections of Semaglutide 1 mg by 2 Different Devices (the DV3372 Device and by the PDS290 Semaglutide Pen-injector)COMPLETEDPHASE12018-08-082019-01-072019-01-07
NCT03611582Research Study to Look at How Well Semaglutide is at Lowering Weight When Taken Together With an Intensive Lifestyle ProgramCOMPLETEDPHASE32018-08-012020-04-282020-03-18
NCT03600480A Research Study of How NNC0174-0833 Taken With Semaglutide Works in People Who Are Overweight or ObeseCOMPLETEDPHASE12018-07-252020-06-122020-06-12
NCT03598621A Research Study to Look at Similarity Between Semaglutide Versions in Different Injection ToolsCOMPLETEDPHASE12018-07-232019-01-172019-01-17
NCT03596450Long Term Comparative Effectiveness of Once Weekly Semaglutide Versus Standard of Care in a Real World Adult US Population With Type 2 Diabetes - a Randomized Pragmatic TrialCOMPLETEDPHASE42018-07-132023-06-092022-06-09
NCT03574584A Research Study of NNC0165-1562 and Semaglutide in People Who Are Overweight or ObeseCOMPLETEDPHASE12018-06-182019-07-272019-07-27
NCT03588741Evaluation of Safety Following Immune Tolerance Induction Treatment With Turoctocog Alfa in Patients With Haemophilia A Following Inhibitor Development in NN7170-4213 TrialTERMINATEDPHASE32018-06-122019-06-192019-06-19
NCT03548987Research Study Investigating How Well Semaglutide Works in People Suffering From Overweight or ObesityCOMPLETEDPHASE32018-06-042020-03-202020-02-22
NCT03548935STEP 1: Research Study Investigating How Well Semaglutide Works in People Suffering From Overweight or ObesityCOMPLETEDPHASE32018-06-042021-03-052020-03-30
NCT03552757Research Study Investigating How Well Semaglutide Works in People With Type 2 Diabetes Suffering From Overweight or ObesityCOMPLETEDPHASE32018-06-042020-05-012020-03-24
NCT03528551A Research Study Looking at How a Factor VIII Medicine Called Turoctocog Alfa Pegol (N8-GP) Works in People With Haemophilia ACOMPLETEDPHASE32018-04-302020-12-032020-12-03
NCT03466567A Trial Investigating the Effect of Probenecid and Ciclosporin on the Concentrations of SNAC in Healthy SubjectsCOMPLETEDPHASE12018-03-152018-07-102018-07-10
NCT03479892A Research Study Looking at a New Study Medicine (NNC0194-0499) for Weight Control in People With Overweight or ObesityCOMPLETEDPHASE12018-03-132019-06-042019-06-04
NCT03449342Research Study to Look at Side Effects During Regular Injection With Factor VIII Medicine Named Turoctocog Alfa for a 8 Weeks PeriodCOMPLETEDPHASE42018-03-012019-04-222019-03-25
NCT03444467First Research Study to Compare a Possible New Medicine NNC9204-1513 to the Medicine Glucagon, in Healthy People.COMPLETEDPHASE12018-02-052018-05-242018-05-24
NCT03407599A Trial Comparing the Pharmacokinetic Properties of Fast-acting Insulin Aspart Between Children, Adolescents and Adults With Type 1 DiabetesCOMPLETEDPHASE12018-01-082018-07-052018-07-05
NCT03392896Study of DCR-PHXC-101 in Normal Healthy Volunteers and Patients With Primary HyperoxaluriaCOMPLETEDPHASE12017-12-062019-11-192019-11-19
NCT03357380A Study on How Semaglutide Works on Early Stages of Scar Tissue in the Liver Assessed by Pictures of the LiverCOMPLETEDPHASE12017-11-282020-03-202020-03-20
NCT03377699Research Study Comparing Insulin Degludec to Insulin Detemir, Together With Insulin Aspart, in Pregnant Women With Type 1 DiabetesCOMPLETEDPHASE32017-11-222020-12-172020-12-17
NCT03308721Research Study Investigating Study Medicine (NNC9204-1177) for Weight Management in People With Overweight or ObesityCOMPLETEDPHASE12017-10-162020-01-032020-01-03
NCT03292185A Trial to Investigate the Single Dose Pharmacokinetics of Insulin Degludec/Liraglutide Compared With Insulin Degludec and Liraglutide in Healthy Chinese SubjectsCOMPLETEDPHASE12017-09-292018-01-022018-01-02
NCT03288740A Trial to Assess the Pharmacokinetics, Safety and Tolerability of Semaglutide in Healthy Chinese SubjectsCOMPLETEDPHASE12017-09-212018-08-072018-07-10
NCT03268005Research Study Comparing a New Medicine "Fast-acting Insulin Aspart" to Another Already Available Medicine "NovoRapid"/"NovoLog" in People With Type 2 DiabetesCOMPLETEDPHASE32017-09-192019-01-292019-01-07
NCT03061214Efficacy and Safety of Semaglutide Once-weekly Versus Sitagliptin Once-daily as add-on to Metformin in Subjects With Type 2 Diabetes (SUSTAIN - CHINA MRCT)COMPLETEDPHASE32017-08-282019-04-152019-03-14
NCT03196297A Trial Evaluating Efficacy and Safety of Prophylactic Administration of Concizumab in Patients With Severe Haemophilia A Without InhibitorsCOMPLETEDPHASE22017-08-162020-06-032018-06-22
NCT03212131Investigation of Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Multiple Doses of Somapacitan in Subjects With Mild and Moderate Degrees of Hepatic Impairment Compared to Subjects With Normal Hepatic Function.COMPLETEDPHASE12017-08-162018-03-082018-03-08
NCT03196284A Trial Evaluating the Efficacy and Safety of Prophylactic Administration of Concizumab in Haemophilia A and B Patients With InhibitorsCOMPLETEDPHASE22017-08-102020-01-312018-09-19
NCT03215498A Research Study of How Faster-acting Insulin Aspart Moves Into, Through, and Out of the Body and How it Works in the Body When Given Through an Insulin Pump to People With Type 1 DiabetesCOMPLETEDPHASE12017-07-032017-11-202017-11-20
NCT03191396Research Study Comparing a New Medicine Semaglutide to Liraglutide in People With Type 2 DiabetesCOMPLETEDPHASE32017-06-272018-08-132018-07-09
NCT03186495Investigation of Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Multiple Doses of Somapacitan in Subjects With Various Degrees of Impaired Renal Function Compared to Subjects With Normal Renal FunctionCOMPLETEDPHASE12017-06-202018-05-172018-05-17
NCT03172494A Trial Comparing Insulin Degludec/Liraglutide, Insulin Degludec, and Liraglutide in Chinese Subjects With Type 2 Diabetes Inadequately Controlled on Oral Antidiabetic Drugs (OADs)COMPLETEDPHASE32017-05-262019-07-132019-06-14
NCT03175120A Trial Comparing Insulin Degludec/Liraglutide and Insulin Degludec in Combination With Metformin in Chinese Subjects With Type 2 Diabetes Mellitus Inadequately Controlled With Basal Insulin Therapy and Metformin With or Without One Other Oral Antidiabetic Drug (OAD)COMPLETEDPHASE32017-05-262019-04-042019-03-05
NCT03095807Investigation of Single Ascending Doses of NNC9204-1706 in Male Subjects Being Overweight or With ObesityCOMPLETEDPHASE12017-03-202017-08-312017-08-31
NCT03086330Efficacy and Safety of Semaglutide Once-weekly Versus Placebo as add-on to SGLT-2i in Subjects With Type 2 Diabetes MellitusCOMPLETEDPHASE32017-03-152018-08-062018-07-04
NCT03136484Efficacy and Safety of Semaglutide Versus Canagliflozin as add-on to Metformin in Subjects With Type 2 DiabetesCOMPLETEDPHASE32017-03-152018-11-162018-10-16
NCT03078478A Trial Comparing the Efficacy and Safety of Insulin Degludec and Insulin Glargine 300 Units/mL in Subjects With Type 2 Diabetes Mellitus Inadequately Treated With Basal Insulin With or Without Oral Antidiabetic DrugsCOMPLETEDPHASE32017-03-132019-03-042019-02-13
NCT03075670A Trial Comparing Nonacog Beta Pegol (N9-GP) and ALPROLIX® in Patients With Haemophilia BCOMPLETEDPHASE12017-03-072017-12-082017-12-08
NCT03075644A Trial to Evaluate the Safety of Once Weekly Dosing of Somapacitan (NNC0195-0092) and Daily Norditropin® FlexPro® for 52 Weeks in Previously Human Growth Hormone Treated Japanese Adults With Growth Hormone DeficiencyCOMPLETEDPHASE32017-03-032018-10-042018-10-04
NCT02964247LIRA-ADD2SGLT2i - Liraglutide Versus Placebo as add-on to SGLT2 Inhibitors.COMPLETEDPHASE32017-03-032018-05-082018-05-04
NCT02963922Effect and Safety of Liraglutide 3.0 mg in Subjects With Overweight or Obesity and Type 2 Diabetes Mellitus Treated With Basal InsulinCOMPLETEDPHASE32017-02-062018-09-252018-09-10
NCT02963935Effect and Safety of Liraglutide 3.0 mg as an Adjunct to Intensive Behaviour Therapy for Obesity in a Non-specialist SettingCOMPLETEDPHASE32017-02-062018-06-192018-05-23
NCT03021187Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 Diabetes Mellitus Treated With InsulinCOMPLETEDPHASE32017-02-022018-08-222018-01-18
NCT02994407Safety, Tolerability, and Pharmacokinetics Study of Turoctocog Alfa Pegol Injected Under the Skin in Patients With Haemophilia ACOMPLETEDPHASE12017-01-302018-10-152018-10-15
NCT02692716A Trial Investigating the Cardiovascular Safety of Oral Semaglutide in Subjects With Type 2 DiabetesCOMPLETEDPHASE32017-01-172018-09-252018-09-25
NCT03015220Safety and Efficacy of Oral Semaglutide Versus Dulaglutide Both in Combination With One OAD (Oral Antidiabetic Drug) in Japanese Subjects With Type 2 DiabetesCOMPLETEDPHASE32017-01-102018-07-122018-07-12
NCT03018028Dose-response, Safety and Efficacy of Oral Semaglutide Versus Placebo and Versus Liraglutide, All as Monotherapy in Japanese Subjects With Type 2 DiabetesCOMPLETEDPHASE32017-01-102018-08-152018-01-09
NCT03015207First Human Dose Trial Investigating Safety, Tolerability and Pharmacokinetics of NNC0194-0499 in Male Subjects With Overweight or ObesityCOMPLETEDPHASE12017-01-062017-10-262017-10-26
NCT03010475A Trial Investigating the Effect of Oral Semaglutide on the Pharmacokinetics of Furosemide and Rosuvastatin in Healthy SubjectsCOMPLETEDPHASE12017-01-052017-08-092017-06-04
NCT02938585Efficacy and Safety of Turoctocog Alfa for Prophylaxis and Treatment of Bleeding Episodes in Previously Treated Chinese Patients With Haemophilia ACOMPLETEDPHASE32016-12-122018-12-122018-03-16
NCT02970942Investigation of Efficacy and Safety of Three Dose Levels of Subcutaneous Semaglutide Once Daily Versus Placebo in Subjects With Non-alcoholic Steatohepatitis.COMPLETEDPHASE22016-11-302020-03-192020-02-13
NCT02964104A Trial Investigating the Safety, Tolerability, Pharmacokinetics (the Exposure of the Trial Drug in the Body) and Pharmacodynamics (the Effect of the Investigated Drug on the Body) of Insulin 287 in Subjects With Type 2 DiabetesCOMPLETEDPHASE12016-11-152017-12-122017-12-12
NCT02958085Investigation of Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Dosing of NNC0174-0833 in Subjects With Obesity or OverweightCOMPLETEDPHASE12016-11-042018-01-242018-01-24
NCT02962440A Trial Investigating the Absorption, Metabolism and Excretion of Somapacitan After Single Dosing in Healthy Male SubjectsCOMPLETEDPHASE12016-112017-012017-01
NCT02938572A Randomised Proof-of-Principle Trial Investigating Pharmacodynamics, Pharmacokinetics, and Safety of NNC0143-0406 in Subjects With Type 1 Diabetes MellitusCOMPLETEDPHASE12016-10-192017-07-042017-06-17
NCT02933853A Trial Investigating the Pharmacokinetic and Pharmacodynamic Properties of Faster-acting Insulin Aspart in Subjects With Type 2 Diabetes MellitusCOMPLETEDPHASE12016-10-142017-12-212017-12-21
NCT02941354Evaluating the Pharmacokinetics of NovoEight® (Turoctocog Alfa) in Relation to BMI in Subjects With Haemophilia ACOMPLETEDPHASE12016-10-102017-06-202017-06-20
NCT02941042A First Human Dose Trial Investigating Safety, Tolerability and Pharmacokinetics for Single Doses of NNC9204-1177 in Subjects Being Overweight or With Obesity.COMPLETEDPHASE12016-10-102017-09-302017-09-30
NCT02920385A Trial Investigating the Influence of Oral Semaglutide on the Pharmacokinetics of Levothyroxine and the Influence of Co-administered Tablets on the Pharmacokinetics of Semaglutide Administered Orally in Healthy Subjects.COMPLETEDPHASE12016-10-102017-06-162017-04-26
NCT02920398A Multi-centre, Comparative, Double Blind, Randomised Cross-over Trial Investigating Single Dose Pharmacokinetics and Safety of Turoctocog Alfa Pegol From the Pivotal Process and Turoctocog Alfa Pegol From the Commercial Process in Patients With Severe Haemophilia ACOMPLETEDPHASE12016-10-042017-04-072017-04-07
NCT02918279Effect of Liraglutide for Weight Management in Pubertal Adolescent Subjects With ObesityCOMPLETEDPHASE32016-09-292019-08-082019-02-14
NCT02911870A Thorough QTc Trial Evaluating the Effect of SNAC on Cardiac Repolarisation in Healthy Male Subjects.COMPLETEDPHASE12016-09-232017-05-112017-05-04
NCT02911948A Double-blinded Trial Comparing the Efficacy and Safety of Insulin Degludec/Liraglutide and Insulin Degludec Both in Combination With Metformin in Japanese Subjects With Type 2 Diabetes Mellitus Inadequately Controlled With Basal or Pre-mix/Combination Insulin Therapy and Oral Anti-diabetic DrugsCOMPLETEDPHASE32016-09-212017-11-222017-11-17
NCT02906930Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 Diabetes Mellitus Treated With Diet and Exercise OnlyCOMPLETEDPHASE32016-09-202017-12-082017-10-30
NCT02849080Efficacy and Safety of Oral Semaglutide Using a Flexible Dose Adjustment Based on Clinical Evaluation Versus Sitagliptin in Subjects With Type 2 Diabetes Mellitus.COMPLETEDPHASE32016-09-202019-03-272018-02-28
NCT02827708Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 Diabetes and Moderate Renal ImpairmentCOMPLETEDPHASE32016-09-202018-05-152018-04-10
NCT02906917A 38 Week Trial Comparing Effect and Safety of Insulin Degludec/Insulin Aspart vs. Insulin Glargine Plus Insulin Aspart in Subjects With Type 2 Diabetes Treated With Basal Insulin With or Without Oral Antidiabetic Treatment in Need of Treatment IntensificationCOMPLETEDPHASE32016-09-202017-12-242017-08-31
NCT02868229Study to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of Multiple Doses of COR-001COMPLETEDPHASE1, PHASE22016-09-122018-12-112018-12-11
NCT02877355Investigation of the Effect of Upper Gastrointestinal Disease on the Pharmacokinetics of Oral Semaglutide in Subjects With Type 2 Diabetes.COMPLETEDPHASE12016-08-222017-11-242017-11-24
NCT02870231Investigating Safety, Tolerability, PK and PD for Multiple Doses of NNC9204-0530 in Combination With Liraglutide in Male and Female Subjects Being Overweight or With ObesityCOMPLETEDPHASE12016-08-182017-09-032017-09-03
NCT02863419Efficacy and Safety of Oral Semaglutide Versus Liraglutide and Versus Placebo in Subjects With Type 2 Diabetes MellitusCOMPLETEDPHASE32016-08-102018-03-302017-08-19
NCT02863328Efficacy and Safety of Oral Semaglutide Versus Empagliflozin in Subjects With Type 2 Diabetes MellitusCOMPLETEDPHASE32016-08-102018-03-082017-08-01
NCT02844790A Trial Investigating the Pharmacokinetic Properties of Insulin Degludec/Insulin Aspart in Healthy Chinese SubjectsCOMPLETEDPHASE12016-07-262016-09-272016-09-26
NCT02835235A Trial Investigating Safety, Tolerability, PK and PD for Multiple Doses of NNC9204-0530 in Male and Female Subjects Being Overweight or With ObesityCOMPLETEDPHASE12016-07-262017-07-072017-07-07
NCT02825251Efficacy and Safety of Continuous Subcutaneous Insulin Infusion of Faster-acting Insulin Aspart Compared to NovoRapid® in Adults With Type 1 DiabetesCOMPLETEDPHASE32016-07-062017-07-212017-06-20
NCT02845219A Trial Investigating the Influence of Oral Semaglutide on Pharmacokinetics of Ethinylestradiol and Levonorgestrel in an Oral Contraceptive Combination Drug in Healthy Postmenopausal FemalesCOMPLETEDPHASE12016-072016-122016-12
NCT02773381A Trial Investigating the Effect of Oral Semaglutide Compared With Placebo on Postprandial Glucose and Triglyceride Metabolism, Energy Intake, Appetite Sensations and Gastric Emptying in Subjects With Type 2 DiabetesCOMPLETEDPHASE12016-06-022018-10-192018-10-19
NCT02773368A Clinical Trial Comparing Glycaemic Control and Safety of Insulin Degludec/Liraglutide (IDegLira) Versus Insulin Glargine (IGlar) as add-on Therapy to SGLT2i in Subjects With Type 2 Diabetes MellitusCOMPLETEDPHASE32016-05-232017-10-232017-09-26
NCT02795325A Study of DCR-PH1 in Patients With Primary Hyperoxaluria Type 1 (PH1)TERMINATEDPHASE12016-05-132016-10-142016-10-14
NCT02500706Efficacy and Safety of Faster-acting Insulin Aspart Compared to NovoRapid® Both in Combination With Insulin Degludec in Adults With Type 1 DiabetesCOMPLETEDPHASE32016-05-042017-08-162017-07-17
NCT02670915Efficacy and Safety of Faster-acting Insulin Aspart Compared to NovoRapid® Both in Combination With Insulin Degludec in Children and Adolescents With Type 1 DiabetesCOMPLETEDPHASE32016-05-042018-03-032018-02-05
NCT02762578Comparing Efficacy and Safety of Insulin Degludec/Insulin Aspart and BIAsp 30 in Subjects With Type 2 DiabetesCOMPLETEDPHASE32016-05-032017-06-192017-05-19
NCT02719574Open-label Study of FT-2102 With or Without Azacitidine or Cytarabine in Patients With AML or MDS With an IDH1 MutationCOMPLETEDPHASE1, PHASE22016-04-302024-01-242023-12-28
NCT02616562Investigating Efficacy and Safety of Once-weekly NNC0195-0092 Treatment Compared to Daily Growth Hormone Treatment (Norditropin® FlexPro®) in Growth Hormone Treatment naïve Pre-pubertal Children With Growth Hormone DeficiencyCOMPLETEDPHASE22016-03-312024-09-262024-09-26
NCT02730377Efficacy in Controlling Glycaemia With Victoza® (Liraglutide) as add-on to Metformin vs. OADs as add-on to Metformin After up to 104 Weeks of Treatment in Subjects With Type 2 DiabetesCOMPLETEDPHASE42016-03-282019-08-122019-08-05
NCT02717858A Trial to Assess the Effects of Liraglutide on Gallbladder Emptying in Overweight and Obese Subjects.COMPLETEDPHASE12016-03-162017-02-272017-02-27
NCT02696148A Trial to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Liraglutide in Obese Children Aged 7 to 11 YearsCOMPLETEDPHASE12016-03-142017-04-132017-04-13
NCT02607865Efficacy and Long-term Safety of Oral Semaglutide Versus Sitagliptin in Subjects With Type 2 DiabetesCOMPLETEDPHASE32016-02-152018-03-282017-02-14
NCT02501161A 104 Week Clinical Trial Comparing Long Term Glycaemic Control of Insulin Degludec/Liraglutide (IDegLira) Versus Insulin Glargine Therapy in Subjects With Type 2 Diabetes MellitusCOMPLETEDPHASE32016-01-312018-10-032018-10-03
NCT02648204Efficacy and Safety of Semaglutide Versus Dulaglutide as add-on to Metformin in Subjects With Type 2 Diabetes.COMPLETEDPHASE32016-01-062017-05-192017-04-10
NCT02648217Comparing Efficacy and Safety of Insulin Degludec/Insulin Aspart Twice Daily and Biphasic Insulin Aspart Twice Daily in Subjects With Type 2 Diabetes Mellitus Before, During and After RamadanCOMPLETEDPHASE32016-01-042016-09-052016-09-04
NCT02627287A Comparative Trial Focusing on Injections With the Medical Device DV3316 Pen-injector Versus FlexPen®COMPLETEDPHASE12015-12-012016-02-252016-02-25
NCT02617693Development of Pre-pregnancy Intervention to Reduce the Risk of Diabetes and PrediabetesCOMPLETEDPHASE42015-11-232017-12-092017-12-09
NCT02607306A Trial Comparing the Efficacy and Safety of Insulin Degludec/Liraglutide, Insulin Degludec and Liraglutide in Japanese Subjects With Type 2 Diabetes Mellitus.COMPLETEDPHASE32015-11-182017-12-222017-12-15
NCT02443155A Clinical Proof-of-principle Trial in Adult Subjects With Newly Diagnosed Type 1 Diabetes Mellitus Investigating the Effect of NNC0114-0006 and Liraglutide on Preservation of Beta-cell FunctionCOMPLETEDPHASE22015-11-102019-02-272018-08-31
NCT02527200Effect of Liraglutide for Weight Management in Paediatric Subjects With Prader-Willi SyndromeCOMPLETEDPHASE32015-11-092020-11-192020-11-04
NCT02612844A Trial Investigating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Subcutaneous NNC0143-0406 A 0.6 mmol/L in Subjects With Type 1 DiabetesCOMPLETEDPHASE12015-112016-062016-06
NCT02594033A Trial to Investigate Different Needle Features Assessed by Comparing Insulin Aspart Pharmacokinetic ProfilesCOMPLETEDPHASE12015-10-272016-01-282016-01-28
NCT02582242Comparing Efficacy and Safety of Thrice Daily Versus Twice Daily NovoMix® 30 (Biphasic Insulin Aspart 30) in Subjects With Type 2 Diabetes Inadequately Controlled With Basal InsulinCOMPLETEDPHASE42015-10-192017-04-182017-03-18
NCT02568280Investigating the Postprandial Glucose Metabolism After Treatment With Faster-acting Insulin Aspart in Subjects With Type 1 DiabetesCOMPLETEDPHASE12015-10-062016-04-252016-04-25
NCT02568306A First Human Dose Trial Investigating Safety, Tolerability and Pharmacokinetics for Single Doses and Multiple Doses of NNC0165-1562 in Overweight to Obese But Otherwise Healthy SubjectsCOMPLETEDPHASE12015-10-052017-02-072017-02-07
NCT02453711Investigation of Safety and Efficacy of Once-daily Semaglutide in Obese Subjects Without Diabetes MellitusCOMPLETEDPHASE22015-10-012017-04-122017-03-30
NCT02461589Dose-finding of Semaglutide Administered Subcutaneously Once Daily Versus Placebo and Liraglutide in Subjects With Type 2 DiabetesCOMPLETEDPHASE22015-09-212016-10-132016-10-13
NCT02490787Trial Investigating Safety, Pharmacokinetics and Pharmacodynamics of Concizumab Administered Subcutaneously to Haemophilia A SubjectsCOMPLETEDPHASE12015-09-102016-10-142016-10-14
NCT02543879Study of a Novel BET Inhibitor FT-1101 in Patients With Relapsed or Refractory Hematologic MalignanciesCOMPLETEDPHASE12015-092019-032019-03
NCT02557620Comparing Semaglutide Administered Subcutaneously Once Daily to Semaglutide Administered Subcutaneously Once WeeklyCOMPLETEDPHASE12015-092016-042016-04
NCT02536859Comparing Pharmacodynamic and Pharmacokinetic Properties of Insulin Degludec and Insulin Glargine 300 U/mL at Steady-state Conditions in Subjects With Type 1 Diabetes MellitusCOMPLETEDPHASE12015-08-312016-04-142016-04-14
NCT02453685A Study to Compare Insulin Intensification of Biphasic Insulin Aspart 30 and Insulin Analogues (Insulin Glargine and Insulin Aspart) in Insulin naïve Type 2 Diabetic PatientsCOMPLETEDPHASE42015-08-312016-09-202016-09-20
NCT02420262A Clinical Trial Comparing Efficacy and Safety of Insulin Degludec/Liraglutide (IDegLira) Versus Basal-bolus Therapy in Subjects With Type 2 Diabetes MellitusCOMPLETEDPHASE32015-07-262016-10-052016-10-05
NCT02505334A Trial Comparing the Efficacy and Safety of Liraglutide 1.8 mg/Day to Liraglutide 0.9 mg/Day in Japanese Subjects With Type 2 Diabetes Mellitus.COMPLETEDPHASE32015-07-212017-11-092017-05-02
NCT02470039Trial to Compare NNC0123-0000-0338 in a Tablet Formulation and Insulin Glargine in Subjects With Type 2 Diabetes Currently Treated With Oral Antidiabetic TherapyCOMPLETEDPHASE22015-06-012015-12-312015-12-31
NCT02479022A Trial Investigating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Insulin 320 in Healthy SubjectsCOMPLETEDPHASE12015-062015-122015-12
NCT02541942Pharmacogenetic Testing of Saliva Samples From Patients With Five or More Exposure Days to rFVIIa Analogue in the Adept™2 TrialCOMPLETEDPHASE22015-04-032016-04-152016-04-15
NCT02382939A Trial to Compare the Safety of Once Weekly Dosing of Somapacitan With Daily Norditropin® FlexPro® for 26 Weeks in Previously Human Growth Hormone Treated Adults With Growth Hormone DeficiencyCOMPLETEDPHASE32015-02-122016-01-042016-01-04
NCT02314052Phase Ib/2, Multicenter, Dose Escalation Study of DCR-MYC in Patients With Hepatocellular CarcinomaTERMINATEDPHASE1, PHASE22015-01-272016-10-112016-10-11
NCT02305381Efficacy and Safety of Semaglutide Once-weekly Versus Placebo as add-on to Basal Insulin Alone or Basal Insulin in Combination With Metformin in Subjects With Type 2 DiabetesCOMPLETEDPHASE32014-12-012015-11-212015-11-21
NCT02300844Investigation on Safety, Tolerability and Pharmacokinetics of Single Doses of NNC0174-0833 in Normal Weight, Overweight to Obese But Otherwise Healthy Male SubjectsCOMPLETEDPHASE12014-12-012016-03-212016-03-21
NCT02304627Effect of Food on the Pharmacokinetics of NNC0123-0000-0338 in a Tablet Formulation in Healthy SubjectsCOMPLETEDPHASE12014-11-242015-07-312015-07-31
NCT02298192A Clinical Trial Comparing Efficacy and Safety of Insulin Degludec/Liraglutide (IDegLira) in Subjects With Type 2 Diabetes Mellitus Using Two Different Titration AlgorithmsCOMPLETEDPHASE32014-11-212015-12-232015-12-23
NCT02229851Trial to Compare the Efficacy and Safety of NNC0195-0092 (Somapacitan) With Placebo and Norditropin® FlexPro® (Somatropin) in Adults With Growth Hormone Deficiency.COMPLETEDPHASE32014-10-312018-05-072017-04-21
NCT02254291A Trial Comparing the Safety and Efficacy of Semaglutide Once Weekly Versus Sitagliptin Once Daily in Japanese Subjects With Type 2 DiabetesCOMPLETEDPHASE32014-10-022015-11-112015-11-11
NCT02249871Investigating the Influence of Omeprazole on the Pharmacokinetics of Oral Semaglutide in Healthy SubjectsCOMPLETEDPHASE12014-09-242015-04-012015-04-01
NCT02249910Investigating the Influence of Oral Semaglutide on Pharmacokinetics of Metformin and Digoxin in Healthy SubjectsCOMPLETEDPHASE12014-09-182015-03-062015-03-06
NCT02243098Investigating the Influence of Semaglutide on the Pharmacokinetics of Single Doses of Atorvastatin and Digoxin in Healthy SubjectsCOMPLETEDPHASE12014-09-162015-04-072015-04-07
NCT02235961Investigate Safety, Tolerability and Pharmacokinetics for Single Doses of NNC9204-0530 Alone and in Combination With Liraglutide in Overweight to Obese But Otherwise Healthy Male SubjectsCOMPLETEDPHASE12014-09-042016-07-062016-07-06
NCT02231684Investigating the Pharmacokinetics of Subcutaneous Injections With 1 mg/mL, 3 mg/mL, and 10 mg/mL Semaglutide Strengths and the Absolute Bioavailability of SemaglutideCOMPLETEDPHASE12014-092015-012015-01
NCT02097264A Trial Investigating the Mechanism of Action of NNC0109-0012 (Anti-IL-20 mAb) Through Synovial Biopsies in Subjects With Rheumatoid Arthritis and an Inadequate Response to MethotrexateWITHDRAWNPHASE22014-092015-092015-09
NCT02220296A Trial Investigating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Subcutaneous NNC0123-0338 in Healthy Subjects and in Subjects With Type 1 Diabetes MellitusCOMPLETEDPHASE12014-08-202015-03-312015-03-31
NCT02205528A Study of Once-Daily NNC0090-2746 in Participants With Type 2 Diabetes Inadequately Controlled With MetforminCOMPLETEDPHASE22014-08-182015-09-152015-09-15
NCT02212067A Trial Investigating the Effects of Semaglutide on ß-cell Function in Subjects With Type 2 DiabetesCOMPLETEDPHASE12014-08-112015-05-112015-05-11
NCT02210871Investigating the Pharmacokinetics, Safety and Tolerability After a Single Subcutaneous Injection of Semaglutide in Subjects With Mild, Moderate or Severe Hepatic Impairment Compared to Subjects With Normal Hepatic FunctionCOMPLETEDPHASE12014-08-072015-06-032015-06-03
NCT02128932Efficacy and Safety of Semaglutide Once Weekly Versus Insulin Glargine Once Daily as add-on to Metformin With or Without Sulphonylurea in Insulin-naïve Subjects With Type 2 DiabetesCOMPLETEDPHASE32014-08-042015-09-032015-09-03
NCT02207374A Trial Comparing the Safety and Efficacy of Semaglutide Once Weekly in Monotherapy or in Combination With One OAD in Japanese Subjects With Type 2 DiabetesCOMPLETEDPHASE32014-08-042016-02-272016-02-27
NCT02207348Investigating Bioequivalence Between Single-dose Liraglutide Administered Subcutaneously With Two Different Pen-injectorsCOMPLETEDPHASE12014-082014-092014-09
NCT02141074Safety and Efficacy of Nonacog Beta Pegol (N9-GP) in Previously Untreated Patients With Haemophilia BCOMPLETEDPHASE32014-07-022022-10-272022-10-27
NCT02137850Safety and Efficacy of Turoctocog Alfa Pegol (N8-GP) in Previously Untreated Patients With Haemophilia ACOMPLETEDPHASE32014-06-262023-06-072023-06-07
NCT02131272A Trial Investigating the Efficacy and Safety of Insulin Detemir Versus Insulin NPH in Combination With Metformin and Diet/Exercise in Children and Adolescents With Type 2 Diabetes Insufficiently Controlled on Metformin With or Without Other Oral Antidiabetic Drug(s) With or Without Basal InsulinTERMINATEDPHASE32014-06-112016-06-142016-06-14
NCT02161588A Trial to Assess the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Oral Semaglutide in Healthy Male Japanese and Caucasian SubjectsCOMPLETEDPHASE12014-062014-112014-11
NCT02172313Effect of Food on the Pharmacokinetics of Oral Semaglutide in Healthy SubjectsCOMPLETEDPHASE12014-062014-102014-10
NCT02148861A Trial Investigating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Subcutaneously Administered NNC0148-0287 (Insulin 287) in Subjects With Type 2 DiabetesCOMPLETEDPHASE12014-05-262015-06-012015-06-01
NCT02147431A Trial Investigating the Effect of Semaglutide on Hypoglycaemic Counterregulation Compared to Placebo in Subjects With Type 2 DiabetesCOMPLETEDPHASE12014-05-212015-05-202015-05-20
NCT02146079A Trial to Assess the Pharmacokinetics, Pharmacodynamics, and the Safety and Tolerability of Semaglutide in Healthy Male Japanese and Caucasian SubjectsCOMPLETEDPHASE12014-05-212014-10-202014-10-20
NCT02131246A Randomised Trial Investigating the Pharmacokinetic and Pharmacodynamic Properties of Faster-acting Insulin Aspart in Subjects With Type 1 DiabetesCOMPLETEDPHASE12014-052014-072014-07
NCT02098395The Efficacy and Safety of Liraglutide Adjunct to Insulin Treatment in Type 1 DiabetesCOMPLETEDPHASE32014-052015-042015-04
NCT02110563Phase I, Multicenter, Dose Escalation Study of DCR-MYC in Patients With Solid Tumors, Multiple Myeloma, or LymphomaTERMINATEDPHASE12014-042016-11-032016-10-05
NCT02100475A Trial Comparing Sequential Addition of Insulin Aspart Versus Further Dose Increase With Insulin Degludec/Liraglutide in Subjects With Type 2 Diabetes Mellitus, Previously Treated With Insulin Degludec/Liraglutide and Metformin and in Need of Further IntensificationCOMPLETEDPHASE32014-042015-042015-04
NCT02089451A Trial Comparing the Pharmacokinetic Properties of Faster-acting Insulin Aspart (FIAsp) After Different Injection Regions and Routes of Administration in Healthy SubjectsCOMPLETEDPHASE12014-03-172014-06-062014-06-06
NCT02079870Trial Investigating the Effect of Semaglutide on Energy Intake, Appetite Sensations, Postprandial Glucose and Triglyceride Metabolism and Gastric Emptying in Obese Subjects Compared With PlaceboCOMPLETEDPHASE12014-03-062015-01-072015-01-07
NCT02094521Evaluation of Optimal Dosing Conditions for GLP-1 Analogue NNC0113-0987 When Administered Orally in Healthy Male SubjectsCOMPLETEDPHASE12014-032014-072014-07
NCT02084810Investigating the Bioequivalence of Eptacog Alfa A 6 mg and NovoSeven® in Healthy Male SubjectsWITHDRAWNPHASE12014-032014-072014-07
NCT02070510A Trial Investigating the Influence of Oral Semaglutide on the Pharmacokinetics of Lisinopril and Warfarin in Healthy SubjectsCOMPLETEDPHASE12014-02-272014-08-202014-08-20
NCT02064348A Thorough QTc Evaluation of the Effect of Semaglutide on Cardiac Repolarisation in Healthy SubjectsCOMPLETEDPHASE12014-02-262015-04-232015-04-23
NCT02060266Trial Investigating the Absorption, Metabolism and Excretion After a Single Subcutaneous Dose of [3H]-Semaglutide in Healthy Male SubjectsCOMPLETEDPHASE12014-02-042014-04-282014-04-28
NCT02054897Efficacy and Safety of Semaglutide Once-weekly Versus Placebo in Drug-naïve Subjects With Type 2 DiabetesCOMPLETEDPHASE32014-02-032015-05-082015-05-08
NCT02035371A Trial Investigating the Pharmacokinetic Properties of FIAsp in Children, Adolescents and Adults With Type 1 DiabetesCOMPLETEDPHASE12014-01-132014-07-242014-07-24
NCT01917656Efficacy and Safety of Liraglutide Versus Sulphonylurea Both in Combination With Metformin During Ramadan in Subjects With Type 2 DiabetesCOMPLETEDPHASE42014-01-092014-09-042014-09-01
NCT02030600A Trial Comparing the Safety and Efficacy of Insulin Degludec and Insulin Glargine, With or Without OADs in Subjects With Type 2 DiabetesCOMPLETEDPHASE32014-01-062015-12-042015-12-04
NCT02034513A Trial Comparing the Safety and Efficacy of Insulin Degludec and Insulin Glargine, Both With Insulin Aspart as Mealtime Insulin in Subjects With Type 1 DiabetesCOMPLETEDPHASE32014-01-052016-01-112016-01-11
NCT02033239A Trial Investigating the Pharmacodynamic Response of Faster Acting Insulin Aspart in Subjects With Type 1 DiabetesCOMPLETEDPHASE12014-012014-062014-06
NCT02022254Influence of Semaglutide on Pharmacokinetics and Pharmacodynamics of Warfarin and Pharmacokinetics of Metformin in Healthy SubjectsCOMPLETEDPHASE12013-12-172014-08-282014-08-28
NCT01973244A Trial Investigating Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of a Single Dose of Long-acting Growth Hormone (Somapacitan) Compared to Daily Dosing of Norditropin® SimpleXx® in Children With Growth Hormone DeficiencyCOMPLETEDPHASE12013-12-162014-11-042014-11-04
NCT02016911Pharmacokinetics, Safety and Tolerability of Oral Semaglutide in Subjects With Hepatic ImpairmentCOMPLETEDPHASE12013-12-122015-01-122015-01-12
NCT02014259Pharmacokinetics, Safety and Tolerability of Oral Semaglutide in Subjects With Various Degrees of Impaired Renal FunctionCOMPLETEDPHASE12013-12-112014-10-242014-10-24
NCT01923181Multiple Dose Trial Examining Dose Range, Escalation and Efficacy of Oral Semaglutide in Subjects With Type 2 DiabetesCOMPLETEDPHASE22013-12-022014-12-112014-12-11
NCT01930188Efficacy and Safety of Semaglutide Once-weekly Versus Sitagliptin Once-daily as add-on to Metformin and/or TZD in Subjects With Type 2 DiabetesCOMPLETEDPHASE32013-12-022015-10-122015-10-12
NCT01885208Efficacy and Safety of Semaglutide Once-weekly Versus Exenatide ER 2.0 mg Once-weekly as add-on to 1-2 Oral Antidiabetic Drugs (OADs) in Subjects With Type 2 DiabetesCOMPLETEDPHASE32013-12-022015-07-132015-07-13
NCT01907854Efficacy and Safety of Switching From Sitagliptin to Liraglutide in Subjects With Type 2 Diabetes Not Achieving Adequate Glycaemic Control on Sitagliptin and MetforminCOMPLETEDPHASE42013-12-022015-06-152015-06-15
NCT02008682The Efficacy and Safety of Liraglutide Compared to Sitagliptin, Both in Combination With Metformin in Chinese Subjects With Type 2 DiabetesCOMPLETEDPHASE42013-122014-112014-11
NCT02003677A Trial Investigating the Pharmacokinetic and Pharmacodynamic Properties of FIAsp in Geriatric and Younger Adult Subjects With Type 1 DiabetesCOMPLETEDPHASE12013-11-292014-08-142014-08-14
NCT01999322A Trial Evaluating Compatibility and Safety of FIAsp and Insulin Aspart With an External Continuous Subcutaneous Insulin Infusion System in Adult Subjects With Type 1 DiabetesCOMPLETEDPHASE32013-11-192014-05-142014-05-14
NCT01836523The Efficacy and Safety of Liraglutide as Adjunct Therapy to Insulin in the Treatment of Type 1 DiabetesCOMPLETEDPHASE32013-112015-062015-06
NCT01992588A Trial Investigating the Pharmacokinetic and Pharmacodynamic Properties of FIAsp When Administered as a Bolus in a Continuous Subcutaneous Infusion Regimen in Subjects With Type 1 DiabetesCOMPLETEDPHASE12013-112014-032014-03
NCT01978613Investigation on Safety, Tolerability and Pharmacokinetics of Multiple Doses of NNC0113-0987 in an Oral Formulation in Healthy SubjectsCOMPLETEDPHASE12013-112014-062014-06
NCT01959529A Trial Comparing Cardiovascular Safety of Insulin Degludec Versus Insulin Glargine in Subjects With Type 2 Diabetes at High Risk of Cardiovascular EventsCOMPLETEDPHASE32013-10-292016-10-162016-10-16
NCT01835431A Trial Investigating the Efficacy and Safety of Insulin Degludec/Insulin Aspart Once Daily Plus Insulin Aspart for the Remaining Meals Versus Insulin Detemir Once or Twice Daily Plus Meal Time Insulin Aspart in Children and Adolescents With Type 1 Diabetes MellitusCOMPLETEDPHASE32013-10-172014-11-072014-11-07
NCT01973231Efficacy and Safety of Liraglutide Versus Lixisenatide as add-on to Metformin in Subjects With Type 2 DiabetesCOMPLETEDPHASE42013-102014-112014-11
NCT01967589Investigation on Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Doses of a Long Acting GLP-1 Analogue (NNC0113-0987) in Healthy Male SubjectsCOMPLETEDPHASE12013-102014-052014-05
NCT01850615Efficacy and Safety of FIAsp in a Basal-bolus Regimen Versus Basal Insulin Therapy, Both in Combination With Metformin in Adult Subjects With Type 2 DiabetesCOMPLETEDPHASE32013-09-232014-11-172014-11-17
NCT01952145A Trial Comparing the Efficacy and Safety of Insulin Degludec/Liraglutide Versus Insulin Glargine in Subjects With Type 2 Diabetes MellitusCOMPLETEDPHASE32013-09-202014-11-042014-11-04
NCT01819129Efficacy and Safety of FIAsp Compared to Insulin Aspart in Combination With Insulin Glargine and Metformin in Adults With Type 2 DiabetesCOMPLETEDPHASE32013-09-092015-01-222015-01-22
NCT01943084A Trial to Investigate the Bioequivalence of Norditropin® (Somatropin) Versus Genotropin® (Somatropin) in Healthy Adult SubjectsCOMPLETEDPHASE12013-092013-102013-10
NCT01949792A Trial Investigating the Pharmacokinetics and Pharmacodynamics of rFVIIa in Patients With Haemophilia A or B With or Without InhibitorsCOMPLETEDPHASE12013-092013-112013-11
NCT01955603A Trial to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of NNC0215-0384 Administered to Subjects With Moderate to Severe Rheumatoid ArthritisCOMPLETEDPHASE12013-092014-102014-10
NCT01934712A Trial Investigating the Pharmacokinetic Properties of FIAsp in Japanese Subjects With Type 1 DiabetesCOMPLETEDPHASE12013-08-302014-01-282014-01-28
NCT01831765Efficacy and Safety of FIAsp Compared to Insulin Aspart Both in Combination With Insulin Detemir in Adults With Type 1 DiabetesCOMPLETEDPHASE32013-08-262015-06-112015-05-12
NCT01927861Investigating the Long-term Efficacy and Safety of Two Doses of NN-220 (Somatropin) in Short Stature Due to Noonan SyndromeCOMPLETEDPHASE32013-08-192018-07-122018-07-12
NCT01924637A Trial Investigating the Pharmacokinetic and Pharmacodynamic Properties of FIAsp in Subjects With Type 1 DiabetesCOMPLETEDPHASE12013-082013-112013-11
NCT01931137A Trial Investigating the Pharmacokinetics and Pharmacodynamics of NNC0123-0000-0338 in a Tablet Formulation With Three Different Coatings in Healthy SubjectsCOMPLETEDPHASE12013-082013-122013-12
NCT01916174A Trial to Demonstrate Bioequivalence Between Two Insulin Degludec/Liraglutide Formulations, B5 and V2 in Healthy SubjectsCOMPLETEDPHASE12013-082013-112013-11
NCT01512095Bioequivalence of Two Products (Norditropin® Versus Nutropin AQ®) in Healthy Adult VolunteersWITHDRAWNPHASE12013-082013-112013-11
NCT01849289A Trial Comparing Efficacy and Safety of Insulin Degludec and Insulin Glargine in Insulin naïve Subjects With Type 2 DiabetesCOMPLETEDPHASE32013-06-022014-05-152014-05-15
NCT01868542A Trial Comparing the Glycaemic Control of Levemir® Administered Once Daily According to Two Insulin Detemir Titration Algorithms After 20 Weeks in Subjects With Type 2 Diabetes Mellitus Inadequately Controlled on Metformin Treatment With or Without Other Anti-diabetic Drugs (OADs)COMPLETEDPHASE42013-062015-052015-05
NCT01880736A Trial Investigating the Efficacy and Safety of Flexible vs. Fixed Dosing and Simple vs. Stepwise Titration With Once Daily (OD) Insulin Degludec in Inadequately Treated Subjects With Type 2 DiabetesCOMPLETEDPHASE32013-062014-042014-04
NCT01892020Investigating Efficacy and Safety of Biphasic Insulin Aspart 50 Twice Daily Versus Biphasic Human Insulin 50 Twice Daily Both in Combination With Metformin in Chinese Subjects With Type 2 Diabetes MellitusCOMPLETEDPHASE42013-062014-052014-05
NCT01866748Investigation on Safety, Tolerability and Pharmacokinetics of Single and Multiple Doses of a Long-acting GLP-1 Analogue (Semaglutide) in an Oral Formulation in Healthy Male SubjectsCOMPLETEDPHASE12013-052014-042014-04
NCT01809184A Trial Investigating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of NNC0148-0000-0287 in Healthy SubjectsCOMPLETEDPHASE12013-03-042013-09-062013-09-06
NCT01814137A Randomised Trial Comparing Efficacy and Safety After Intensification With Either Insulin Aspart Once Daily as add-on or Changing to Basal Bolus Treatment With Insulin Degludec and Insulin Aspart in Subjects With Type 2 Diabetes Previously Treated With Insulin Degludec/Insulin Aspart Twice DailyCOMPLETEDPHASE32013-032014-032014-03
NCT01720446Trial to Evaluate Cardiovascular and Other Long-term Outcomes With Semaglutide in Subjects With Type 2 DiabetesCOMPLETEDPHASE32013-02-212016-03-152016-03-15
NCT01713530A 26-week Trial Comparing Efficacy and Safety of Insulin Degludec/Insulin Aspart BID and Insulin Degludec OD Plus Insulin Aspart in Subjects With Type 2 Diabetes Mellitus Treated With Basal Insulin in Need of Treatment Intensification With Mealtime InsulinCOMPLETEDPHASE32013-02-212014-01-092014-01-09
NCT01796366A Multiple Dose Trial Investigating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of NNC0123-0000-0338 in Subjects With Type 2 DiabetesCOMPLETEDPHASE12013-02-212013-08-192013-08-19
NCT01731600A Multinational, Open-Label, Non-Controlled Trial on Safety, Efficacy and Pharmacokinetics of NNC 0129-0000-1003 in Previously Treated Paediatric Patients With Severe Haemophilia ACOMPLETEDPHASE32013-02-202018-09-282014-09-15
NCT01751152A Randomised, Double-blind, Placebo-controlled, Parallel-group Trial to Assess Clinical Efficacy and Safety of NNC0114-0006 in Subjects With Active Crohn's DiseaseCOMPLETEDPHASE22013-022014-122014-12
NCT01789086A Randomised, Double-blind, Placebo-controlled Trial to Assess Safety, Tolerability and Pharmacokinetics of Liraglutide in Obese Adolescent Subjects Aged 12 to 17 YearsCOMPLETEDPHASE12013-022014-052014-05
NCT01778023Efficacy and Safety of Recombinant Human Growth Hormone on Height Velocity in Subjects With Idiopathic Short StatureCOMPLETEDPHASE32013-01-172014-12-172014-12-17
NCT01789593A Trial Investigating the Effect of Acute Hypoglycaemia on Cognitive Function and Brain Activation Patterns in Subjects With Type 1 DiabetesCOMPLETEDPHASE12013-01-142013-12-012013-12-01
NCT01780272A Trial to Investigate the Impact of Nocturnal Hypoglycaemia on Sleep in Subjects With Type 2 DiabetesCOMPLETEDPHASE12013-012013-092013-09
NCT01773798A Trial Investigating the Pharmacodynamic and Pharmacokinetic Properties of Insulin Degludec/Insulin Aspart 15 in Subjects With Type 1 DiabetesCOMPLETEDPHASE12013-012013-082013-08
NCT01692925Investigation of the Pharmacokinetics of Turoctocog Alfa in Subjects With Haemophilia ACOMPLETEDPHASE12012-122013-032013-03
NCT01766245A Randomised, Single Centre, Double-blind, Two-period, Cross-over Trial in Healthy Subjects Investigating the Bioequivalence Between Subcutaneous Injections of Semaglutide Produced by Two Manufacturing ProcessesCOMPLETEDPHASE12012-122013-052013-05
NCT01541215Efficacy and Safety of Liraglutide in Combination With Metformin Compared to Metformin Alone, in Children and Adolescents With Type 2 DiabetesCOMPLETEDPHASE32012-11-132020-05-202017-11-15
NCT01636843A Trial of NNC0109-0012, an Anti-IL-20 Biologic, in Patients With Active Rheumatoid Arthritis Who Are Inadequate Responders to MethotrexateTERMINATEDPHASE22012-10-302014-11-102014-11-10
NCT01706783A Trial Investigating the Safety, Tolerability, Availability and Distribution in the Body of Once-weekly Long-acting Growth Hormone (Somapacitan) Compared to Once Daily Norditropin NordiFlex® in Adults With Growth Hormone DeficiencyCOMPLETEDPHASE12012-10-122013-11-182013-11-18
NCT01664247The Effect of Insulin Degludec in Combination With Liraglutide and Metformin in Subjects With Type 2 Diabetes Qualifying for Treatment IntensificationCOMPLETEDPHASE32012-10-012013-12-312013-12-31
NCT01704417A Trial Comparing the Effect of Exercise on Blood Glucose in Subjects With Type 1 Diabetes, Who Are Treated With Either Insulin Degludec or Insulin GlargineCOMPLETEDPHASE12012-102013-032013-03
NCT01706159A Placebo-controlled Trial With rFXIII Administered to Subjects With Mild to Moderate Active Ulcerative ColitisTERMINATEDPHASE22012-102013-072013-07
NCT01730014A Trial Investigating the Safety, Tolerability, and Distribution and Activity in the Body of NNC0148-0000-0287 Injected Under the Skin in Healthy Subjects and in Subjects With Type 1 DiabetesCOMPLETEDPHASE12012-102013-072013-07
NCT01686945Investigation on Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Doses of a Long-acting GLP-1 Analogue in Healthy Male Subjects and Male Subjects With Type 2 DiabetesCOMPLETEDPHASE12012-09-192013-04-082013-04-08
NCT01493778Safety and Efficacy of Turoctocog Alfa in Prevention and Treatment of Bleeds in Previously Untreated Children With Haemophilia ACOMPLETEDPHASE32012-09-172018-12-052017-08-16
NCT01690169Investigation on Safety, Tolerability, and Pharmacokinetics of Single Doses of NNC0113-0987 in Healthy Male SubjectsCOMPLETEDPHASE12012-09-142012-12-112012-12-11
NCT01647451A Randomised, Double-blind, Placebo-controlled, Parallel-group Trial to Assess Clinical Efficacy of NNC0114-0006 in Subjects With Active Rheumatoid ArthritisCOMPLETEDPHASE22012-092013-082013-08
NCT01617434The Effect of Liraglutide Versus Placebo When Added to Basal Insulin Analogues With or Without Metformin in Subjects With Type 2 DiabetesCOMPLETEDPHASE32012-092013-102013-10
NCT01682902A Randomised Trial Evaluating Continuous Subcutaneous Infusion of Formulations of NN1218 and NovoLog® in Subjects With Type 1 DiabetesCOMPLETEDPHASE12012-092013-032013-03
NCT01689025An Investigation of Safety and Tolerability of NNC0114-0006 in Subjects With Systemic Lupus Erythematosus (SLE)TERMINATEDPHASE12012-092014-022014-02
NCT01680341Comparison of the Efficacy and Safety of Two Different Dose Adjustment Regimens for Insulin Degludec/Insulin Aspart in Subjects With Type 2 Diabetes Mellitus Previously Treated With Insulin GlargineCOMPLETEDPHASE32012-08-312013-08-222013-08-22
NCT01676116The Efficacy of Insulin Degludec/Liraglutide in Controlling Glycaemia in Adults With Type 2 Diabetes Inadequately Controlled on GLP-1 Receptor Agonist and OAD TherapyCOMPLETEDPHASE32012-08-292014-03-112014-03-11
NCT01618162The Efficacy of Insulin Degludec/Liraglutide as add-on Therapy in Controlling Glycaemia in Adults With Type 2 Diabetes Inadequately Controlled on Sulphonylurea With or Without Metformin TherapyCOMPLETEDPHASE32012-08-292013-10-232013-10-23
NCT01489111Evaluating the Haemostatic Effect of NNC 0129-0000-1003 During Surgical Procedures in Subjects With Haemophilia A.COMPLETEDPHASE32012-08-032018-12-102018-12-10
NCT01636817A Trial of NNC0109-0012, an Anti-IL-20 Biologic, in Patients With Active Rheumatoid Arthritis Who Are Inadequate Responders to Anti-TNFa BiologicsTERMINATEDPHASE22012-082014-112014-11
NCT01680328Investigation of Pain During Subcutaneous Injections With Different Injection Speed and Volume CombinationsCOMPLETEDPHASE12012-082012-102012-10
NCT01631942A Multi-centre, Open Labelled, Multiple Dosing Trial Investigating Safety, Pharmacokinetics and Pharmacodynamics of NNC 0172-2021 Administered Subcutaneously to Healthy Male Subjects and Haemophilia SubjectsTERMINATEDPHASE12012-06-262012-09-042012-09-04
NCT01620489Efficacy and Safety of Liraglutide Versus Placebo as add-on to Existing Diabetes Medication in Subjects With Type 2 Diabetes and Moderate Renal ImpairmentCOMPLETEDPHASE32012-06-142013-08-202013-08-20
NCT01618188A Trial Investigating the Pharmacodynamic Properties of NN1218 in Subjects With Type 1 DiabetesCOMPLETEDPHASE12012-06-112012-09-072012-09-07
NCT01557166Effect of Liraglutide in Obese Subjects With Moderate or Severe Obstructive Sleep Apnoea: SCALE™ - Sleep ApnoeaCOMPLETEDPHASE32012-06-072013-06-172013-06-01
NCT01386528Efficacy and Safety of NNC-0156-0000-0009 During Surgical Procedures in Subjects With Haemophilia BCOMPLETEDPHASE32012-06-072013-12-012013-12-01
NCT01611688First Human Dose Trial of NNC0215-0384 in Subjects With Rheumatoid ArthritisCOMPLETEDPHASE12012-06-042013-06-172013-06-17
NCT01519674Treatment Intensification With Biphasic Insulin Aspart 30 in Subjects With Type 2 Diabetes Inadequately Controlled on Sitagliptin and MetforminCOMPLETEDPHASE42012-062013-102013-10
NCT01618214Comparison of Subject-driven Titration of Biphasic Insulin Aspart (BIAsp) 30 Twice Daily Versus Investigator-driven Titration of BIAsp 30 Twice Daily Both in Combination With Oral Antidiabetic Drugs in Subjects With Type 2 DiabetesCOMPLETEDPHASE42012-062013-012013-01
NCT01623375A Trial Investigating the Absolute Bioavailability of Insulin Degludec in Healthy SubjectsCOMPLETEDPHASE12012-062012-082012-08
NCT01619345Pharmacoscintigraphic Investigation of NN9924 in Healthy Male SubjectsCOMPLETEDPHASE12012-062012-082012-08
NCT01559103Study to Assess the Safety and Tolerability of MEDI5117 in Rheumatoid Arthritis PatientsTERMINATEDPHASE12012-05-312014-02-282014-02-28
NCT01589653Comparing Patient-adjusted Versus Physician-adjusted Titration of BIAsp 30 Combined With Metformin in Type 2 Diabetes PatientsCOMPLETEDPHASE42012-05-262015-07-092015-07-09
NCT01467427Safety, Efficacy and Pharmacokinetics of NNC-0156-0000-0009 in Previously Treated Children With Haemophilia B.COMPLETEDPHASE32012-05-162023-11-172023-11-17
NCT01597713A Trial Investigating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of NNC0148-0000-0362 in Healthy SubjectsCOMPLETEDPHASE12012-052012-102012-10
NCT01395810Safety and Efficacy of NNC-0156-0000-0009 After Long-Term Exposure in Patients With Haemophilia B: An Extension to Trials NN7999-3747 and NN7999-3773COMPLETEDPHASE32012-04-152014-03-302014-03-30
NCT01572753Investigation of Optimal Dosing Conditions for a Long Acting GLP-1 Analogue in Healthy Male SubjectsCOMPLETEDPHASE12012-04-122012-09-082012-09-08
NCT01572740Efficacy and Safety of Liraglutide in Combination With Insulin Therapy Compared to Insulin Alone in Japanese Subjects With Type 2 DiabetesCOMPLETEDPHASE32012-04-052013-03-272012-11-01
NCT01590836A Trial Investigating the Pharmacodynamic Properties of NN5401 in Subjects With Type 1 DiabetesCOMPLETEDPHASE12012-042012-062012-06
NCT01570751A Trial Comparing the Efficacy, Patient-reported Outcomes and Safety of Insulin Degludec 200 U/mL vs Insulin Glargine in Subjects With Type 2 Diabetes Mellitus Requiring High-dose InsulinCOMPLETEDPHASE32012-042014-012014-01
NCT01569841A Trial Comparing the Efficacy of Insulin Degludec With Insulin Glargine on Glycaemic Control Using Continuous Glucose Monitoring in Patients With Type 1 DiabetesCOMPLETEDPHASE32012-042012-112012-11
NCT01206101Efficacy and Safety of Liraglutide in Subjects With Type 1 Diabetes Undergoing Islet Cell TransplantationTERMINATEDPHASE22012-03-212013-06-032013-06-03
NCT01555749Investigation of the Pharmacokinetics of NNC172-2021, at Two Different Dose Levels, in Healthy Japanese SubjectsCOMPLETEDPHASE12012-03-122012-05-082012-05-08
NCT01565408Safety and Tolerability of NNC0114-0006 at Increasing Dose Levels in Subjects With Rheumatoid ArthritisCOMPLETEDPHASE12012-032013-102013-10
NCT01536665The Effect of Liraglutide Adjunct to Insulin on Glucagon Response to Hypoglycaemia in Subjects With Type 1 DiabetesCOMPLETEDPHASE12012-022012-082012-08
NCT01480180Evaluation of Safety and Efficacy, Including Pharmacokinetics, of NNC 0129-0000-1003 When Administered for Treatment and Prophylaxis of Bleeding in Subjects With Haemophilia ACOMPLETEDPHASE32012-01-302018-12-102018-12-10
NCT01514500First Human Dose Trial of NNC0195-0092 (Somapacitan) in Healthy SubjectsCOMPLETEDPHASE12012-01-162013-03-182013-03-18
NCT01513473A Trial Investigating the Efficacy and Safety of Insulin Degludec in Children and Adolescents With Type 1 Diabetes MellitusCOMPLETEDPHASE32012-01-162013-07-302013-07-30
NCT01513590A Trial Comparing Efficacy and Safety of Insulin Degludec/Insulin Aspart and BIAsp 30 in Insulin naïve Subjects With Type 2 DiabetesCOMPLETEDPHASE32012-01-162012-11-192012-11-19
NCT01512108Safety and Efficacy of Liraglutide in Combination With an OAD in Subjects With Type 2 Diabetes Insufficiently Controlled on OAD AloneCOMPLETEDPHASE32012-01-102013-04-262013-04-26
NCT01392573A Trial Comparing the Efficacy and Safety of Insulin Degludec/Liraglutide and Insulin Degludec in Subjects With Type 2 DiabetesCOMPLETEDPHASE32011-11-282012-10-042012-10-01
NCT01486966Comparing Efficacy and Safety of Insulin Detemir Plus Insulin Aspart and NPH Insulin Plus Human Soluble Insulin With or Without Metformin in Chinese Patients With Type 2 DiabetesTERMINATEDPHASE42011-112012-062012-06
NCT01469143A Trial Investigating the Pharmacokinetic Properties of Formulations of NN1218 in Subjects With Type 1 DiabetesCOMPLETEDPHASE12011-112012-012012-01
NCT01473953Safety, Tolerability and Pharmacokinetics of Liraglutide-depot in Healthy SubjectsCOMPLETEDPHASE12011-102012-032012-03
NCT01455142A Trial to Test for Bioequivalence Between NN1045 and NN5401 in Subjects With Type 1 DiabetesCOMPLETEDPHASE12011-102012-012012-01
NCT01467414A Trial Investigating the Effect of NN1250 in Japanese Subjects With Type 2 DiabetesTERMINATEDPHASE12011-102011-122011-12
NCT01437592Investigating the Pharmacokinetic Properties of NN1250 in Healthy Chinese SubjectsCOMPLETEDPHASE12011-09-062011-11-222011-11-22
NCT01427920Comparison of Biphasic Insulin Aspart 30 Individually Adjusted by the Subject and the Trial Physician, Both Combined With Metformin in Subjects With Type 2 DiabetesCOMPLETEDPHASE42011-092012-072012-07
NCT01388361Comparison of the Efficacy and Safety of Two Intensification Strategies in Subjects With Type 2 Diabetes Inadequately Controlled on Basal Insulin and MetforminCOMPLETEDPHASE32011-092012-072012-07
NCT01405261Trial Investigating the Safety of NNC 0113-0987 in Healthy Male SubjectsCOMPLETEDPHASE12011-082012-052012-05
NCT01401244Bioequivalence of Two Somatropin Products (Norditropin® Versus Genotropin®) in Healthy Adult VolunteersCOMPLETEDPHASE12011-07-142011-09-272011-09-27
NCT01392547Efficacy and Safety of NNC 0078-0000-0007 in Patients With Congenital Haemophilia and InhibitorsCOMPLETEDPHASE32011-072012-082012-08
NCT01272232Effect of Liraglutide on Body Weight in Overweight or Obese Subjects With Type 2 Diabetes: SCALE™ - DiabetesCOMPLETEDPHASE32011-06-012013-01-252013-01-01
NCT01272219Effect of Liraglutide on Body Weight in Non-diabetic Obese Subjects or Overweight Subjects With Co-morbidities: SCALE™ - Obesity and Pre-diabetesCOMPLETEDPHASE32011-06-012015-03-022013-03-18
NCT01365520A Single Dose Trial of NNC 0155-0000-0004 in Patients With Haemophilia ACOMPLETEDPHASE12011-062011-092011-09
NCT01365507Efficacy and Safety of Insulin Degludec/Insulin Aspart in Insulin-naïve Subjects With Type 2 Diabetes Using Two Dosing RegimensCOMPLETEDPHASE32011-062012-042012-04
NCT01364428Comparison of Two Insulin Degludec Formulations in Subjects With Type 2 Diabetes MellitusCOMPLETEDPHASE32011-062012-012012-01
NCT01336023Dual Action of Liraglutide and Insulin Degludec in Type 2 Diabetes: A Trial Comparing the Efficacy and Safety of Insulin Degludec/Liraglutide, Insulin Degludec and Liraglutide in Subjects With Type 2 DiabetesCOMPLETEDPHASE32011-05-232012-11-222012-05-24
NCT01333111Safety and Efficacy of NNC-0156-0000-0009 in Haemophilia B PatientsCOMPLETEDPHASE32011-04-272013-03-312013-03-31
NCT01334034Safety of NNC 0123-0000-0338 in Healthy SubjectsCOMPLETEDPHASE12011-04-112011-09-162011-09-16
NCT01324505Effect of Oral Contraceptives After Administration of Semaglutide in Subjects With Type 2 DiabetesCOMPLETEDPHASE12011-032012-012012-01
NCT01326026Comparing the Efficacy and Safety of NN1250 Once Daily When Titrated Using 2 Different Algorithms in Insulin naïve Subjects With Type 2 Diabetes MellitusCOMPLETEDPHASE32011-032011-122011-12
NCT01319240Safety and Tolerability of Insulin Degludec/Liraglutide (A3) in Healthy SubjectsCOMPLETEDPHASE12011-032011-052011-05
NCT01215435Comparison of Two Biphasic Insulin Aspart 30 Treatment Regimens in Subjects With Type 2 Diabetes Not Achieving HbA1c Treatment Targets on OADs AloneCOMPLETEDPHASE42011-032012-092012-09
NCT01282255Efficacy of NNC109-0012 in Subjects With Active Rheumatoid ArthritisCOMPLETEDPHASE22011-022012-012012-01
NCT01242826Investigation of the Pharmacokinetic Properties of Biphasic Insulin Aspart 50 in Healthy Chinese SubjectsCOMPLETEDPHASE12011-022011-032011-03
NCT01296438A Trial Investigating the Pharmacokinetic Properties of NN1218 in Subjects With Diabetes Mellitus, Type 1COMPLETEDPHASE12011-022011-032011-03
NCT01272193Comparison of NN5401 With Insulin Glargine in Insulin Naive Subjects With Type 2 DiabetesCOMPLETEDPHASE32011-012011-092011-09
NCT01223911A Multiple Dose Trial of NNC 0151-0000-0000 in Subjects With Rheumatoid ArthritisCOMPLETEDPHASE22011-012013-022013-02
NCT01288391Investigating Safety and Pharmacokinetics of 2 Different Single Doses of NNC128-0000-2011 in Haemophilia A or B PatientsCOMPLETEDPHASE12011-012011-072011-07
NCT01253811Safety and Efficacy of Monthly Replacement Therapy With Recombinant Factor XIII (rFXIII) in Paediatric Subjects With Congenital Factor XIII A-subunit DeficiencyCOMPLETEDPHASE32011-012015-032015-03
NCT01272973Investigation on Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of NN9924 in Healthy Male SubjectsCOMPLETEDPHASE12011-012011-072011-07
NCT01278160Comparison of Biphasic Insulin Aspart 30 Twice Daily With Two Different Initial Dosage Split Regimens in Subjects With Type 2 Diabetes: An Extension to Trial BIASP-3756COMPLETEDPHASE42011-012011-092011-09
NCT01272206Investigating Safety and Pharmacokinetics of NNC 0128-0000-2011 Compared to NNC 0128-0000-2021 in Healthy Male SubjectsCOMPLETEDPHASE12011-012011-032011-03
NCT01269606Comparing Insulin Aspart With Fast-acting Insulin Human in Subjects With Type 1 DiabetesCOMPLETEDPHASE12011-012011-032011-03
NCT01238367A Single Dose Trial of Recombinant Factor VIII (N8) in Japanese Subjects With Haemophilia A: An Extension to Trial NN7008-3543COMPLETEDPHASE12010-112011-102011-10
NCT01230021Safety of a Single Intravenous Dose of Recombinant Factor XIII in Children With Congenital FXIII A-subunit DeficiencyCOMPLETEDPHASE32010-112012-012012-01
NCT01245374Norditropin NordiFlex® Device Compared to the Device Previously Used by Patients or ParentsCOMPLETEDPHASE42010-112011-042011-04
NCT01232491Impact of Dietary Intervention on Weight Change in Subjects With Type 2 DiabetesCOMPLETEDPHASE42010-10-292011-11-142011-11-01
NCT01228669Safety of NNC 0172-0000-2021 in Healthy Male Subjects and Subjects With Haemophilia A or BCOMPLETEDPHASE12010-10-252012-09-102012-09-10
NCT01165684Efficacy and Safety of Basal-bolus Therapy, Comparing Stepwise Addition of Insulin Aspart Versus Complete Basal-bolus RegimenCOMPLETEDPHASE42010-102012-042012-04
NCT01208506First-in-Man Trial of NNC114-0005 in Healthy Subjects and Subjects With Rheumatoid ArthritisCOMPLETEDPHASE12010-092012-022012-02
NCT01205724Safety and Pharmacokinetics of NNC 0129-0000-1003 in Subjects With Haemophilia ACOMPLETEDPHASE12010-092011-042011-04
NCT01179048Liraglutide Effect and Action in Diabetes: Evaluation of Cardiovascular Outcome ResultsCOMPLETEDPHASE32010-08-312015-12-172015-12-17
NCT01174303A Trial Investigating the Exposure of NN5401 in Young Adults and Elderly Subjects With Type 1 DiabetesCOMPLETEDPHASE12010-082010-112010-11
NCT01193387Comparison of Two Identical NN1250 Formulations in Healthy VolunteersCOMPLETEDPHASE12010-082010-112010-11
NCT01173926Comparison of the Effect of NN5401 With the Effect of NN1250 and Insulin Aspart in Subjects With Type 1 DiabetesCOMPLETEDPHASE12010-072010-112010-11
NCT01138501Safety and Efficacy of Turoctocog Alfa in Previously Treated Male Children With Haemophilia ACOMPLETEDPHASE32010-062011-112011-11
NCT01138488A Trial Investigating the Total Exposure of NN5401 (Insulin Degludec/Insulin Aspart) in Children, Adolescents and Adult Subjects With Type 1 DiabetesCOMPLETEDPHASE12010-062010-112010-11
NCT01154881A Trial Evaluating the Blood Glucose-lowering Effect of NN1250 in Subjects With Type 2 DiabetesCOMPLETEDPHASE12010-062010-112010-11
NCT01151072A Trial Comparing the Effect of NN1250 After Different Routes of Injection in Healthy SubjectsCOMPLETEDPHASE12010-062010-102010-10
NCT01135927A Trial Investigating the Effect of NN1250 in Japanese Subjects With Type 1 DiabetesCOMPLETEDPHASE12010-062010-102010-10
NCT01135992Switching From Insulin Glargine to Insulin Degludec in Subjects With Type 2 Diabetes Mellitus (BEGIN™)COMPLETEDPHASE32010-062010-112010-11
NCT01153997Safety of Recombinant Factor XIII (rFXIII) in Healthy Japanese VolunteersCOMPLETEDPHASE12010-062010-082010-08
NCT01114542A Trial Evaluating the Effect of NN1250 at Steady State Conditions in Subjects With Type 1 DiabetesCOMPLETEDPHASE12010-05-032010-08-102010-08-10
NCT01123980Comparison of the Blood Sugar Lowering Effect of Biphasic Insulin Aspart 30 and Insulin Glargine Both Combined With Metformin and Glimepiride in Chinese and Japanese Subjects With Type 2 Diabetes New to Insulin TreatmentCOMPLETEDPHASE42010-052011-062011-06
NCT01125553A Comparison Between Two Formulations of NN5401 in Healthy SubjectsCOMPLETEDPHASE12010-052010-082010-08
NCT01134224A Trial Investigating the Effect of NN5401 in Subjects With Type 2 DiabetesCOMPLETEDPHASE12010-052010-112010-11
NCT01121276A Trial Investigating NN1218 in Subjects With Type 1 and Type 2 DiabetesCOMPLETEDPHASE12010-042010-092010-09
NCT01121289A Trial Investigating NN1218 in Subjects With Type 1 DiabetesCOMPLETEDPHASE12010-042010-072010-07
NCT01087645A Two Part Trial Investigating the Safety of NN9925 in Healthy Male SubjectsCOMPLETEDPHASE12010-03-122010-09-162010-09-16
NCT01068665Comparison of NN1250 With Insulin Glargine in Subjects With Type 2 DiabetesCOMPLETEDPHASE32010-032010-112010-11
NCT01076647Comparison of NN1250 With Insulin Glargine in Subjects With Type 2 DiabetesCOMPLETEDPHASE32010-032010-122010-12
NCT01079234Comparison of NN1250 With Insulin Glargine in Type 1 DiabetesCOMPLETEDPHASE32010-032011-052010-11
NCT01068652Effect of Different Insulin Administrations, All in Combination With Metformin, on Glycaemic Control in Subjects With Type 2 Diabetes Inadequately Controlled by Oral Anti-diabetic DrugsCOMPLETEDPHASE42010-032012-052012-05
NCT01082406Comparison of a Blood Clotting Drug (Recombinant Factor XIII) Produced by Two Different Manufacturers in Healthy Male SubjectsCOMPLETEDPHASE12010-032010-072010-07
NCT01085877Comparison of Two Vaginal Tablets, Produced at Different Sites, in Postmenopausal Women With Atrophic VaginitisCOMPLETEDPHASE12010-032010-052010-05
NCT01059812A Pan Asian Trial Comparing Efficacy and Safety of NN5401 and Biphasic Insulin Aspart 30 in Type 2 DiabetesCOMPLETEDPHASE32010-02-012010-12-232010-12-23
NCT01059799Comparison of NN1250 Versus Insulin Glargine in Subjects With Type 2 DiabetesCOMPLETEDPHASE32010-02-012010-12-162010-12-16
NCT01038674Safety and Tolerability of Anti-IL-20 in Subjects With Rheumatoid ArthritisCOMPLETEDPHASE12010-022010-122010-12
NCT01068678Comparison of NN1250 With Insulin Glargine in Subjects With Type 2 DiabetesCOMPLETEDPHASE32010-022010-112010-11
NCT01074268Comparison of NN1250 Plus Insulin Aspart With Insulin Detemir Plus Insulin Aspart in Type 1 DiabetesCOMPLETEDPHASE32010-022010-122010-12
NCT01076634Comparison of Two NN1250 Formulations in Subjects With Type 1 DiabetesCOMPLETEDPHASE12010-022010-072010-07
NCT01044108A Two Part Trial Investigating an Anti-obesity Drug in Overweight/Obese Male and Female Healthy VolunteersTERMINATEDPHASE12010-01-052011-09-202010-12-13
NCT01045447Comparison of NN5401 With Insulin Glargine, Both in Combination With Oral Antidiabetic Drugs, in Subjects With Type 2 DiabetesCOMPLETEDPHASE32010-012010-102010-10
NCT01051102Effect of NN5401 in Japanese Subjects With Type 1 DiabetesCOMPLETEDPHASE12010-012010-042010-04
NCT01043510The Effect of NN1250 in Subjects With Type 2 Diabetes of Different Race and/or Ethnic OriginCOMPLETEDPHASE12010-012010-102010-10
NCT01046110Comparison of NN1250 With Sitagliptin in Subjects With Type 2 Diabetes Never Treated With InsulinCOMPLETEDPHASE32010-012010-112010-11
NCT01045707Comparison of NN5401 Versus Insulin Glargine, Both Combined With Metformin Treatment, in Subjects With Type 2 DiabetesCOMPLETEDPHASE32010-012010-102010-10
NCT01037582A Two Part Trial Investigating the Safety of NN9924 in Healthy Male SubjectsCOMPLETEDPHASE12009-12-172010-05-072010-05-07
NCT01030926A Trial Investigating the Concentration in the Blood of NN1250 in Children, Adolescents and Adults With Type 1 DiabetesCOMPLETEDPHASE12009-122010-052010-05
NCT01009580Comparison of NN5401 With Biphasic Insulin Aspart 30 in Type 2 DiabetesCOMPLETEDPHASE32009-11-052010-08-232010-08-23
NCT01028404A Two Part Trial Investigating NN1952 in Healthy Subjects and Subjects With Type 1 and Type 2 DiabetesCOMPLETEDPHASE12009-112010-062010-06
NCT01006057A Trial Investigating the NN1250 Concentration-time Curve in Subjects With Various Degrees of Renal Impairment and in Subjects With Normal Renal FunctionCOMPLETEDPHASE12009-112010-052010-05
NCT00943501Safety of Liraglutide in Pediatric Patients With Type 2 DiabetesCOMPLETEDPHASE12009-112011-092011-09
NCT01006291Comparison of NN1250 With Insulin Glargine in Type 2 DiabetesCOMPLETEDPHASE32009-112010-092010-09
NCT01018238An Investigation of NNC 0151-0000-0000 in Subjects With Systemic Lupus Erythematosus (SLE)WITHDRAWNPHASE12009-112009-112009-11
NCT01022762Comparison of Repaglinide and Gliclazide in Chinese Subjects With Type 2 Diabetes Never Received Oral Antidiabetic Drug TreatmentCOMPLETEDPHASE42009-112010-112010-11
NCT00984126Safety and Efficacy of Turoctocog Alfa (N8) in Prevention and On-demand Treatment of Bleeding Episodes in Subjects With Haemophilia A: An Extension to Trials NN7008-3543, NN7008-3545, NN7008-3600, NN7008-3893 and NN7008-4015COMPLETEDPHASE32009-10-262016-06-292016-06-28
NCT01002768Comparison of Hypoglycaemic Response Between NN1250 and Insulin Glargine in Type 1 DiabeticsCOMPLETEDPHASE12009-102010-032010-03
NCT00993304A Trial to Assess the Effect of Liraglutide on Blood Triglyceride (Fat) Levels After a Meal in Type 2 DiabeticsCOMPLETEDPHASE12009-102010-122010-12
NCT00992537Comparison of the Effect of NN5401 With the Effect of NN1250 and Insulin Aspart in Type 1 DiabeticsCOMPLETEDPHASE12009-102010-012010-01
NCT00978380Safety of Monthly Recombinant Factor XIII Replacement Therapy in Subjects With Congenital Factor XIII Deficiency: An Extension to Trial F13CD-1725COMPLETEDPHASE32009-09-212015-10-202015-10-20
NCT00978393A Trial to Assess the Effect of Liraglutide on Gastric Emptying in Healthy Obese VolunteersCOMPLETEDPHASE12009-09-162011-06-082011-06-08
NCT00951405Safety and Efficacy of 3 Different Doses of Long Acting Factor VII in Haemophilia A or B Patients With InhibitorsCOMPLETEDPHASE22009-09-012011-03-292011-03-29
NCT00972283Comparison of NN1250 With Insulin Glargine Plus Insulin Aspart With/Without Metformin and With/Without Pioglitazone in Type 2 DiabetesCOMPLETEDPHASE32009-09-012010-10-282010-10-28
NCT00982228Comparison of NN1250 Plus Insulin Aspart With Insulin Glargine Plus Insulin Aspart in Type 1 DiabetesCOMPLETEDPHASE32009-09-012010-11-082010-11-08
NCT00993096Investigation of the Response Relationship of NN5401 in Type 1 DiabeticsCOMPLETEDPHASE12009-092009-122009-12
NCT00983021Safety and Tolerability of NN9068 in Healthy Male VolunteersCOMPLETEDPHASE12009-092009-122009-12
NCT00982644Comparison of NN1250 Versus Insulin Glargine in Subjects With Type 2 DiabetesCOMPLETEDPHASE32009-092010-122010-12
NCT00936403A Single Dose Trial in Growth Hormone Deficient Children Investigating Safety, Pharmacokinetics and Pharmacodynamics of Long Acting Growth HormoneCOMPLETEDPHASE22009-082010-072010-07
NCT00978627Comparison of NN5401 Plus Insulin Aspart With Insulin Detemir Plus Insulin Aspart in Type 1 DiabetesCOMPLETEDPHASE32009-082010-052010-05
NCT00964418A Trial Investigating the Effect of NN1250 in Young and Elderly Subjects With Type 1 DiabetesCOMPLETEDPHASE12009-082009-112009-11
NCT00956345Safety of 40K Pegylated Recombinant Factor IX in Non-Bleeding Patients With Haemophilia BCOMPLETEDPHASE12009-082010-072010-07
NCT00976326A Trial Investigating the Pharmacokinetic (Mode of Action in the Body) and Safety Profiles of NN1250 (Insulin Degludec) in Subjects With Various Degrees of Impaired Liver Function and in Subjects With Normal Liver FunctionCOMPLETEDPHASE12009-082010-032010-03
NCT00966368Comparison of Two NN1250 Formulations in Healthy VolunteersCOMPLETEDPHASE12009-082009-102009-10
NCT00959101Comparison of Repaglinide and Metformin Combination Tablet Versus Repaglinide and Metformin as Separate Tablets in Healthy VolunteersCOMPLETEDPHASE12009-082009-102009-10
NCT00964964A Trial Assessing Changes in Blood Sugar and the Number of Periods Where Supplementation of Carbohydrate is Needed to Treat Low Blood Sugar, During Two Different Treatment Regimens of NN1250 in Type 1 DiabeticsCOMPLETEDPHASE12009-082009-092009-09
NCT00961324A Trial Investigating the Within-subject Variability of NN1250 in Subjects With Type 1 DiabetesCOMPLETEDPHASE12009-07-272009-10-262009-10-26
NCT00914589Multi-national Study Investigating the Effect and Safety of rFXIII on Transfusion Needs in Patients Undergoing Heart SurgeryCOMPLETEDPHASE22009-072011-022011-02
NCT00951873A Single Dose Trial Investigating Safety and Local Tolerability of Ascending Doses of Long Acting Activated Recombinant Human Factor VII in Healthy Male VolunteersCOMPLETEDPHASE12009-072010-042010-04
NCT00897169A Trial Investigating the Possible Difference in Development of Type 2 Diabetes Between Caucasian and Japanese SubjectsCOMPLETEDPHASE12009-062010-122010-12
NCT00922792Safety and Mode of Action of a Single Dose and Multiple Doses of Long Acting Activated Recombinant Human Factor VII in Patients With Haemophilia A and BCOMPLETEDPHASE12009-062009-092009-09
NCT00909480Effect of Insulin Detemir and Insulin Glargine on Blood Glucose Control in Subjects With Type 2 DiabetesCOMPLETEDPHASE42009-052010-062010-06
NCT00840086Safety and Efficacy of Turoctocog Alfa in Haemophilia A SubjectsCOMPLETEDPHASE32009-042011-092011-09
NCT00795600Comparison of the Change in Fat Distribution in Overweight and Obese Subjects With Type 2 Diabetes After Insulin TreatmentCOMPLETEDPHASE42009-042010-082010-08
NCT00837356Comparison of the Action of Drugs in the Body and Safety of N8 and Advate® in Haemophilia A SubjectsCOMPLETEDPHASE12009-032009-102009-10
NCT00856986The Effect of Insulin Detemir in Combination With Liraglutide and Metformin Compared to Liraglutide and Metformin in Subjects With Type 2 DiabetesCOMPLETEDPHASE32009-032010-112010-04
NCT00873223Examination of the Effects of Liraglutide on the Mode of Action of Insulin DetemirCOMPLETEDPHASE12009-032009-092009-09
NCT00833716Effect of Renal Impairment on the Pharmacokinetics of NN9535COMPLETEDPHASE12009-02-022010-07-262010-07-26
NCT00819741Comparison of the Blood Sugar Lowering Effect Between Repaglinide Plus Metformin and Repaglinide Alone in Type 2 Diabetics Not Previously Treated With Oral Sugar-lowering DrugsCOMPLETEDPHASE42009-022009-112009-11
NCT00851773Safety, Tolerability, and Profile of Action of Drug in the Body of NN9535 in Healthy Male Japanese and Caucasian SubjectsCOMPLETEDPHASE12009-022009-102009-10
NCT00841087Comparison of NN1250 Versus Insulin Detemir, Both Combined With Insulin Aspart in Subjects With Type 1 DiabetesCOMPLETEDPHASE22009-012009-052009-05
NCT00842361Comparison of NN5401 Versus Biphasic Insulin Aspart 30 on a Twice Daily Regimen in Subjects With Type 2 Diabetes MellitusCOMPLETEDPHASE22009-012009-062009-06
NCT00813020A Clinical Trial Investigating the Comparison of Three Different Concentrations of NN9535 in Healthy Male SubjectsCOMPLETEDPHASE12009-012009-042009-04
NCT00822185Safety, Tolerability and Pharmacokinetics of NN1731 in Healthy VolunteersCOMPLETEDPHASE12009-012009-072009-07
NCT00818064Safety and Tolerability of Anti-IL-20 in Healthy Volunteers and Patients With Rheumatoid ArthritisCOMPLETEDPHASE12008-122010-012010-01
NCT00807092Comparing the Efficacy and Safety of Biphasic Insulin Aspart 30 and Biphasic Human Insulin 30 on Blood Sugar Control in Subjects With Type 2 DiabetesCOMPLETEDPHASE42008-122009-102009-10
NCT00789191Effect of Detemir and Sitagliptin on Blood Glucose Control in Type 2 DiabetesCOMPLETEDPHASE32008-112009-082009-08
NCT00781937Comparison of Liraglutide Versus Placebo in Weight Loss Maintenance in Obese Subjects: SCALE - MaintenanceCOMPLETEDPHASE32008-10-302010-09-012010-09-01
NCT00761540To Investigate the Blood Concentration of Liraglutide as Well as the Effects on Glucose and Insulin After 21 Days of Daily Subcutaneous Injections of Liraglutide or PlaceboCOMPLETEDPHASE12008-102008-122008-12
NCT01529944Genetic Testing of Noonan Subjects Previously Treated With Norditropin®. An Extension to Trial GHNOO-1658COMPLETEDPHASE32008-092008-102008-10
NCT00773279Efficacy, Safety and Preference Study of a Insulin Pen PDS290 vs. a Novo Nordisk Marketed Insulin Pen in DiabeticsCOMPLETEDPHASE32008-092009-062009-06
NCT00713648Evaluation of Recombinant Factor XIII for Prevention of Bleeding in Patients With FXIII Inherited DeficiencyCOMPLETEDPHASE32008-082010-042010-04
NCT00715689Dose Study in Growth Hormone Deficient Adults Investigating Safety, Pharmacokinetics and Pharmacodynamics of NNC126-0083COMPLETEDPHASE22008-072009-032009-03
NCT00722540Dose Study in Healthy Japanese Males Investigating Safety, Pharmacokinetics and Pharmacodynamics of NNC126-0083COMPLETEDPHASE12008-072009-042009-04
NCT00728455Examination of the Safety and Tolerability of NNC 0070-0002-0349 in Overweight/Obese VolunteersWITHDRAWNPHASE12008-072009-122009-12
NCT00696657A Randomised Controlled Clinical Trial in Type 2 Diabetes Comparing Semaglutide to Placebo and LiraglutideCOMPLETEDPHASE22008-06-032009-02-052009-02-05
NCT02151409Dose-escalation Trial of Anti-C5aR Antibody in Healthy SubjectsCOMPLETEDPHASE12008-062009-102009-10
NCT00700817The Effect of Liraglutide Compared to Sitagliptin, Both in Combination With Metformin on Glycaemic Control in Subjects With Type 2 Diabetes MellitusCOMPLETEDPHASE32008-062010-062009-06
NCT01464099Bioequivalence of Two NovoLog® Formulations in Subjects With Type 1 DiabetesCOMPLETEDPHASE12008-062008-112008-11
NCT00698802Safety and Efficacy of Biphasic Human Insulin Compared to EX1000 in Type 2 DiabetesCOMPLETEDPHASE22008-062009-032009-03
NCT01561950Efficacy of Activated Recombinant Human Factor VII in Healthy Volunteers Treated for Punch Biopsy Mediated BleedingTERMINATEDPHASE12008-052009-012009-01
NCT01868581Bioequivalence Between Two Explorative Insulin Degludec Formulations and Between Two Explorative IDegAsp Formulations in Healthy SubjectsCOMPLETEDPHASE12008-052008-082008-08
NCT01261767First Human Dose Study of Anti-IL-20 in Psoriasis: A Study of Safety, Tolerability and Early Signals of Biologic and Clinical EffectsTERMINATEDPHASE12008-042011-012011-01
NCT01868568Comparison of IDegAsp (Inclusive Three Explorative Formulations) With Insulin Degludec and Insulin Aspart Separately Injected in Subjects With Type 1 DiabetesCOMPLETEDPHASE12008-042008-082008-08
NCT00601861Effect of rIL-21 on Metastases in Lymph Nodes in Melanoma Skin CancerTERMINATEDPHASE22008-02-132008-06-252008-06-25
NCT00620282The Effect of Liraglutide on Endothelial Function in Subjects With Type 2 Diabetes MellitusCOMPLETEDPHASE32008-022010-052010-05
NCT00634842Effect of Two Different Fasting Blood Glucose Targets on Glucose Control in Patients With Type 2 Diabetes Using Insulin Detemir Once DailyCOMPLETEDPHASE42008-022008-102008-10
NCT00623194Safety Follow-up on Children and Adolescents With Type 1 Diabetes Treated With Insulin Detemir. An Extension to Trial NN304-1689COMPLETEDPHASE32008-022009-092009-09
NCT00660374Safety and Efficacy of Insulin NPH Compared to a New Insulin Formulation in Subjects With Type 2 DiabetesCOMPLETEDPHASE22008-022009-032009-03
NCT00627445Effect of Biphasic Insulin Aspart 50 on Blood Glucose Control in Subjects With Type 2 DiabetesCOMPLETEDPHASE32008-022009-012009-01
NCT00613951Comparison of Two NN5401 Formulations Versus Biphasic Insulin Aspart 30, All in Combination With Metformin in Subjects With Type 2 DiabetesCOMPLETEDPHASE22008-012008-082008-08
NCT00614055Comparison of Two NN5401 Formulations Versus Insulin Glargine, All in Combination With Metformin in Subjects With Type 2 DiabetesCOMPLETEDPHASE22008-012008-072008-07
NCT00614120Effect of Liraglutide or Glimepiride Added to Metformin on Blood Glucose Control in Subjects With Type 2 DiabetesCOMPLETEDPHASE32008-012009-022009-02
NCT00611884Comparison of Two NN1250 Formulations Versus Insulin Glargine, All in Combination With Metformin in Subjects With Type 2 DiabetesCOMPLETEDPHASE22008-012008-082008-08
NCT00612040Comparison of Two NN1250 Formulations Versus Insulin Glargine, All in Combination With Insulin Aspart in Subjects With Type 1 DiabetesCOMPLETEDPHASE22008-012008-062008-06
NCT01868529Comparison of Insulin Degludec With Insulin Glargine in Subjects With Type 1 Diabetes MellitusCOMPLETEDPHASE12008-012008-062008-06
NCT01603342A Pilot Study to Determine the Impact of Clopidogrel (Plavix®) on Bleeding Associated With Punch Biopsies in Healthy VolunteersCOMPLETEDPHASE12007-122008-012008-01
NCT01868555Safety, Pharmacokinetics and Pharmacodynamics of Two IDegAsp (One Explorative) Preparations and Two Insulin Degludec (One Explorative) Preparations in Japanese SubjectsCOMPLETEDPHASE12007-122008-022008-02
NCT00455858Evaluation of the Glycaemic Control With Insulin Detemir as an add-on to Current Oral Anti-diabetic Drug Treatment in Subjects With Type 2 Diabetes in KoreaCOMPLETEDPHASE42007-112008-102008-10
NCT00665665Safety, Efficacy, Tolerability and Pharmacokinetics of NNC 0070-0002-0182 in Overweight or Obese Male and Female VolunteersTERMINATEDPHASE12007-112008-102008-10
NCT00669864Effect of Biphasic Insulin Aspart 30 Combined With Metformin on Blood Glucose Control in Subjects With Type 2 Diabetes Inadequately Controlled With Basal InsulinCOMPLETEDPHASE42007-112009-042009-04
NCT00523380Efficacy Study of Recombinant Interleukin-21 in the Treatment of Ovarian CancerCOMPLETEDPHASE22007-10-042009-01-072009-01-07
NCT00537303Comparison of the Blood Sugar Lowering Effect and Safety of Two Insulin Treatments in Type 2 DiabetesCOMPLETEDPHASE42007-102009-032009-03
NCT01596010Investigation of 2 Different Oral Formulations of Estradiol and Norethisterone in Healthy WomenCOMPLETEDPHASE12007-102007-112007-11
NCT00537277Efficacy and Safety of Biphasic Insulin Aspart 30 in Type 2 Diabetes Mellitus When Failing on OADsCOMPLETEDPHASE42007-102009-012009-01
NCT00542620Comparison of Insulin Detemir and Insulin Aspart in 2 Separate Injections Twice Daily to Extemporaneous Mixing Injection Regimen Twice Daily - The Paediatric Mixing TrialCOMPLETEDPHASE42007-092009-032009-03
NCT00523042Safety of Inhaled Preprandial Human Insulin in Subjects With Diabetes and AsthmaTERMINATEDPHASE32007-08-302008-02-282008-02-28
NCT01034202Dose Study in Healthy Males Investigating Safety, Pharmacokinetics and Pharmacodynamics of NNC126-0083 Compared to Norditropin® SimpleXx®COMPLETEDPHASE12007-082008-012008-01
NCT00518882Effect of Liraglutide or Exenatide Added to an Ongoing Treatment on Blood Glucose Control in Subjects With Type 2 DiabetesCOMPLETEDPHASE32007-082009-042008-04
NCT00824668Comparison of Pharmacodynamics and Pharmacokinetics of Biphasic Insulin Aspart 30 and Insulin Glargine and Insulin Glulisine Therapy in Subjects With Type 2 DiabetesCOMPLETEDPHASE12007-082007-102007-10
NCT01498939Pharmacokinetics of Insulin Detemir in Healthy Chinese Male SubjectsCOMPLETEDPHASE12007-082007-092007-09
NCT00617253Combination of Recombinant Human IL-21 (rIL-21) and Sunitinib in Stage IV Renal Cell Carcinoma PatientsCOMPLETEDPHASE22007-07-122008-06-302008-06-30
NCT00506662Comparison of Insulin Detemir and NPH Insulin Given Once Daily in Ageing Subjects With Type 2 DiabetesTERMINATEDPHASE42007-072008-122008-12
NCT00509925Effect of Insulin Detemir on Use of Energy in Type 1 DiabetesTERMINATEDPHASE42007-072008-072008-07
NCT00503698The Effect of Somatropin Treatment in Adult Patients on Chronic DialysisTERMINATEDPHASE32007-072008-122008-12
NCT03144271Dose Escalation Trial of Single Subcutaneous Doses of NNC 0113-0217 to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics in Healthy Male SubjectsCOMPLETEDPHASE12007-06-112007-10-082007-10-08
NCT00486278Haemophilia Patients With Inhibitors Being Treated for Acute Joint BleedsCOMPLETEDPHASE22007-062010-062010-06
NCT00472953Safety of Inhaled Human Insulin in Subjects With Diabetes Mellitus and Chronic Obstructive Pulmonary Disease (COPD)TERMINATEDPHASE32007-05-152008-03-052008-03-05
NCT00474045Efficacy and Safety of Insulin Detemir Versus Neutral Protamine Hagedorn (NPH) Insulin in Pregnant Women With Type 1 DiabetesCOMPLETEDPHASE32007-052010-082010-08
NCT00469092Comparison of Biphasic Insulin Aspart 30 Versus Insulin Glargine Both in Combination With Metformin and Glimepiride in Subjects With Type 2 DiabetesCOMPLETEDPHASE42007-052008-042008-04
NCT00469586Efficacy and Safety of Inhaled Insulin Compared to Metformin and Glimepiride in Type 2 DiabetesTERMINATEDPHASE32007-04-262008-04-242008-04-24
NCT00476437Safety and Effect of Biphasic Insulin Aspart 50 in Patients With Type 2 Diabetes Mellitus.COMPLETEDPHASE32007-042007-112007-11
NCT00447382Safety of Insulin Detemir Produced by a New Process as Measured by Antibody Formation in Subjects With Type 1 DiabetesCOMPLETEDPHASE32007-032008-072008-07
NCT00825253Pharmacokinetics and Pharmacodynamics of Biphasic Insulin Aspart 30 and Biphasic Human Insulin 30 in Type 2 DiabetesCOMPLETEDPHASE12007-032007-052007-05
NCT01513525Comparison of Liraglutide Injected at Three Different Injection Sites in Healthy VolunteersCOMPLETEDPHASE12007-022007-052007-05
NCT00435019Comparison of NPH Insulin and Insulin Detemir in Children and Adolescents With Type 1 DiabetesCOMPLETEDPHASE32007-022008-092008-09
NCT00427154Effect of Inhaled Pre-prandial Human Insulin on Blood Glucose Control in Type 2 DiabetesTERMINATEDPHASE32007-01-102008-03-112008-03-11
NCT00422058The Effect of Liraglutide on Body Weight in Obese Subjects Without DiabetesCOMPLETEDPHASE22007-01-102009-04-302007-09-13
NCT01486979Pharmacokinetic Assessment of the Absorption of Estradiol in Postmenopausal Women With Atrophic VaginitisCOMPLETEDPHASE12007-012007-052007-05
NCT00431132Endometrial Safety of a Low Dose of Vagifem® in Postmenopausal Women With Atrophic VaginitisCOMPLETEDPHASE32007-012008-112008-11
NCT01561937Use of Activated Recombinant Human Factor VII to Reduce Bleeding Caused by Warfarin TreatmentCOMPLETEDPHASE12007-012008-072008-07
NCT01515553Bioequivalence of Two Liraglutide Formulations in Healthy VolunteersCOMPLETEDPHASE12007-012007-042007-04
NCT00521690The Effect of Insulin Detemir on Blood Glucose Control in Taiwanese Patients With Type 2 Diabetes Failing on OADCOMPLETEDPHASE42006-122007-082007-08
NCT01865331Safety, Tolerability and Pharmacokinetic and Pharmacodynamic Characteristics of Explorative Formulations of Insulin Degludec and IDegAsp 50 in Healthy Japanese SubjectsCOMPLETEDPHASE12006-122007-032007-03
NCT00411892Effect of Inhaled Insulin (AERx® iDMS) on Blood Glucose Control in Type 2 DiabetesTERMINATEDPHASE32006-11-292008-03-182008-03-18
NCT00399711Effect of Repaglinide and Metformin Combination Tablet or Rosiglitazone and Metformin in Fixed Dose Combination on Blood Glucose Control in Patients With Type 2 DiabetesCOMPLETEDPHASE32006-112007-112007-11
NCT00393718Effect of Liraglutide on Blood Glucose Control in Subjects With Type 2 DiabetesCOMPLETEDPHASE32006-112008-052007-11
NCT01517568Metabolism and Excretion of Liraglutide in Healthy Male VolunteersCOMPLETEDPHASE12006-112006-122006-12
NCT01508858Influence on the Effect of an Oral Contraceptive Drug After Administration of Liraglutide in Postmenopausal WomenCOMPLETEDPHASE12006-112007-042007-04
NCT00348712Efficacy and Safety of Inhaled Pre-prandial Human Insulin in Type 2 DiabetesTERMINATEDPHASE32006-10-302008-03-052008-03-05
NCT00343980Safety and Efficacy of Inhaled Pre-prandial Human Insulin in Type 2 DiabetesTERMINATEDPHASE32006-10-102008-03-102008-03-10
NCT01517555Effect of Liraglutide on Absorption of Paracetamol in Subjects With Type 2 DiabetesCOMPLETEDPHASE12006-102007-052007-05
NCT00395746Effect of Liraglutide in Combination With Sulfonylurea (SU) on Blood Glucose Control in Subjects With Type 2 DiabetesCOMPLETEDPHASE32006-102008-052007-10
NCT00383877Effect of Insulin Detemir on Blood Glucose Control in Subjects With Type 2 DiabetesCOMPLETEDPHASE32006-092007-082007-08
NCT01865305Comparison of Explorative Formulation of Insulin Degludec and Insulin Aspart Co-formulation Versus Explorative Formulation of Insulin Degludec and Insulin Aspart Separately Compared With Biphasic Insulin Aspart 30 in Male Subjects With DiabetesCOMPLETEDPHASE12006-092007-022007-02
NCT01865318Investigation of Pharmacodynamic Characteristics of Explorative Formulation of Insulin Degludec in Male Subjects With Type 1 DiabetesCOMPLETEDPHASE12006-092007-012007-01
NCT00331604Safety and Efficacy of Inhaled Insulin in Type 2 DiabetesTERMINATEDPHASE32006-08-312008-05-052008-05-05
NCT01490099Comparison of Insulin Detemir Produced by the Current Process and the NN729 Process in Healthy SubjectsCOMPLETEDPHASE12006-082006-112006-11
NCT01865292Comparing the Pharmacodynamics and Pharmacokinetics of Explorative Formulation of Insulin Degludec With Insulin Glargine in Subjects With Type 1 and Type 2 DiabetesCOMPLETEDPHASE12006-082006-112006-11
NCT01516255Effect of Liraglutide on Heart Frequency in Healthy VolunteersCOMPLETEDPHASE12006-072006-112006-11
NCT01538511Insulin Profile of Biphasic Insulin Aspart 70 to That of Biphasic Insulin Aspart 30 in Healthy VolunteersCOMPLETEDPHASE12006-06-052007-03-132007-03-13
NCT00343343Comparison of NovoFine® Needles (4 mm vs. 6 mm)COMPLETEDPHASE22006-062006-082006-08
NCT01490658Single Dose Pharmacokinetics of Repaglinide, Metformin and Combination Tablet in Fed Healthy VolunteersCOMPLETEDPHASE12006-062006-082006-08
NCT01489644Single Dose Pharmacokinetics of Repaglinide, Metformin and Combination Tablet in Healthy VolunteersCOMPLETEDPHASE12006-062006-072006-07
NCT00322257Safety and Efficacy of Inhaled Insulin in Type 1 DiabetesTERMINATEDPHASE32006-05-012008-04-022008-04-02
NCT01518166Effect of Liraglutide on Gastrointestinal Absorption of Several Drugs and Potential Influence of Liraglutide on Intragastric pHCOMPLETEDPHASE12006-052007-042007-04
NCT00331851Effect of Liraglutide on Blood Glucose Control in Subjects With Type 2 DiabetesCOMPLETEDPHASE32006-052007-042007-04
NCT00318461To Compare the Effect of Liraglutide When Given Together With Metformin With the Effect of Metformin Given Alone and With the Effect of Glimepiride and Metformin Given TogetherCOMPLETEDPHASE32006-052008-112007-05
NCT00318422Effect of Liraglutide on Blood Glucose Control in Subjects With Type 2 DiabetesCOMPLETEDPHASE32006-052007-052007-05
NCT00333151Effect of Liraglutide on Blood Glucose Control in Subjects With Type 2 DiabetesCOMPLETEDPHASE32006-052007-082007-08
NCT01486901Bioequivalence of Two Insulatard® Formulations in Healthy SubjectsCOMPLETEDPHASE12006-052006-072006-07
NCT01486888Bioequivalence of Two Mixtard® 30 Formulations in Healthy SubjectsCOMPLETEDPHASE12006-052006-072006-07
NCT00323570Evaluation of Recombinant Factor VIIa in Patients With Severe Bleeding Due to TraumaWITHDRAWNPHASE32006-052007-062007-06
NCT00313742The Effect of Exercise on Blood Glucose Levels in Patients With Type 1 Diabetes: A Comparison of 3 Long-acting InsulinsCOMPLETEDPHASE42006-042006-112006-11
NCT01536028Comparison of the Pharmacodynamics and Pharmacokinetics of Biphasic Insulin Aspart 30, 50, 70 and Insulin Aspart in Subjects With Type 1 DiabetesCOMPLETEDPHASE12006-042006-072006-07
NCT00318786Efficacy and Safety of Three Times a Day BIAsp-70 Compared to Two Times a Day BIAsp-30 in Subjects With Type 2 DiabetesCOMPLETEDPHASE32006-042007-062007-06
NCT01561417Bioequivalence of NovoSeven® and a NovoSeven® Formulation Stable at Room Temperature in Healthy Male SubjectsCOMPLETEDPHASE12006-042006-092006-09
NCT00313001Effects of Biphasic Insulin Aspart 70/30 vs. Exenatide in Type 2 Diabetes Patients Not Reaching Blood Glucose Targets on Metformin and a Sulfonylurea.COMPLETEDPHASE32006-042007-072007-07
NCT01515579Comparison of Two Liraglutide Formulations in Healthy SubjectsCOMPLETEDPHASE12006-042006-062006-06
NCT01530048Bioequivalence of Two Insulin Aspart Formulations (100 U/mL Versus 200 U/mL)COMPLETEDPHASE12006-032006-052006-05
NCT01507389Safety of Liraglutide in Subjects With Liver Impairment and in Subjects With Normal Liver FunctionCOMPLETEDPHASE12006-032006-062006-06
NCT00294723To Evaluate the Effect of Liraglutide Versus Glimepiride (Amaryl®) on Haemoglobin A1cTERMINATEDPHASE32006-022008-112008-11
NCT00282451Effect of Biphasic Insulin Compared to Biphasic Insulin Combined With Insulin Aspart, With or Without Metformin in Type 2 DiabetesCOMPLETEDPHASE42006-022006-082006-08
NCT01515592Safety and Tolerability of Liraglutide in Healthy Japanese Male VolunteersCOMPLETEDPHASE12006-012006-042006-04
NCT00266006Factor VIIa in Acute Intracerebral HaemorrhageCOMPLETEDPHASE22006-012007-042007-04
NCT00267683Efficacy and Safety of Insulin Aspart Versus Glibenclamide in Type 2 DiabetesTERMINATEDPHASE32005-122006-042006-04
NCT01865279Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Explorative Formulation of Insulin DegludecCOMPLETEDPHASE12005-122006-042006-04
NCT01511692Effect of Liraglutide Compared to Glimepiride on Appetite in Subjects With Type 2 DiabetesCOMPLETEDPHASE12005-112007-092007-09
NCT01561924Prediction of the Efficacy of Activated Recombinant Human Factor VII in Adult Congenital Haemophilia A or B Patients With Inhibitors by Use of ThromboelastographyCOMPLETEDPHASE12005-112006-052006-05
NCT01562457Intra-subject Variability Following Administrations of Activated Recombinant Human Factor VII in Haemophilia Patients in a Non-bleeding StateCOMPLETEDPHASE12005-112006-042006-04
NCT01498926Comparison of Two Insulin Detemir Formulations in Healthy VolunteersCOMPLETEDPHASE12005-112006-022006-02
NCT01486862Efficacy of Biphasic Insulin Aspart 30 in Subjects With Type 2 Diabetes Failing on OADsCOMPLETEDPHASE42005-102006-072006-07
NCT00419718Effect of Exercise on the Absorption of Inhaled Human Insulin in Subjects With Type 1 DiabetesCOMPLETEDPHASE12005-102005-112005-11
NCT00264901Comparison of Self Adjustment Versus Standard of Care Treatment in Subjects With Type 2 DiabetesCOMPLETEDPHASE42005-102006-112006-11
NCT02239146Safety of rFXIII in Patients Following First Time Myocardial Revascularization Requiring Cardiopulmonary BypassCOMPLETEDPHASE12005-102008-012008-01
NCT01709929Safety of Insulin Detemir for the Treatment of Insulin Dependent Type 1 or Type 2 Diabetes MellitusCOMPLETEDPHASE32005-102006-042006-04
NCT00184548Evaluation of Recombinant Factor VIIa in Patients With Severe BleedingTERMINATEDPHASE32005-102008-092008-09
NCT00491725Efficacy and Safety of Repaglinide and Metformin Combination Therapy in Type 2 Diabetes Failing on Oral Anti-diabetic DrugsCOMPLETEDPHASE42005-092006-062006-06
NCT00274274Efficacy and Safety of a Fixed or a Flexible Supplementary Insulin Therapy in Type 2 DiabetesCOMPLETEDPHASE42005-092006-112006-11
NCT01497587Pharmacokinetics of Insulin Detemir in Healthy Volunteers From TaiwanCOMPLETEDPHASE12005-082005-122005-12
NCT01508806Safety and Tolerability of Liraglutide in Subjects With Impaired Kidney Function and in Subjects With Normal Kidney FunctionCOMPLETEDPHASE12005-082006-032006-03
NCT00127296Reliability of Dosing With NovoLog® Mix 70/30 FlexPen® Compared With Vial and SyringeCOMPLETEDPHASE12005-072005-092005-09
NCT00184561Effectiveness and Safety of Biphasic Insulin Aspart 70/30 in Subjects With Type 2 DiabetesCOMPLETEDPHASE42005-072006-072006-07
NCT00121355Novofine Autocover Safety Needle Versus BD Safety GlideCOMPLETEDPHASE42005-072006-062006-06
NCT00519844Growth Hormone Treatment in Children Born Small for Gestational Age: Assessment of SatisfactionCOMPLETEDPHASE42005-072006-012006-01
NCT00117780Comparison of Insulin Detemir Given Once or Twice Daily in Type 1 DiabetesCOMPLETEDPHASE42005-062006-102006-10
NCT01502137Pharmacokinetics of Somatropin in Patients With End Stage Renal Disease Receiving Chronic HaemodialysisCOMPLETEDPHASE12005-062005-112005-11
NCT00115973A Study of the Treatment of Type 2 Diabetes With an Insulin Infusion PumpCOMPLETEDPHASE12005-062006-012006-01
NCT01487811Comparison of Two Biphasic Insulin Aspart 30 Formulations (Current and New Formulation) in Healthy VolunteersCOMPLETEDPHASE12005-052005-112005-11
NCT00127283Recombinant Factor VIIa in Acute Intracerebral HaemorrhageCOMPLETEDPHASE32005-052007-012007-01
NCT01497574Within-subject Variability of Insulin Detemir in Children and Adolescents With Type 1 DiabetesCOMPLETEDPHASE12005-052005-102005-10
NCT00184613Comparison of Insulin Glargine Against Insulin Aspart Infused Under the Skin in Patients With Type 2 DiabetesCOMPLETEDPHASE12005-052006-012006-01
NCT00504673Comparison of Insulin Detemir Versus Insulin NPH on Weight Change in Overweight and Obese With Type 2 DiabetesCOMPLETEDPHASE32005-042006-122006-12
NCT00569426Evaluating the Use of Two Different Needles in Subjects With DiabetesCOMPLETEDPHASE42005-042005-062005-06
NCT00184574Comparison of Biphasic Insulin Aspart 70/30, 50/50, and 30/70 in Subjects With Type 2 DiabetesCOMPLETEDPHASE32005-042006-032006-03
NCT00108849Vagifem Low Dose for Postmenopausal Atrophic Vaginitis SymptomsCOMPLETEDPHASE32005-032007-052007-05
NCT00106366Comparison of Insulin Detemir With Insulin Glargine in Type 2 DiabetesCOMPLETEDPHASE32005-032005-122005-12
NCT01477632Bioavailability of Three Oral Formulations for Hormone Replacement Therapy in Postmenopausal WomenCOMPLETEDPHASE12005-032005-062005-06
NCT00104182Comparison of Insulin Detemir Morning, Insulin Detemir Evening and NPH Insulin Evening in Patients With Type 2 DiabetesCOMPLETEDPHASE32005-022006-022006-02
NCT01514487Comparison of Three Liraglutide Formulations in Healthy VolunteersCOMPLETEDPHASE12005-01-132005-03-302005-03-30
NCT00154401Effect of Liraglutide on Blood Glucose Control in Subjects With Type 2 DiabetesCOMPLETEDPHASE22005-012005-102005-10
NCT00097877Comparison of Biphasic Insulin Aspart 70/30 Versus Insulin Glargine in Subjects With Type 2 DiabetesCOMPLETEDPHASE32005-012006-112006-11
NCT00154414Effect of Liraglutide on Blood Glucose Control in Japanese Subjects With Type 2 DiabetesCOMPLETEDPHASE22005-012006-052006-05
NCT00123591Safety and Preliminary Efficacy of Recombinant Activated Factor VII in Subjects With Traumatic Brain InjuryCOMPLETEDPHASE22005-012006-052006-05
NCT01024218Preference Study Between NovoFine® Autocover™ and a NovoFine® 8 mm NeedleCOMPLETEDPHASE42004-12-012005-04-262005-04-26
NCT00494988Self-control Trial to Evaluate the Remission Rate in Newly Diagnosed Type 2 Diabetes Patients After Treatment With Insulin AspartCOMPLETEDPHASE42004-122006-042006-04
NCT01620450Comparison of Insulin Aspart Produced by Current Process and the NN2000 Process in Healthy JapaneseCOMPLETEDPHASE12004-11-202005-02-262005-02-26
NCT00184600Comparison of Insulin Detemir, Insulin Aspart and Biphasic Insulin Aspart 30 With OAD Treatment in Type 2 DiabetesCOMPLETEDPHASE32004-112009-082009-08
NCT00184730Long-term Trial on Growth Hormone Deficiency in Adults (GHDA)COMPLETEDPHASE32004-112006-092006-09
NCT00101751INITIATE Plus (INITiation of Insulin to Reach A1c TargEt) StudyCOMPLETEDPHASE42004-102006-062006-06
NCT00097071Safety and Efficacy of NovoLog vs. Humalog in Insulin Pumps in Children and AdolescentsCOMPLETEDPHASE32004-102006-052006-05
NCT00184626Comparison of Insulin Glargine Versus Biphasic Insulin Aspart 30/70 or Biphasic Insulin Aspart 30/70 in Combination With Metformin in Subjects With Type 2 Diabetes.COMPLETEDPHASE42004-09-102005-10-242005-10-24
NCT00336986Efficacy Study of IL-21 to Treat Metastatic MelanomaCOMPLETEDPHASE22004-092007-102007-10
NCT00097084Comparison of Insulin Detemir Plus Insulin Aspart Against Insulin Glargine Plus Insulin Aspart in Type 2 DiabetesCOMPLETEDPHASE32004-092005-122005-12
NCT00095082Safety and Efficacy of Insulin Detemir Plus Insulin Aspart Against Insulin Glargine Plus Insulin Aspart as Mealtime Insulin in Type 1 DiabetesCOMPLETEDPHASE32004-092005-122005-12
NCT00184717Growth Hormone Treatment in Children Born Small for Gestational Age (SGA)COMPLETEDPHASE32004-08-182009-12-282006-03-29
NCT00184639Comparison of Insulin Detemir and Insulin Semilente®MC in Type 1 DiabetesCOMPLETEDPHASE32004-08-162005-11-222005-11-22
NCT00097279Comparison of Biphasic Insulin Aspart 70/30 With Anti-Diabetic Drugs in Subjects With Type 2 DiabetesCOMPLETEDPHASE32004-082005-082005-08
NCT00154427Use of Activated Recombinant Human Factor VII in Cardiac SurgeryTERMINATEDPHASE22004-082007-112007-11
NCT00095446NovoLog Observation Trial in Subjects With Type 1 and Type 2 DiabetesCOMPLETEDPHASE42004-072005-032005-03
NCT00102037Use of Activated Recombinant FVII in Spinal SurgeryCOMPLETEDPHASE22004-072006-022006-02
NCT00593255Efficacy and Safety of Insulin Aspart in Subjects With Type 1 or Type 2 DiabetesCOMPLETEDPHASE42004-072005-042005-04
NCT00564668Comparison of Biphasic Insulin Aspart Produced by the NN2000 Process to Current Process to in Type 2 DiabetesCOMPLETEDPHASE32004-06-192005-04-122005-04-12
NCT00104455Dose Response to Recombinant Factor VIIa When Administered for BleedCOMPLETEDPHASE12004-062004-112004-11
NCT00184665Comparison of Insulin Detemir With NPH Insulin in Type 1 DiabetesCOMPLETEDPHASE32004-062006-092006-09
NCT00184795Bleed Free Treatment of Menopausal Symptoms With New Ultra Low Dose Hormonal CombinationsCOMPLETEDPHASE32004-05-282005-05-042005-05-04
NCT01508897Comparison of Two Liraglutide Formulations in Healthy VolunteersCOMPLETEDPHASE12004-05-282004-06-302004-06-30
NCT01497535Within-subject Variability of Insulin Detemir in Healthy VolunteersCOMPLETEDPHASE12004-05-272004-10-312004-10-31
NCT00605137Safety of Insulin Detemir in Children With Type 1 DiabetesCOMPLETEDPHASE32004-05-212005-04-232005-04-23
NCT00624364Efficacy and Safety of Biphasic Insulin Aspart 30 With Metformin in Type 2 DiabetesCOMPLETEDPHASE42004-052005-052005-05
NCT01507337Comparison of the Effect of Liraglutide in Young Versus Elderly Healthy VolunteersCOMPLETEDPHASE12004-042004-062004-06
NCT00760448Comparison of Insulin Detemir and NPH With Respect to Lowering the Blood Sugar and Symptoms Experienced by Type 1 Diabetics During HypoglycaemiaCOMPLETEDPHASE12004-042005-102005-10
NCT00592527Safety and Efficacy of Insulin Detemir in Combination With OADs in Type 2 DiabetesCOMPLETEDPHASE32004-042004-122004-12
NCT00154492Use of NovoSeven® in Active Variceal BleedingCOMPLETEDPHASE22004-042006-082006-08
NCT00108758Efficacy of NovoSeven® in Bleeding Prophylaxis in HemophiliaCOMPLETEDPHASE22004-032005-112005-11
NCT00600366Efficacy and Safety of Biphasic Insulin Aspart 30 FlexPen® in Insulin Naive Subjects With Type 2 DiabetesCOMPLETEDPHASE42004-032005-012005-01
NCT01497600Pharmacokinetics of Insulin Detemir in Subjects With Type 2 DiabetesCOMPLETEDPHASE12004-022004-082004-08
NCT00600626Basal Bolus of Insulin Aspart Including Insulin NPH and Biphasic Insulin Aspart in Type 2 DiabetesCOMPLETEDPHASE32004-012004-072004-07
NCT00568074Efficacy and Safety of Repaglinide, Glurenorm® and Glucobay® in Chinese Subjects With Type 2 DiabetesCOMPLETEDPHASE42003-12-162004-09-022004-09-02
NCT00184743Long-term Trial on Growth Hormone Deficiency in Adults (GHDA)COMPLETEDPHASE32003-12-062005-12-282005-12-28
NCT00592969Efficacy and Safety of Metformin Plus Biphasic Insulin Aspart 30 in Type 2 DiabetesCOMPLETEDPHASE42003-12-032004-11-022004-11-02
NCT00605020Efficacy and Safety of Insulin Detemir in Combination With Insulin Aspart and Biphasic Insulin Aspart 30 in Type 2 DiabetesCOMPLETEDPHASE32003-12-022005-03-032005-03-03
NCT00595374Efficacy and Safety of Insulin Detemir in Type 1 DiabetesCOMPLETEDPHASE32003-12-022004-10-072004-10-07
NCT01527656Bioequivalence of Two Formulations of Biphasic Insulin Aspart 70 in Healthy SubjectsCOMPLETEDPHASE12003-122004-022004-02
NCT00604253Efficacy and Safety of Insulin Detemir in Type 2 Diabetes Inadequately Controlled on OHA Therapy AloneCOMPLETEDPHASE32003-122005-052005-05
NCT00619697Efficacy and Safety of Biphasic Insulin Aspart 30 in Combination With Metformin in Type 2 DiabetesCOMPLETEDPHASE42003-122005-032005-03
NCT01615978Safety and Tolerability of Liraglutide in Japanese Subjects With Type 2 DiabetesCOMPLETEDPHASE12003-122004-032004-03
NCT00605111Efficacy and Safety of Biphasic Insulin Aspart 30 in Subjects With Type 2 DiabetesCOMPLETEDPHASE42003-122004-102004-10
NCT01620437Bioequivalence of Two Formulations of Biphasic Insulin Aspart 50 in Japanese SubjectsCOMPLETEDPHASE12003-11-292003-12-302003-12-30
NCT01527643Bioequivalence of Two Formulations of Biphasic Insulin Aspart 50 in Healthy SubjectsCOMPLETEDPHASE12003-11-112003-12-172003-12-17
NCT00280046Effect of Biphasic Insulin Aspart 30 on Blood Glucose Control in Subjects With Type 2 DiabetesCOMPLETEDPHASE32003-112004-072004-07
NCT00799448Comparison of Efficacy and Safety of Repaglinide Combined With Insulin NPH Versus Biphasic Human Insulin 30 Alone in Inadequately Controlled Subjects With Type 2 DiabetesTERMINATEDPHASE42003-09-162004-09-202004-09-20
NCT00612599Comparison of Pharmacodynamics and Pharmacokinetics of Biphasic Insulin Aspart 50 to Biphasic Insulin Aspart 70 in Type 2 DiabetesCOMPLETEDPHASE32003-092004-062004-06
NCT01620476Safety and Tolerability of Liraglutide in Healthy Japanese VolunteersCOMPLETEDPHASE12003-092004-032004-03
NCT00569998Comparison of Two Pen Systems in Patients With Diabetes Treated With InsulinCOMPLETEDPHASE32003-082004-022004-02
NCT00571935Efficacy and Safety of Insulin Aspart in MDI or CSII in Children Below 7 Years of Age With Type 1 DiabetesCOMPLETEDPHASE42003-082004-102004-10
NCT00557336Efficacy and Safety of Growth Hormone Treatment in Children Small for Gestational AgeCOMPLETEDPHASE32003-07-282005-06-292005-06-29
NCT00617565Efficacy and Safety of Biphasic Insulin Aspart 30 in Type 1 or 2 DiabetesCOMPLETEDPHASE32003-07-082003-11-262003-11-26
NCT00791895Efficacy of Biphasic Insulin Aspart 30 in Type 2 Diabetics Failing on OADsCOMPLETEDPHASE42003-06-262004-11-292004-10-31
NCT00519558Growth Hormone Deficiency in Adults (GHDA)COMPLETEDPHASE32003-05-312005-01-242005-01-24
NCT00604656Comparison of Insulin Aspart Produced by the NN2000 Process to the Current Process in Type 1 DiabetesCOMPLETEDPHASE32003-05-052004-01-292004-01-29
NCT00569400Comparison of Human Insulin Produced by the Current Process and the NN729 Process in Type 1 DiabetesCOMPLETEDPHASE32003-05-012004-01-192004-01-19
NCT00102817Somatropin (Norditropin) in Insulin-like Growth Factor (IGF) Deficient ChildrenCOMPLETEDPHASE32003-052006-122006-12
NCT01848002Safety and Pharmacokinetics of Recombinant Factor XIII Administration in Healthy VolunteersCOMPLETEDPHASE12003-052003-082003-08
NCT00184652Growth Hormone Treatment in Adult Patients With Chronic Kidney DiseaseCOMPLETEDPHASE22003-042005-092005-09
NCT00604344Efficacy and the Safety of Insulin Detemir in Subjects With Insulin Requiring DiabetesCOMPLETEDPHASE32003-042005-032005-03
NCT00560924Preventive Effect of Treatment With Estradiol Vaginal Tablets on Recurrent Urinary Tract Infections in Post-menopausal WomenTERMINATEDPHASE32003-03-212004-03-172004-03-17
NCT00567385Liquid Somatropin Formulation in Children With Growth Hormone DeficiencyCOMPLETEDPHASE42003-03-102004-03-222004-03-22
NCT00604396Safety and Efficacy of Insulin Detemir in Combination With OAD in Type 2 DiabetesCOMPLETEDPHASE32003-032004-012004-01
NCT00056589Safety and Pharmacokinetics of Recombinant Factor XIII in Patients With Congenital Factor Xlll DeficiencyCOMPLETEDPHASE12003-032003-102003-10
NCT00283751Comparison of Insulin Detemir or Insulin Glargine as Add on to Oral Antidiabetic Drugs in Type 2 DiabetesCOMPLETEDPHASE32003-032004-112004-11
NCT01497561Pharmacodynamics and Pharmacokinetics of Insulin Detemir in Subjects With Type 2 DiabetesCOMPLETEDPHASE12003-032003-062003-06
NCT00572806Initiation of Insulin Aspart in Type 2 DiabetesCOMPLETEDPHASE42003-02-052004-02-022004-02-02
NCT01527565Bioequivalence of Two Formulations of Biphasic Insulin Aspart 70 in Healthy Male SubjectsCOMPLETEDPHASE12003-01-202003-02-262003-02-26
NCT01486914Comparison of Insulin Aspart Produced by Current Process and the NN2000 ProcessCOMPLETEDPHASE12003-01-192003-02-242003-02-24
NCT01847989Safety and Pharmacokinetics of Recombinant Factor XIII in Healthy VolunteersCOMPLETEDPHASE12003-012003-052003-05
NCT00572052Comparison of Glycemic Control Achieved With 2 Different NeedlesCOMPLETEDPHASE42002-122003-102003-10
NCT01620463Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Liraglutide in Healthy Japanese VolunteersCOMPLETEDPHASE12002-122003-032003-03
NCT00568984Efficacy and Safety of Repaglinide and Metformin Combined in Type 2 DiabetesCOMPLETEDPHASE42002-11-212003-11-102003-11-10
NCT01527630Bioequivalence of Two Formulations of Biphasic Insulin Aspart 50 in Healthy Japanese SubjectsCOMPLETEDPHASE12002-11-162003-01-082003-01-08
NCT01527552Bioequivalence of Two Formulations of Biphasic Insulin Aspart 50 in Healthy Male SubjectsCOMPLETEDPHASE12002-11-052002-12-182002-12-18
NCT00184756Efficacy on Height in SGA Children Treated With Growth HormoneCOMPLETEDPHASE32002-112006-072006-07
NCT00598793Biphasic Insulin Aspart 30 in Type 2 Diabetes Failing OAD TherapyCOMPLETEDPHASE32002-112004-032004-03
NCT00571584High Dose of Activated Recombinant Human Factor VII for Treatment of Mild/Moderate Joint Bleeds in Haemophilia Patients With InhibitorsCOMPLETEDPHASE42002-112004-032004-03
NCT00567775Comparison of Human Insulin to Insulin Inhalation Solution in Children With Type 1 DiabetesCOMPLETEDPHASE22002-10-212002-11-202002-11-20
NCT01448070Comparison of Human Insulin Produced by the Current Process and the NN729 Process in Healthy VolunteersCOMPLETEDPHASE12002-10-152002-12-202002-12-20
NCT00597233Human Insulin NPH and Insulin Aspart in Type 1 DiabetesCOMPLETEDPHASE42002-102002-122002-12
NCT01720303Efficacy and Safety of Repaglinide Combined With Insulin in Type 2 DiabetesCOMPLETEDPHASE42002-09-192003-04-102003-04-10
NCT01698697Comparison of Two Insulin Aspart Formulations in Healthy VolunteersCOMPLETEDPHASE12002-09-022002-10-182002-10-18
NCT00725036Long Term Safety Trial to Compare Insulin Treatment With Preprandial Inhaled Human Insulin to s.c. Insulin Aspart Both Combined With NPH in Subjects With Type 1 DiabetesCOMPLETEDPHASE32002-09-022004-12-142004-12-14
NCT01601457Activated Recombinant Human Factor VII in Pelvic-acetabular Fracture ReconstructionCOMPLETEDPHASE22002-092004-042004-04
NCT01562587Pharmacokinetics of Single Bolus Dose of NovoSeven® in Paediatric and Adult Patients With Haemophilia A or B in a Non- Bleeding StateCOMPLETEDPHASE12002-092003-052003-05
NCT00365170Efficacy and Safety of Insulin Aspart vs. Human Insulin During Pregnancy by Women With Type 1 DiabetesCOMPLETEDPHASE42002-092005-042005-04
NCT01467401Efficacy and Safety of NovoMix® 30 in Subjects With Type 2 DiabetesCOMPLETEDPHASE42002-08-192003-05-152003-05-15
NCT00426803Recombinant Factor VIIa in Acute Intracerebral HaemorrhageCOMPLETEDPHASE22002-082004-062004-06
NCT01511172Effect of Liraglutide as add-on to Metformin Compared to Either Liraglutide or Metformin Alone, or to a Combination of Metformin and a SU (Sulphonylurea) Agent in Subjects With Type 2 DiabetesCOMPLETEDPHASE22002-082002-122002-12
NCT01542450Pharmacokinetics of Insulin Detemir in Subjects With Type 1 DiabetesCOMPLETEDPHASE12002-082003-022003-02
NCT00312156Comparison of Efficacy and Safety of Insulin Detemir and NPH Insulin in Children and Adolescents With Type 1 DiabetesCOMPLETEDPHASE32002-082003-082003-08
NCT01720290Comparison of Repaglinide and Metformin Administered Alone or in Combination in Type 2 DiabetesCOMPLETEDPHASE42002-07-252003-02-252003-02-25
NCT01697631Glycemic Control of Biphasic Insulin Aspart 30 in Type 2 DiabetesCOMPLETEDPHASE42002-07-222003-04-242003-04-24
NCT01564563Efficacy and Safety of Activated Recombinant Human Factor VII in Treatment of Bleeding in Patients Following Hematopoietic Stem Cell TransplantationTERMINATEDPHASE22002-06-282003-10-272003-10-27
NCT01467141Safety and Efficacy of Insulin Aspart in Children With Type 1 DiabetesCOMPLETEDPHASE42002-06-192003-10-152003-10-15
NCT01487798Frequency of Episodes of Hypoglycaemia During Treatment With Biphasic Insulin Aspart 30 in Type 2 DiabetesCOMPLETEDPHASE42002-062003-112003-11
NCT00071448Insulin Aspart vs. Insulin Lispro vs. Regular Insulin in Paediatric PopulationCOMPLETEDPHASE32002-062004-062004-06
NCT01526980Glycaemic Control of Biphasic Insulin Aspart 70 and 30 in Subjects With Type 2 DiabetesCOMPLETEDPHASE22002-052002-112002-11
NCT01698931Efficacy of Repaglinide in Subjects With Type 2 DiabetesCOMPLETEDPHASE42002-04-262003-03-062003-03-06
NCT00312104Comparison of Efficacy and Safety of Insulin Detemir and Insulin Glargine in Patients With Type 1 DiabetesCOMPLETEDPHASE32002-042003-032003-03
NCT01486381Long Term Safety of Biphasic Insulin Aspart 30 in Juveniles With Type 1 DiabetesCOMPLETEDPHASE32002-03-202003-05-302003-05-30
NCT01465152Comparison of Metformin, Repaglinide or the Combination of Both in Subjects With Type 2 DiabetesCOMPLETEDPHASE42002-03-062004-10-212004-10-21
NCT01486940Comparison of Insulin Detemir Plus Insulin Aspart With Insulin NPH Plus Human Soluble Insulin in Subjects With Type 1 DiabetesCOMPLETEDPHASE32002-032002-102002-10
NCT01563523Efficacy and Safety of Activated Recombinant Human Factor VII in Severely Injured Trauma PatientsCOMPLETEDPHASE22002-032003-102003-10
NCT01649570Safety and Efficacy of Insulin Aspart in Type 2 DiabetesCOMPLETEDPHASE42002-032003-082003-08
NCT00184678Effect of Growth Hormone on Bone Mineral Density in Young Adults With Child-hood Onset Growth Hormone DeficiencyCOMPLETEDPHASE32002-022006-072006-07
NCT00676819Comparison of the Pharmacodynamics and Pharmacokinetics of Insulin Aspart and Human Insulin in Elderly People With Type 2 DiabetesCOMPLETEDPHASE42002-01-102002-07-192002-07-19
NCT01562574Activated Recombinant Human Factor VII Following Cardiac Bypass Surgery for Paediatric Congenital Heart DiseaseCOMPLETEDPHASE32002-012004-082004-08
NCT01527539Long Term Safety and Efficacy of Biphasic Insulin Aspart 30 in Subjects With Type 2 DiabetesCOMPLETEDPHASE32001-11-232004-10-122004-10-12
NCT01605773Effect of Repaglinide on Postprandial Lipemia in Type 2 DiabetesCOMPLETEDPHASE42001-11-082003-03-132003-03-13
NCT01563445Safety and Preliminary Efficacy of Activated Recombinant Human Factor VII for Preventing Early Hematoma Growth in Acute Intracerebral HaemorrhageCOMPLETEDPHASE22001-112003-032003-03
NCT01563471Safety and Tolerability of Intravenous Doses of Activated Recombinant Human Factor VII in Healthy VolunteersCOMPLETEDPHASE12001-102002-072002-07
NCT01511159Comparison of Liraglutide Inhaled Into the Lungs Compared to Liraglutide Injected Under the Skin in Healthy Male VolunteersCOMPLETEDPHASE12001-102001-122001-12
NCT01561352Efficacy and Safety of Activated Recombinant Human Factor VII in Refractory Haemorrhagic CystitisCOMPLETEDPHASE22001-092003-112003-11
NCT00108797Trial of NovoSeven® in Haemophilia - Joint BleedsCOMPLETEDPHASE42001-092006-022006-02
NCT01697657Frequency of Hypoglycaemic Episodes During Treatment With Insulin Detemir in Well Controlled Subjects With Type 1 DiabetesCOMPLETEDPHASE32001-092002-112002-11
NCT01705249Bleeding Profile With Continuous Hormone Replacement Therapy of Activelle® in Postmenopausal WomenCOMPLETEDPHASE42001-08-142003-06-062003-06-06
NCT01566786Safety and Preliminary Efficacy of Activated Recombinant Human Factor VII in Acute Intracerebral HaemorrhageCOMPLETEDPHASE22001-082002-102002-10
NCT01563458Safety and Efficacy of Activated Recombinant Human Factor VII in Patients Undergoing Orthotopic Liver TransplantationCOMPLETEDPHASE22001-082003-082003-08
NCT00254514Controlled Study to Evaluate the Efficacy and Safety of the Treatment With Growth Hormone in Tibia FracturesCOMPLETEDPHASE22001-082003-102003-10
NCT01562821Safety and Efficacy of Activated Recombinant Human Factor VII in Cirrhotic Patients Undergoing Partial HepatectomyCOMPLETEDPHASE22001-072002-122002-12
NCT01601613Activated Recombinant Human Factor VII in Patients With Dengue Haemorrhagic FeverCOMPLETEDPHASE22001-072002-112002-11
NCT01508949Effect of Liraglutide on Weight and Appetite in Obese Subjects With Type 2 DiabetesCOMPLETEDPHASE22001-062002-032002-03
NCT01562561Efficacy and Safety of Repaglinide Combined With Insulin NPH in Subjects With Type 2 DiabetesCOMPLETEDPHASE32001-06-012002-12-202002-12-20
NCT01698944Cardiovascular Effects on Growth Hormone Therapy in Adults With Growth Hormone DeficiencyTERMINATEDPHASE42001-05-162002-11-182002-11-18
NCT01502124Safety and Efficacy of Somatropin in Children With Growth Hormone DeficiencyCOMPLETEDPHASE32001-05-082003-03-052003-03-05
NCT01508923Effect of Liraglutide on Glucose Profiles and Gastric Emptying in Subjects With Type 2 DiabetesCOMPLETEDPHASE22001-052002-022002-02
NCT01526941Comparison of Single Dose and Steady State Pharmacodynamics of Biphasic Insulin Aspart 30 and 70 in Subjects With Type 1 DiabetesCOMPLETEDPHASE12001-052001-072001-07
NCT01704378Efficacy and Safety of Biphasic Insulin Aspart 30 FlexPen™ in Subjects With Type 2 DiabetesCOMPLETEDPHASE42001-04-182003-03-142003-03-14
NCT01509742Effect of Liraglutide on Glucagon Secretion in Subjects With Type 2 DiabetesCOMPLETEDPHASE12001-042001-112001-11
NCT01562158Efficacy and Safety of Activated Recombinant Human Factor VII in Treatment of Bleeding in Patients Following Allogeneic Stem Cell TransplantationCOMPLETEDPHASE22001-042003-102003-10
NCT03220425Evaluation of the Efficacy and Safety of Insulin Detemir Compared With That of NPH Insulin in Subjects With Type 1 Diabetes.COMPLETEDPHASE32001-02-012001-11-122001-11-12
NCT01511185Effect of Liraglutide on the Beta-cell Responsiveness in Subjects With Type 2 Diabetes Compared to a Healthy Control GroupCOMPLETEDPHASE12001-022001-102001-10
NCT01620424Pharmacokinetics and Pharmacodynamics of Biphasic Insulin Aspart 30 and 50 in Subjects With Type 2 DiabetesCOMPLETEDPHASE12001-022001-042001-04
NCT01511198Efficacy and Safety of Metformin and Liraglutide in Obese Subjects With Type 2 Diabetes Previously Treated With an Oral Hypoglycemic AgentCOMPLETEDPHASE22001-022001-102001-10
NCT00400283A Study Looking Into the Effect of NNC 55-0414 in Subjects With Type 2 DiabetesCOMPLETEDPHASE12001-01-192001-05-032001-05-03
NCT01467375Long Term Safety and Efficacy of Biphasic Insulin Aspart 30 in Type 2 DiabetesCOMPLETEDPHASE32001-01-082004-10-222004-10-22
NCT01524809Pharmacokinetics of Biphasic Insulin Aspart 30 and 70 in Subjects With Type 1 DiabetesCOMPLETEDPHASE12001-012001-062001-06
NCT01650129Safety and Efficacy of Biphasic Insulin Aspart 50 in Subjects With Type 2 DiabetesCOMPLETEDPHASE32000-12-132001-10-182001-10-18
NCT01563926Evaluating Acceptance of New Liquid Somatropin Formulation in Children With Growth Hormone DeficiencyCOMPLETEDPHASE32000-10-232002-10-102002-10-10
NCT01509755Comparison of Liraglutide and Glimepiride on Blood Sugar Control in Subjects With Type 2 DiabetesCOMPLETEDPHASE22000-102001-102001-10
NCT00262249Effect of Growth Hormone in Children With Growth Hormone DeficiencyCOMPLETEDPHASE32000-082004-052004-05
NCT01734447Long Term Effect of Somatropin in Subjects With Intrauterine Growth RetardationCOMPLETEDPHASE42000-04-302003-04-302003-04-30
NCT00931476A Single Dose Trial in Healthy Caucasians and Japanese Subjects Investigating the Pharmacokinetics of SomatropinCOMPLETEDPHASE12000-04-062000-06-082000-06-08
NCT00065130Safety and Efficacy of Insulin Aspart vs. Regular Human Insulin in Gestational DiabetesCOMPLETEDPHASE32000-042003-122003-12
NCT01520818Comparison of Biphasic Human Insulin 30 With Biphasic Insulin Aspart in Subjects With DiabetesCOMPLETEDPHASE32000-032001-042001-04
NCT01620333Pharmacokinetics of Biphasic Insulin Aspart 50 and 70 in Japanese Healthy VolunteersCOMPLETEDPHASE12000-022000-042000-04
NCT00832182Examining the Long-term Safety of Insulin Aspart When Used as a Part of the Treatment for Type 1 DiabetesCOMPLETEDPHASE31999-12-222002-11-252002-11-25
NCT01523041Comparison of Two Formulations of Biphasic Insulin Aspart 70COMPLETEDPHASE11999-11-031999-11-301999-11-30
NCT02162407A Trial Investigating the Relationship Between Pharmacodynamic and Interstitial Concentration for Insulin Detemir and Human InsulinCOMPLETEDPHASE11999-101999-121999-12
NCT01507311Effect of Liraglutide on Pulsatile Insulin Secretion in Subjects With Type 2 DiabetesCOMPLETEDPHASE11999-091999-121999-12
NCT01507285Safety and Tolerability of Liraglutide in Healthy Volunteers and Subjects With Type 2 DiabetesCOMPLETEDPHASE11999-081999-111999-11
NCT01520831Comparison of Biphasic Insulin Aspart (30, 50 and 70) and Insulin Aspart in Healthy SubjectsCOMPLETEDPHASE11999-042000-052000-05
NCT00184691Growth Hormone Treatment of Children Born With Retarded Intrauterine Growth at Age 2-5 YearsCOMPLETEDPHASE31999-042005-062005-06
NCT01520753Comparison of Two Biphasic Insulin Aspart Treatments in Subjects With Type 2 DiabetesCOMPLETEDPHASE31999-031999-061999-06
NCT01507272Safety and Tolerability of Liraglutide in Healthy Male VolunteersCOMPLETEDPHASE11999-031999-121999-12
NCT01562834Effect of Somatropin on Left Ventricular Mass in Growth Hormone Deficient Adult PatientsCOMPLETEDPHASE41998-10-212002-12-012002-12-01
NCT01710696Induction of Puberty With 17-beta Estradiol in Girls With Turner SyndromeCOMPLETEDPHASE31998-07-232004-07-262004-07-26
NCT01467323Efficacy and Safety of Biphasic Insulin Aspart 30 in Type 1 or Type 2 DiabetesCOMPLETEDPHASE31998-041998-091998-09
NCT01561391Safety and Efficacy of Activated Recombinant Human Factor VII in Haemophilia Patients With Inhibitors During and After Major SurgeryCOMPLETEDPHASE41998-042004-052004-05
NCT00184769Growth Hormone Treatment in Infants Aged 1 to 2 Years With Chronic Renal Insufficiency (CRI) and Growth Retardation.COMPLETEDPHASE41998-01-292005-12-212005-12-21
NCT00872560Comparison of 2 NovoFine® Needles on the Reflux of InsulinCOMPLETEDPHASE31998-01-201998-07-271998-07-27
NCT01707134Safety and Efficacy of Insulin Aspart in Subjects With Type 1 DiabetesCOMPLETEDPHASE31997-092000-052000-05
NCT00871416Localisation of Potential Insulin Deposits in Normal Weight and Obese Diabetics Using 6 mm and 12 mm Long NeedlesCOMPLETEDPHASE31997-04-091997-07-181997-07-18
NCT01697618Pharmacokinetics, Pharmacodynamics and Safety of Biphasic Insulin Aspart 30 in Type 2 DiabetesCOMPLETEDPHASE21997-041998-111998-11
NCT01734486Growth Response in Girls With Turner SyndromeCOMPLETEDPHASE41996-09-232003-05-212003-05-21
NCT01707160Pharmacokinetics and Pharmacodynamics of Biphasic Insulin Aspart 30 in Healthy VolunteersCOMPLETEDPHASE11995-111995-121995-12
NCT00464971Evaluation of Safety and Efficacy of 17-Beta Estradiol in Treatment of Atrophic Vaginitis: An Extension TrialCOMPLETEDPHASE31995-01-311996-11-301996-11-30
NCT00465192Efficacy and Safety of 17-Beta Estradiol in Treatment of Atrophic VaginitisCOMPLETEDPHASE31994-08-311995-11-301995-11-30
NCT01697644Growth Hormone Treatment of Children Diagnosed of Intrauterine Growth RetardationCOMPLETEDPHASE41990-102005-052005-05
NCT01529840Somatropin Effect on Linear Growth and Final Height in Subjects With Noonan SyndromeCOMPLETEDPHASE31990-062005-092005-09
NCT00410033Comparison of Antibody Levels in Children and Adolescents After Initiation of Insulin Therapy by Either Insulin Aspart or Soluble Human InsulinCOMPLETEDNA1989-122006-052006-05
NCT01518062Safety of Somatropin and Induction of Puberty With 17-beta-oestradiol in Girls With Turner SyndromeCOMPLETEDPHASE41989-112003-092003-09
NCT01518036Use of Somatropin in Turner SyndromeCOMPLETEDPHASE31987-09-142004-04-112004-04-11